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Foreword
On the occasion of the International Pharmaceutical Federation’s 100th anniversary, a number 
ofcrucial initiatives are taking place towards advancing pharmacy practice, science and education,
including holding a Ministers Summit on the Added Value of the Responsible Use of Medicines. 
In recognition of our past 100 years of achievement, this 2012 Global Pharmacy Workforce Report
serves as an important reminder of the efforts that national professional and scientific associations,
governments and academic institutions have made - and continue to make - to prepare a competent
pharmacy workforce that adds value to health care systems through ensuring the responsible use 
of medicines.
Findings from this report clearly show that professional associations are important stakeholders 
in advancing the pharmacy workforce. Collaboration between Ministries of Health, Ministries 
of Education, educational institutions and professional associations pave the way to better plan 
and coordinate a pharmacy workforce that can respond to the current and future needs of the local
population. Political will and investment are crucial aspects to secure pharmacy human resource 
capacity building. If the pharmacy workforce is to add value through responsible medicines
use, the workforce must be present in sufficient numbers and with the competencies required 
to fulfil the needs of the local population.
We hope that this report will serve as a valuable evidence based instrument to stimulate further
research, discussion and policy action.
This report was only possible with the support of over 120 contributors across 90 countries 
and territories from pharmacy professional and regulatory bodies, schools of pharmacy, research 
centres, agencies, and pharmaceutical service providers who generously gave their time to obtain 
data and share their experiences. Thank you also to members of the Report Working Group, FIP 
volunteers and World Health Organization staff, for their leadership, close collaboration and extensive
input to make this report a reality. On behalf of FIP, I would like to express our sincere appreciation 
of the efforts made by all contributors.
Michel Buchmann, PhD
President
International Pharmaceutical Federation (FIP)
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• A needs-based education strategy allows local systems to   
  best assess the needs of its community and then develop   
  (or adapt) the supporting educational system to produce 
  a workforce relevant to these needs. National health care   
  demands are diverse and complex, often varying widely 
  within and between regions. Although broad and general 
  frameworks may be beneficial at the macro level, a “one-size 
  fits-all” system does not offer the authenticity needed for full   
  engagement and sustainability at the local level.
• Pharmaceutical Human Resources continue to be a priority 
  issue for FIP Education initiatives (FIPEd) to engage 
  collaboratively with all stakeholders; we need to work 
  together towards developing a profession that can meet  
  present and future societal and pharmaceutical health 
  needs around the world.  
  (www.fip.org/education)
KEY MESSAGES
.................................................................................
• Access to quality medicines and competent, capable health     
  care professionals are fundamental aspects of any health 
  care system. Pharmaceutical human resources should ensure 
  the uninterrupted supply of quality medicines to the 
  population, their management, and responsible use, as vital    
  components in improving the health of nations.
• Multi-stakeholder collaboration incorporating best available 
  evidence is required to inform needs-based pharmaceutical 
  human resources planning. When relevant, well-informed 
  stakeholders partner to address workforce issues, there 
  are greater possibilities for coordinated workforce planning 
  and implementation.
• Pharmacy workforce per capita varies considerably between   
  countries and regions and generally correlates with country   
  level economic development indicators. Countries 
  and territories with lower economic indicators, such as those   
  Africa, tend to have relatively fewer pharmacists 
  and pharmacy support workers. This has implications 
  for observed inequalities in access to medicines 
  and medicines expertise. In addition, some countries 
  and territories have many times more pharmacies than 
  pharmacists, which may imply a renewed need for 
  supervision of medicines and medicines use.
• Strategic frameworks and policies related to the pharmacy   
   workforce are being successfully developed and implemented 
   at the country level through multi-stakeholder processes 
   involving ministries of health, health professional associa  tions,  
   regulators, and educators to drive and achieve both 
   competence and practitioner excellence for care quality.
• Improving workforce performance productivity, capability 
  and the ability to adapt to new roles is an on going challenge 
  in the increasingly dynamic environment of rising health care 
  costs, increased demand for health services, and increased 
  burden of chronic diseases. Fuelled in part by an increased 
  focus on patient care and inter-professional collaboration, 
  these elements provide the opportunity for pharmacists to 
  use their professional skills to provide safe, high quality, and 
  cost-effective pharmaceutical services for the benefit of 
  populations. Leadership is a key aspect in empowering 
  pharmacy professionals to maximize these opportunities and  
  to innovate and shape their practice.
• Investment in transforming and scaling up professional  
  education is crucial, as education provides the foundation 
  for building a capable health care workforce. The capacity to 
  provide pharmaceutical services in each country is 
  dependent upon having an assured, competent workforce  
  and an integrated academic workforce to train sufficient  
  numbers of new pharmacists and other support staff at both 
  foundation and advanced levels. Ongoing effort is needed to   
  ensure capacity building of skilled medicines expertise meets  
  the pharmaceutical health needs of populations.
PART 1
The Kampala Declaration and Agenda for Global Action in 
2008 [5] acknowledges that the highest attainable standard of 
health is a fundamental human right, and highlights the need 
for immediate action to resolve the accelerating global health 
workforce crisis. It calls for concerted governmental, civil 
society, private sector, and professional organisation action to 
ensure that health workforce issues are addressed. 
The G8 Communiqué of July 2008 [6] states that members will 
work towards increasing health workforce coverage towards 
the WHO threshold of 2.3 health workers per 1000 people. 
It also supports efforts by partner countries and relevant 
stakeholders in developing robust health workforce plans and 
establishing specific, country-led milestones.
The WHO report on social determinants of health [7] 
recognises that a competent, supported health workforce 
is fundamental to developing robust health systems and for 
reaching health and development goals. It calls for whole system 
action on social determinants of health that must involve the 
government, civil society and local communities, business, global 
fora, and international agencies. It states that to be effective 
policies and programmes must embrace all sectors of society not 
just the health sector - and that providing more health workers 
alone will not reduce health inequalities.
The High-level Taskforce on Innovative International 
Financing for Health Systems [8] calls for different 
mechanisms for financing national health care systems in 
order to meet the MDGs. The Venice statement on maximizing 
positive synergies between health systems and global health 
initiatives [9] makes a number of recommendations and calls 
for the health systems strengthening agenda to be infused 
with a sense of ambition, scale, speed, and increased resources 
and to promote country capacity for strong national planning 
processes and better alignment of resources with national 
planning processes.
In many countries, pharmacists are the most accessible of all 
health care workers and as such play a key role in the delivery 
of health care services, particularly the safe distribution of 
medicines at all levels. In an era of rapidly accelerating change 
in health care delivery, the roles of pharmacists are constantly 
being redefined, as roles, competency, and training 
requirements change. Thus, understanding the current work-
force and the factors that influence it are key components to 
human resource planning in pharmacy. As the recent report 
from the Office of The Chief Pharmacist to the US Surgeon 
General states, a health system improvement that is well sup-
ported by the evidence-base is to maximize the expertise and 
scope of pharmacists and minimize expansion barriers for an 
already existing and successful health care delivery model [10].
INTRODUCTION
.................................................................................
Authors
Claire Anderson, Professor of Social Pharmacy and Tapash Roy, 
Research Associate, Division of Social Research in Medicines 
and Health, School of Pharmacy, University of Nottingham, UK.
Summary
• Increased demand for health services and increasing 
   expectations for service delivery have a significant effect in   
   shaping workforce dynamics.
• Contemporary issues surrounding the global pharmacy 
   workforce identified from the literature include the 
   importance of working conditions and job satisfaction on   
   retention, workforce development and revalidation, wide
   ranging supply and demand factors affecting the workforce   
   and migration.
• To support growth in the establishment of pharmacy practice 
   and its aspiration for increased patient focused care, work
   force needs and other trends will need to be factored into 
   pharmaceutical service development plans.
2.1 The global policy context
The world’s health workforce is facing significant challenges.
With an estimated shortage of more than four million health 
workers worldwide, the global health workforce crisis is possibly 
the greatest health system constraint on countries seeking to 
meet their 2015 Millennium Development Goals (MDGs). 
Increased demand for health services and increasing 
expectations for service delivery have had a significant effect in 
shaping labour market dynamics. As a result, health workforce 
issues have generated huge interest and international action to 
bring about change. The publication of the World Health Report 
in 2006 [1] highlighted health workforce issues and stimulated 
widespread investigation and international action to bring about 
this change. This report was a major driving force for expansion 
of the international health workforce in order to meet the health 
related Millennium Development Goals. There have since been a 
number of calls to action. The 2008 World Health Report [3] 
states that the health workforce shortages and inefficiencies are 
also seriously hampering effective implementation of primary 
health care. The 2010 World Health Report [4] identifies that 
health workforce shortages are hindering the expansion of health 
service coverage and calls for more efficient and equitable use 
of financial resources. The 2011 WHO resolution on health 
workforce strengthening recognises the centrality of human re-
sources for health to the effective operation of health systems [2].
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Recent focus on the pharmacy workforce in Australia, Canada, 
Great Britain, and the USA [11-18]; the 2006 and 2009 FIP Global 
Pharmacy Workforce reports [19,20]; and a systematic review 
of the literature [21] add to our understanding of the complex 
issues that countries face. It is not just a simple case of supply 
and demand. There is also a need for countries to model their 
workforce needs based on predicted future provision of 
services and care, roles and responsibilities of the pharmacy 
support workforce, increased use of technology, the 
advancement of biotechnology and personalised medicine, 
demographic changes, and future patterns of working all while 
ensuring there is a sustainable academic workforce to 
maintain the supply of suitably trained pharmacists. 
2.2 Systematic review of the literature 
on the pharmacy workforce 
A systematic review of the literature from January 2006 to 
March 2012 was undertaken that focuses upon the issues 
facing the expansion of the global pharmacy workforce. 
Contemporary issues surrounding the global pharmacy 
workforce and, more specifically, the published methods used 
to expand the workforce were systematically identified and 
reviewed. One hundred and nine studies were included in the 
review, to be published separately. Findings from the review 
(in press) are summarised below.
Working conditions and job satisfaction
The level of job satisfaction among pharmacy personnel 
is an important indicator of staff turnover and retention. 
The primary determinants of job satisfaction were intrinsic 
aspects of the job; that is, factors that make people satisfied 
are the work that they do or the way in which they are used. 
A number of studies found female pharmacists hold high 
levels of job satisfaction compared with their male 
counterparts. Job position was consistently found to be a 
significant predictor of job satisfaction. Other factors 
identified as increasing pharmacist retention were good 
remuneration, good relationships with co-workers, and flexible 
schedules. Factors increasing staff turnover included high 
stress, insufficient or unqualified staff, and poor salary. 
Further, job stress and excessive workload negatively affect 
job satisfaction. Evidence also suggests that pharmacists 
engaged in shift work might present unique characteristics, 
which has implications for labour supply and pharmacy 
services delivery.
Workforce development: 
education, training, and leadership
Continuing professional development (CPD) has the potential 
to be useful in pharmacy workforce revalidation. Time, finan-
cial costs, resource issues, understanding of CPD, facilitation      
.................................................................................
and support for CPD, motivation and interest in CPD, attitudes 
towards compulsory CPD, system constraints, and technical 
problems were identified as key barriers to CPD. Pharmacy 
professionals on the whole agreed with the principle of 
engaging with CPD, but there was little evidence to suggest 
widespreadand wholehearted acceptance and uptake of CPD, 
essential for revalidation. Direct experience of effective CPD in 
the absence of perceived barriers could impact personal and 
professional development and patient benefit, thus 
strengthening personal beliefs in the value of CPD.
Supply and demand issues: Current status 
and future directions
Increased demand and limited supply of pharmacists 
constrains the ability of the workforce to expand. 
Many different supply and demand factors that influence the 
pharmacy profession were identified, the majority of which 
were common to most countries. The most common factors 
increasing demand for pharmacists were increased 
feminisation, increased clinical governance measures through 
continually reviewing and improving the quality of patient 
care, increased numbers of prescriptions, and increased 
complexity of medication therapy. The most common factors 
mitigating demand for pharmacists included increased use of 
technology, expansion in the numbers and roles of pharmacy 
technicians, and increased numbers of pharmacy graduates.
Pharmacy workforce migration
There is greater migration from less-developed countries to 
more-developed countries. The pharmacist workforce from 
African and Asian countries was disproportionately affected 
by migration. A significant number of pharmacists from 
developing countries migrate to the developed world; 
however, the extent of such migration was not properly 
captured. Postulated reasons for migration include better 
remuneration, joining or supporting family, political and social 
instability, poor living conditions, poor working conditions 
and management, unsafe environment, further training and 
qualifications, and job opportunities and satisfaction.
2.3 Conclusion
This systematic review updates and builds a better 
understanding of the current challenges affecting the global 
pharmacy workforce in ensuring equitable access and 
responsible use of safe, effective and quality medicines. 
This review complements findings from the 2012 Global 
Pharmacy Workforce Survey on workforce composition and 
expands on findings from the 2006 and 2009 workforce reports.
.................................................................................
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issues that countries face. It is not just a simple case of supply 
and demand. There is also a need for countries to model their 
workforce needs based on predicted future provision of 
services and care, roles and responsibilities of the pharmacy 
support workforce, increased use of technology, the 
advancement of biotechnology and personalised medicine, 
demographic changes, and future patterns of working all while 
ensuring there is a sustainable academic workforce to 
maintain the supply of suitably trained pharmacists. 
2.2 Systematic review of the literature 
on the pharmacy workforce 
A systematic review of the literature from January 2006 to 
March 2012 was undertaken that focuses upon the issues 
facing the expansion of the global pharmacy workforce. 
Contemporary issues surrounding the global pharmacy 
workforce and, more specifically, the published methods used 
to expand the workforce were systematically identified and 
reviewed. One hundred and nine studies were included in the 
review, to be published separately. Findings from the review 
(in press) are summarised below.
Working conditions and job satisfaction
The level of job satisfaction among pharmacy personnel 
is an important indicator of staff turnover and retention. 
The primary determinants of job satisfaction were intrinsic 
aspects of the job; that is, factors that make people satisfied 
are the work that they do or the way in which they are used. 
A number of studies found female pharmacists hold high 
levels of job satisfaction compared with their male 
counterparts. Job position was consistently found to be a 
significant predictor of job satisfaction. Other factors 
identified as increasing pharmacist retention were good 
remuneration, good relationships with co-workers, and flexible 
schedules. Factors increasing staff turnover included high 
stress, insufficient or unqualified staff, and poor salary. 
Further, job stress and excessive workload negatively affect 
job satisfaction. Evidence also suggests that pharmacists 
engaged in shift work might present unique characteristics, 
which has implications for labour supply and pharmacy 
services delivery.
Workforce development: 
education, training, and leadership
Continuing professional development (CPD) has the potential 
to be useful in pharmacy workforce revalidation. Time, finan-
cial costs, resource issues, understanding of CPD, facilitation      
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and support for CPD, motivation and interest in CPD, attitudes 
towards compulsory CPD, system constraints, and technical 
problems were identified as key barriers to CPD. Pharmacy 
professionals on the whole agreed with the principle of 
engaging with CPD, but there was little evidence to suggest 
widespreadand wholehearted acceptance and uptake of CPD, 
essential for revalidation. Direct experience of effective CPD in 
the absence of perceived barriers could impact personal and 
professional development and patient benefit, thus 
strengthening personal beliefs in the value of CPD.
Supply and demand issues: Current status 
and future directions
Increased demand and limited supply of pharmacists 
constrains the ability of the workforce to expand. 
Many different supply and demand factors that influence the 
pharmacy profession were identified, the majority of which 
were common to most countries. The most common factors 
increasing demand for pharmacists were increased 
feminisation, increased clinical governance measures through 
continually reviewing and improving the quality of patient 
care, increased numbers of prescriptions, and increased 
complexity of medication therapy. The most common factors 
mitigating demand for pharmacists included increased use of 
technology, expansion in the numbers and roles of pharmacy 
technicians, and increased numbers of pharmacy graduates.
Pharmacy workforce migration
There is greater migration from less-developed countries to 
more-developed countries. The pharmacist workforce from 
African and Asian countries was disproportionately affected 
by migration. A significant number of pharmacists from 
developing countries migrate to the developed world; 
however, the extent of such migration was not properly 
captured. Postulated reasons for migration include better 
remuneration, joining or supporting family, political and social 
instability, poor living conditions, poor working conditions 
and management, unsafe environment, further training and 
qualifications, and job opportunities and satisfaction.
2.3 Conclusion
This systematic review updates and builds a better 
understanding of the current challenges affecting the global 
pharmacy workforce in ensuring equitable access and 
responsible use of safe, effective and quality medicines. 
This review complements findings from the 2012 Global 
Pharmacy Workforce Survey on workforce composition and 
expands on findings from the 2006 and 2009 workforce reports.
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Summary
• The 2012 FIP Global Pharmacy Workforce Survey is a tool that  
   is used to collect data on the pharmacy workforce at the 
   country level, with the objective of analysing and monitoring 
   the status of the pharmacy workforce and pharmacy education.
• The survey was conducted using English, French and Spanish 
   on-line submission forms; workforce data was received for 
   90 countries and territories representing 2.5 million 
   pharmacists and nearly one and half million technicians 
   and support cadres (available for download from 
   www.fip.org/humanresources.
• Pharmacy workforce density varies considerably between 
   countries and WHO regions and generally correlates with 
   population numbers and country level economic 
   development indicators. Those countries and territories 
   with lower economic indicators tend to have relatively 
   fewer pharmacists and pharmacy technicians.
• African countries tended to have lower densities of pharmacists, 
   pharmacy technicians and support cadres, and also pharmacies. 
   This shortage has implications for inequalities in access to 
   medicines and medicines expertise. Ongoing efforts are needed  
   to ensure capacity building of skilled medicines expertise to  
   meet the pharmaceutical health needs of populations. In 
   addition, some countries and territories have many times more  
   pharmacies than pharmacists, which may imply a renewed need  
   for supervision of medicines and medicines use in these 
   geographies.
• The proportion of the female workforce is a majority globally, 
   with some regions having an average female workforce of 
   more than 65%.
• Most pharmacists are employed in community retail 
   pharmacy, followed by hospital, industry, research and 
   academia, and regulation. The distribution across sectors 
   varies among countries though regional trends can be seen.
3.1 Introduction and methods
The 2012 FIP Global Pharmacy Workforce Survey was conducted 
between September 2011 and June 2012; the objective of the 
survey being to analyse, monitor and report on the status of the 
pharmacy workforce and pharmacy education. 
GLOBAL PHARMACY 
WORKFORCE DESCRIPTION
PART 3
.................................................................................
FIP Member Organisations, and respondents to the 2009 FIP 
Global Pharmacy Workforce Survey together with other 
contacts for professional bodies, regulatory bodies and
 universities were approached to provide country-level data.
The survey was developed in collaboration with the FIP 
Collaborating Centre, University College London, School of 
Pharmacy and the FIP Education Initiatives (FIPEd) Working 
Group on Pharmaceutical Sector Human Resources. The survey 
sought data relating to pharmacy education, workforce and 
relevant regulations for both pharmacists and pharmacy 
technicians and was available in English, French and Spanish. 
The dataset was cleaned and checked with respondents before 
being prepared for analysis. The survey tool, data table, and 
the final report are available for download from www.fip.org/
humanresources.
A total of 90 countries and territories responded to the survey, 
an increase on 56 respondent countries from the 2009 report. 
Of these 90 countries and territories, 10 were from the Pacific 
Island nations; due to low relative frequencies these countries 
were aggregated into a single Pacific Island Countries (PIC) 
case entity for analysis in the 2012 report. The subsequent 
aggregated count for the 2012 report is 80 cases. The total case 
load represents around three-quarters of the current world 
population and around half of all UN member states. 
The data collection was conducted using multiple languages 
and this has assisted with country level engagement for the 
2012 report compared with previous reports. The analysis 
presented here should be interpreted within the confines of 
generalisation and based on best available validated data 
collated by the FIPEd team. A listing of contributing countries 
and territories is supplied in Annex 1.
Table 3.1 shows the respondent countries and territories 
categorised by WHO region, compared with the formal listing 
of all WHO member states, showing good proportionality 
between the FIP country and territory level responses and the 
global WHO member states.
Table 3.1. Respondent frequencies by WHO region
.................................................................................
3.2 Global overview: The pharmacy workforce and global comparisons
The case load (n=90 countries and territories) comprises descriptive data covering around 2.5 million pharmacists and 1.4 
million pharmacy technicians (or equivalent). There are strong correlations with total pharmacists and technicians and country 
population (Figure 3.1, R2 = 0.36, p<0.0001 and R2 = 0.45, p<0.0001 respectively). In both cases, African countries tend to have data 
that shows a greater tendency for fewer pharmacists and support cadres per country population, a human resource for health 
situation also replicated in other health care professions (see also Figure 3.2).
A more standardised measure is to use the population density of pharmacists (presented as per 10,000 population), which varies 
considerably between countries and territories ranging from 0.02 (Somalia) to 25.07 (Malta), with the mean of the 82 countries 
and territories (sample mean) being 6.02 pharmacists/10,000 population. Figure 3.2 presents the global density of pharmacists per 
country or territory per 10,000 population. African nations by comparison, have significantly fewer pharmacists per capita.
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In most countries and territories, there is a greater density of pharmacists than pharmacies. However, some have many times 
more pharmacies than pharmacists (Afghanistan, Bangladesh, Bhutan, Burundi, India, Nepal, Pakistan, Somalia, Vietnam and 
Zambia; see also Figure 3.4), flagging the issue of appropriate supervision of pharmaceutical services. Figure 3.3 shows the 
density of both pharmacists and pharmacies by WHO region for comparison. Regions with fewer pharmacists tend to have 
more pharmacies per capita – showing as a smaller gap between pharmacists and pharmacies per capita.
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There is a correlation between the density of pharmacies (facilities that dispense medicines) and pharmacists (Figure 3.4). 
Countries with higher densities of pharmacists also tend to have higher densities of pharmacies (R2 = 0.38, p < 0.001). 
African countries lack both pharmacies and pharmacists, which has implications for access to medicines given the 
inadequate availability (and likely inequitable distribution) of access points and skilled workforce.
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Figure 3.4. Pharmacists and pharmacies per 10,000 population
(n=76 countries and territories)
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There are also relationships between the economic status of a country as measured by Gross National Income (GNI) per capita, 
health expenditure per capita, and pharmacist densities (Figure 3.5). There is an implication that spending on health and 
pharmacist availability are functions of economic development. Pharmacist density regresses independently with GNI.
[GNI and Health expenditure data source: World Bank 2011. GNI and health expenditure adjusted for purchasing power parity 
(PPP) in US$]
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The relationship of workforce with economic indicators is also shown by mapping pharmacists per capita with World Bank  
classification. There is a linear association with standardised pharmacist numbers and World Bank classification (Figure 3.6). 
There are demographic similarities with the lower-middle and upper-middle categories, but large differences between low income 
and high income. The gap between pharmacists and pharmacies also increases with economic income, perhaps as a result of greater 
role opportunities for pharmacists in high-income nations. The density of pharmacies is greater than that of pharmacists in 
low-income countries and territories, suggesting medicines access and supply challenges in these economic environments.
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Total licensed pharmacist frequencies may not be representative of the active workforce. Survey data captured frequencies 
of active establishment and compared this with total registrants (expressed as a ratio of ‘active:registered’). The ratio of actively 
practicing pharmacists to registered is described in Figure 3.7. The proportion of pharmacists that are actively practicing ranges 
from 8% to 100% (n=69 countries and territories). There are significant mean differences between WHO regions in this ratio, 
with Southeast Asia and Western Pacific having the lowest means, and the Americas and Europe having the highest (Table 3.2). 
It is important to consider discrepancies between the practicing and registered workforce to obtain greater accuracy 
in workforce planning.
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Figure 3.7. Ratio of active to total pharmacist workforce
 by country (n=69 countries and territories)
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Table 3.2. Active: Registered workforce
 ratios by WHO region. 
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The relationship of workforce with economic indicators is also shown by mapping pharmacists per capita with World Bank  
classification. There is a linear association with standardised pharmacist numbers and World Bank classification (Figure 3.6). 
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role opportunities for pharmacists in high-income nations. The density of pharmacies is greater than that of pharmacists in 
low-income countries and territories, suggesting medicines access and supply challenges in these economic environments.
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Total licensed pharmacist frequencies may not be representative of the active workforce. Survey data captured frequencies 
of active establishment and compared this with total registrants (expressed as a ratio of ‘active:registered’). The ratio of actively 
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Global workforce gender distribution
The proportion of workforce gender mix shows increased ratios of females in the profession; this is now an average of 54.9% 
(range 4.8% to 92.4%). However, the country level distribution shows a varied picture (Figure 3.8). There is also variance between 
WHO regions (Figure 3.9).
This change in proportion in favour of women suggests that pharmacy, as a professional qualification and career, remains 
attractive for women. Evolving roles towards more patient-facing roles could be one factor, in addition to greater flexibility 
of career structures and breaks.
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Workforce distribution by sector
The 2012 global sample reveals that, on average, 55% of pharmacists were found to work in community pharmacy enviroments, 
18% in hospitals, 10% in industry, 5% in research and academia and 5% in regulation. The African region has less than 5% of 
its workforce employed in the pharmaceutical industry, in contrast to the Southeast Asian region where the pharmaceutical 
industry employs up to 30% of the pharmacist workforce (Figure 3.10). The European region has the highest proportion of the 
pharmacy workforce working in community settings.
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   train and support sufficient numbers of new pharmacists and  
   other members of the support workforce at both basic and   
   advanced levels.
• There remains variance in the scope and range of pharmacy 
   education quality assurance systems. An adaptable quality 
   assurance framework has been developed and adopted by FIP.
   Advocacy continues to encourage systems to improve quality 
   assurance and accreditation of pre-service education.
• Ensuring mechanisms for assured practitioner competence 
   (and ultimately performance) and expert practice is now a 
   key goal for pharmacy education policy. Systems and 
   Continuing Professional Development (CPD) support should   
   be oriented to enable competency-based lifelong 
   development for all practitioners.
• Increased focus needs to be placed on building a competent 
   pharmacy support workforce, on developing leadership 
   across pharmacy education and on ensuring that there is a 
   greater sharing, reporting and publishing of education 
   innovations and research.
4.1 Advancing pharmacy education globally
FIP Education Initiatives (FIPEd) is the umbrella 
directorate bringing together all of FIP’s education focused 
actions, strengthening projects and partnerships with WHO 
and UNESCO.
FIPEd comprises the Academic Institutional Membership (AIM), 
the Academic Pharmacy Section (AcPS) and the Pharmacy 
Education Taskforce (PET). FIPEd advocates for the use of 
needs-based education and training strategies (Figure 4.1) 
where pharmacy education provision is socially accountable, 
practice and science are evidence-based and practitioners 
have the required competencies to provide needs-based
 services to their communities.
FIPEd provides a global platform for exchange, providing 
mentorship and learning opportunities for academics and 
students, as well as the development of leadership and 
management, and pedagogic skills. FIPEd builds on, advocates 
for, and disseminates evidence-based guidance, 
consensus-based standards, tools, and resources for 
educational development and quality assurance. It also 
develops and facilitates education-related policy that supports 
advancement of the profession. FIPEd also advocates for and 
works with stakeholders at global, regional, and local levels.
Building on the success of the 2008-2010 Action Plan [1] the 
current domains (www.fip.org/education_taskforce) of activity 
will continue to develop and grow in a sustainable way.
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Summary
• As part of a tri-partite agreement, the International 
   Pharmaceutical Federation (FIP), World Health Organization 
   (WHO), and United Nations Educational, Scientific and 
   Cultural Organization (UNESCO) endorsed the establishment  
   of the Global Pharmacy Education Taskforce (PET). The 
   Taskforce was officially launched at the 1st Global Health 
   Workforce Alliance meeting of the WHO in Kampala in 2008.
• The Pharmacy Education Taskforce has successfully
   implemented its 2008-2010 Action Plan, providing 
   evidence-based support to facilitate needs-based pharmacy   
   education development. A work plan for 2011/2012 was 
   developed to continue and expand the work, as well as a    
   strategic vision for 2012 and beyond.
• FIP Education Initiatives (FIPEd) was established by FIP in 
   2011, bringing together and building on all of FIP’s 
   education-focused activities, with the aim of stimulating 
   transformational change in pharmacy education and 
   facilitating the development of the profession, towards 
   meeting present and future societal and pharmacy workforce 
   needs around the world (www.fip.org/education).
• The capacity to provide pharmacy services in each country is 
   dependent upon having an assured, competent, and capable 
   workforce and a similarly integrated academic workforce to 
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   train and support sufficient numbers of new pharmacists and  
   other members of the support workforce at both basic and   
   advanced levels.
• There remains variance in the scope and range of pharmacy 
   education quality assurance systems. An adaptable quality 
   assurance framework has been developed and adopted by FIP.
   Advocacy continues to encourage systems to improve quality 
   assurance and accreditation of pre-service education.
• Ensuring mechanisms for assured practitioner competence 
   (and ultimately performance) and expert practice is now a 
   key goal for pharmacy education policy. Systems and 
   Continuing Professional Development (CPD) support should   
   be oriented to enable competency-based lifelong 
   development for all practitioners.
• Increased focus needs to be placed on building a competent 
   pharmacy support workforce, on developing leadership 
   across pharmacy education and on ensuring that there is a 
   greater sharing, reporting and publishing of education 
   innovations and research.
4.1 Advancing pharmacy education globally
FIP Education Initiatives (FIPEd) is the umbrella 
directorate bringing together all of FIP’s education focused 
actions, strengthening projects and partnerships with WHO 
and UNESCO.
FIPEd comprises the Academic Institutional Membership (AIM), 
the Academic Pharmacy Section (AcPS) and the Pharmacy 
Education Taskforce (PET). FIPEd advocates for the use of 
needs-based education and training strategies (Figure 4.1) 
where pharmacy education provision is socially accountable, 
practice and science are evidence-based and practitioners 
have the required competencies to provide needs-based
 services to their communities.
FIPEd provides a global platform for exchange, providing 
mentorship and learning opportunities for academics and 
students, as well as the development of leadership and 
management, and pedagogic skills. FIPEd builds on, advocates 
for, and disseminates evidence-based guidance, 
consensus-based standards, tools, and resources for 
educational development and quality assurance. It also 
develops and facilitates education-related policy that supports 
advancement of the profession. FIPEd also advocates for and 
works with stakeholders at global, regional, and local levels.
Building on the success of the 2008-2010 Action Plan [1] the 
current domains (www.fip.org/education_taskforce) of activity 
will continue to develop and grow in a sustainable way.
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Summary
• As part of a tri-partite agreement, the International 
   Pharmaceutical Federation (FIP), World Health Organization 
   (WHO), and United Nations Educational, Scientific and 
   Cultural Organization (UNESCO) endorsed the establishment  
   of the Global Pharmacy Education Taskforce (PET). The 
   Taskforce was officially launched at the 1st Global Health 
   Workforce Alliance meeting of the WHO in Kampala in 2008.
• The Pharmacy Education Taskforce has successfully
   implemented its 2008-2010 Action Plan, providing 
   evidence-based support to facilitate needs-based pharmacy   
   education development. A work plan for 2011/2012 was 
   developed to continue and expand the work, as well as a    
   strategic vision for 2012 and beyond.
• FIP Education Initiatives (FIPEd) was established by FIP in 
   2011, bringing together and building on all of FIP’s 
   education-focused activities, with the aim of stimulating 
   transformational change in pharmacy education and 
   facilitating the development of the profession, towards 
   meeting present and future societal and pharmacy workforce 
   needs around the world (www.fip.org/education).
• The capacity to provide pharmacy services in each country is 
   dependent upon having an assured, competent, and capable 
   workforce and a similarly integrated academic workforce to 
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Figure 4.1. Needs-based professional educational model (PET 2008-present)
The global workforce needs to be competent, capable, 
adaptable, and oriented to a medicinescentered, 
patient-focused approach, with development and professional 
practice, centred on the tenets of needs-based education [2-5].
For health care professionals, the capability to improve 
therapeutic outcomes, patients’ quality of life, scientific 
advancement, and public health imperatives is dependent on 
a foundation of sound education and training [3]. Likewise, a 
capable practitioner workforce is an essential pre-requisite 
for all health care professions, and pharmacy is no exception. 
Evolving roles towards more patientfocused service provision 
have been a steady trend in the last two decades. Modern, 
contemporary forms of initial education and training are vital 
for professions to be able to meet the increasingly complex 
health care demands of populations [4-7]. Additionally, there 
is a need to understand national priorities and the resource 
requirements and constraints that are present in all national 
economies, and to be able to describe the context and need 
for pharmacy education within these economies. Globally, this 
requires a coordinated and multi-system approach to the 
continued development of intelligent planning, supply, and 
initial and advanced training and education to prepare the 
pharmacy workforce for such roles.
When using the term pharmacy education, it is to be understood 
that this refers to the educational design and capacity to develop the 
workforce for a diversity of settings (e.g. community, hospital, 
research and development, academia) across varying levels of 
service provision and competence (e.g. pharmacy support staff/
workforce, pharmacists and pharmaceutical scientists) and scope 
of education (e.g. undergraduate, post-graduate, life-long learning). 
This multi-dimensional conceptualization embodies a systematic 
approach to education development that enables and supports a 
capable and flexible workforce to provide access to medicines 
 expertise and to effectively improve the health of nations.
Pharmacy education worldwide continues to have many issues 
that challenge the quality of teaching and learning at a time 
when there are limited resources to meet these challenges. 
The data in this report provides evidence that there is a global 
scarcity of qualified pharmacists to provide patient care at a time 
when there are more opportunities for pharmacists to expand 
their roles and responsibilities [8]. From this perspective, 
pharmacy is no different from other health care professions. 
FIPEd and the associated Pharmacy Education Taskforce (PET), 
advocates for professional needs-based education, working in 
partnership with the UNESCO and WHO [6,7].
PET currently oversees the implementation of the Work Plan 
2011/2012, which continues the work initially developed by the 
2008-2010 Action Plan [1,9]. The Work Plan is oriented towards 
identifying locally-determined needs and using this 
information to facilitate comprehensive education 
development and achievement of the competencies required 
to provide the local services (Figure 4.1). The domains for 
action prioritised in the work plans relate to developing a 
pharmacy education vision and framework, preparing the 
pharmacy workforce, and integrating quality assurance and 
education leadership for these efforts. From these domains, 
five project teams have been created to support the areas 
of (1) vision and competency, (2) academic and institutional 
capacity, (3) quality assurance, (4) pharmacy support worforce, 
and (5) educational leadership. The leadership for these project 
teams comes from PET, which serves as the coordination, 
analysis, and dissemination hub. It includes both a core of key 
stakeholders and a dynamic shell of voluntary regional 
collaborators.
4.2 Pharmacy education capacity 
and training institution distribution
The supply side of the workforce capacity pipeline is clearly 
important, and valid data about institutional capacity for 
providing initial education and training are critical in order to 
provide workforce intelligence for the profession. This section 
aims to provide comparative data on the supply side capacity 
challenges in order to provide indicators for planning at global 
and regional levels. The data presented here are concerned 
with capacity; competence and quality are dealt with in 
subsequent sections. It is clear that nations will need sufficient 
numbers of students in initial education programmes to 
provide for a future capable workforce; in addition, the 
academic establishment data also need to be determined. 
Without an adequate academic workforce, there cannot be a 
competent and capable health care workforce.
Education-related data from this survey are derived from a 
total of 90 country/territory level responses across a number 
of variables. Three countries in our sample reported they had 
no university-based schools of pharmacy and 14 (19%) reported 
only a single national pharmacy school. Conversely USA  
reported 127 accredited schools and India reported 1400. The 
sample reported a total of 2347 schools of pharmacy from 82 
countries and territories, of which 1568 were reported as 
accredited. The reported academic workforce (as a proportion of 
the total pharmacy workforce) ranges from 0.1% (China) to 35.7% 
(Cameroon) with a sample mean of 5.2% of the workforce.
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The respondents reported a total of 58,239 (n=54 countries and territories) pharmacy graduates per year, with a sample mean 
of 71.4 graduates per year per school. Figure 4.2 shows the country and territory level production of newly qualified graduate 
pharmacists per year (for available data).
There is a strong correlation with numbers of institutions providing initial pharmacy education and the country and territory 
level population. Institutional and national infrastructures for pharmacy education and training tend to be aligned with 
population size, although many African nations are situated below the regression line (Figure 4.4). The Figure 4.5 illustrates the 
total number of pharmacy schools and total number of pharmacy technician training schools (n= 46 countries and territories).
There is also variance associated with length of education and training programmes leading up to registration. Figure 4.3 shows 
both the length of time for the full-time undergraduate period and any additional time for internship (or pre-registration) periods 
before licensing of the practitioner. 
.................................................................................
Figure 4.2. Country and territory level graduates in pharmacy per year
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Figure 4.3. Undergraduate and internship periods of initial education
 for pharmacists (n=82 countries and territories)
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Figure 4.1. Needs-based professional educational model (PET 2008-present)
The global workforce needs to be competent, capable, 
adaptable, and oriented to a medicinescentered, 
patient-focused approach, with development and professional 
practice, centred on the tenets of needs-based education [2-5].
For health care professionals, the capability to improve 
therapeutic outcomes, patients’ quality of life, scientific 
advancement, and public health imperatives is dependent on 
a foundation of sound education and training [3]. Likewise, a 
capable practitioner workforce is an essential pre-requisite 
for all health care professions, and pharmacy is no exception. 
Evolving roles towards more patientfocused service provision 
have been a steady trend in the last two decades. Modern, 
contemporary forms of initial education and training are vital 
for professions to be able to meet the increasingly complex 
health care demands of populations [4-7]. Additionally, there 
is a need to understand national priorities and the resource 
requirements and constraints that are present in all national 
economies, and to be able to describe the context and need 
for pharmacy education within these economies. Globally, this 
requires a coordinated and multi-system approach to the 
continued development of intelligent planning, supply, and 
initial and advanced training and education to prepare the 
pharmacy workforce for such roles.
When using the term pharmacy education, it is to be understood 
that this refers to the educational design and capacity to develop the 
workforce for a diversity of settings (e.g. community, hospital, 
research and development, academia) across varying levels of 
service provision and competence (e.g. pharmacy support staff/
workforce, pharmacists and pharmaceutical scientists) and scope 
of education (e.g. undergraduate, post-graduate, life-long learning). 
This multi-dimensional conceptualization embodies a systematic 
approach to education development that enables and supports a 
capable and flexible workforce to provide access to medicines 
 expertise and to effectively improve the health of nations.
Pharmacy education worldwide continues to have many issues 
that challenge the quality of teaching and learning at a time 
when there are limited resources to meet these challenges. 
The data in this report provides evidence that there is a global 
scarcity of qualified pharmacists to provide patient care at a time 
when there are more opportunities for pharmacists to expand 
their roles and responsibilities [8]. From this perspective, 
pharmacy is no different from other health care professions. 
FIPEd and the associated Pharmacy Education Taskforce (PET), 
advocates for professional needs-based education, working in 
partnership with the UNESCO and WHO [6,7].
PET currently oversees the implementation of the Work Plan 
2011/2012, which continues the work initially developed by the 
2008-2010 Action Plan [1,9]. The Work Plan is oriented towards 
identifying locally-determined needs and using this 
information to facilitate comprehensive education 
development and achievement of the competencies required 
to provide the local services (Figure 4.1). The domains for 
action prioritised in the work plans relate to developing a 
pharmacy education vision and framework, preparing the 
pharmacy workforce, and integrating quality assurance and 
education leadership for these efforts. From these domains, 
five project teams have been created to support the areas 
of (1) vision and competency, (2) academic and institutional 
capacity, (3) quality assurance, (4) pharmacy support worforce, 
and (5) educational leadership. The leadership for these project 
teams comes from PET, which serves as the coordination, 
analysis, and dissemination hub. It includes both a core of key 
stakeholders and a dynamic shell of voluntary regional 
collaborators.
4.2 Pharmacy education capacity 
and training institution distribution
The supply side of the workforce capacity pipeline is clearly 
important, and valid data about institutional capacity for 
providing initial education and training are critical in order to 
provide workforce intelligence for the profession. This section 
aims to provide comparative data on the supply side capacity 
challenges in order to provide indicators for planning at global 
and regional levels. The data presented here are concerned 
with capacity; competence and quality are dealt with in 
subsequent sections. It is clear that nations will need sufficient 
numbers of students in initial education programmes to 
provide for a future capable workforce; in addition, the 
academic establishment data also need to be determined. 
Without an adequate academic workforce, there cannot be a 
competent and capable health care workforce.
Education-related data from this survey are derived from a 
total of 90 country/territory level responses across a number 
of variables. Three countries in our sample reported they had 
no university-based schools of pharmacy and 14 (19%) reported 
only a single national pharmacy school. Conversely USA  
reported 127 accredited schools and India reported 1400. The 
sample reported a total of 2347 schools of pharmacy from 82 
countries and territories, of which 1568 were reported as 
accredited. The reported academic workforce (as a proportion of 
the total pharmacy workforce) ranges from 0.1% (China) to 35.7% 
(Cameroon) with a sample mean of 5.2% of the workforce.
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The respondents reported a total of 58,239 (n=54 countries and territories) pharmacy graduates per year, with a sample mean 
of 71.4 graduates per year per school. Figure 4.2 shows the country and territory level production of newly qualified graduate 
pharmacists per year (for available data).
There is a strong correlation with numbers of institutions providing initial pharmacy education and the country and territory 
level population. Institutional and national infrastructures for pharmacy education and training tend to be aligned with 
population size, although many African nations are situated below the regression line (Figure 4.4). The Figure 4.5 illustrates the 
total number of pharmacy schools and total number of pharmacy technician training schools (n= 46 countries and territories).
There is also variance associated with length of education and training programmes leading up to registration. Figure 4.3 shows 
both the length of time for the full-time undergraduate period and any additional time for internship (or pre-registration) periods 
before licensing of the practitioner. 
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Figure 4.2. Country and territory level graduates in pharmacy per year
 (Egypt = 480, not included in figure due to scaling)
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Figure 4.3. Undergraduate and internship periods of initial education
 for pharmacists (n=82 countries and territories)
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A key challenge in addressing the global health workforce 
shortage is that countries in Africa tend to have fewer trained 
pharmacy personnel and fewer training institutions within the 
country infrastructure. Physical resource and supply capacity 
therefore remain an important issue for FIPEd.
4.3 Quality assurance
While virtually all countries have established systems for 
oversight and quality assurance (QA) of education in general, 
fewer countries have QA systems specific to pharmacy 
education that are well developed. In some countries, such 
systems are emerging; in others, they are non-existent or, 
at best, rely on internal (institutional) QA processes.
Data from the Global Pharmacy Workforce Survey suggest 
that only one respondent country (Uruguay) did not have any 
pharmacy schools accredited and only one respondent 
country (Burundi) did not have any pharmacy technician 
training schools accredited. Eight (out of 49) countries have 
variance between the total number and the number of 
accredited pharmacy schools and five (out of 26) countries 
have variance between total number and the number of 
accredited pharmacy technician training schools; Forty-two 
countries have their full national compliment under a national 
accreditation system for pharmacy schools and 23 countries 
for pharmacy technician training schools.
Further study of national accreditation systems is needed to 
gain greater insights into how such systems impact the 
quality of pharmacy education; such research has been 
proposed by PET. Ideally, countries should have their own 
national QA system and standards for pharmacy education 
that reflect contemporary and emerging pharmacy practice 
and education and meet the specific needs of the country.
To support national efforts to improve systems and standards for 
QA of pharmacy education, FIP developed and adopted the Global 
Framework for Quality Assurance of Pharmacy Education [10].
The framework (available at www.fip.org/education_taskforce) 
provides the context for QA of pharmacy education, presents a 
framework for a national QA system, and offers quality criteria 
for pharmacy education. The Framework is intended to serve 
as a foundation that can be adapted and built upon to suit 
national needs, systems, and conditions; it focuses on the 
elements that need to be included and how these elements are 
applied in principle, rather than being specific or prescriptive.
The Framework does not advocate for any one overall model or 
QA system, but comments on different approaches that exist 
and outlines trends that are emerging globally [11].
In 2008, WHO and PET supported studies in Ghana and Zambia 
to undertake a preliminary examination of the potential 
relevance of the Framework for advancing quality assurance 
of pharmacy education through detailed stakeholder 
analysis. Content validity of the Framework was evaluated by 
the Department of Pharmacy at the University of Zambia and 
the Faculty of Pharmacy at the Kwame Nkrumah University of 
Science and Technology in Ghana. There was an overwhelming
acceptance of the concept by policy makers, regulators, 
educators, and practitioners who emphasized the need for 
broader stakeholder involvement in developing QA systems.
In 2009-10, the Framework underwent further validation involving 
expert reviewers (representing pharmacy practice, academia, 
regulation and quality assurance of pharmacy education) from 
24 participating countries. The survey instrument used examined 
the validity and national applicability of each component of the 
Framework. All sections of the Framework including the 
philosophy and purpose of quality assurance; structure, policies, 
and procedures for a national quality assurance system; 
and quality criteria for the outcomes, structure and processes 
of a pharmacy school and its professional degree program
achieved high percentage validity scores: 60 of the 62 elements 
rating greater than 90%. Data and comments from the validation 
exercise are being used to inform the revision of the Framework, 
and release of the updated version is anticipated in 2013.
The quality assurance domain of PET is collaborating with 
WHO to develop an instrument that institutions can use 
for self-assessment and quality improvement of their 
academic program in pharmacy. The instrument, which uses 
the quality criteria of the Framework, has been piloted in
Nigeria and the findings and conclusions from that exercise 
will inform its revision. It is planned that the updated 
instrument will be further tested and validated in several 
additional countries prior to final adoption. Also under 
consideration is adaptation of the instrument for use with 
other health professional education.
4.4 Practitioner development approaches 
in professional education
Over the last ten years, competency frameworks in health 
care have become increasingly popular due to the need for 
transparency in the training, development, and accreditation 
of health care professionals [12]. Continuing Professional 
Development (CPD) is advocated as a means of ensuring
the competence of health care professionals and is now 
mandatory for many of the health care professions. 
In order for CPD to be meaningful, health care professionals 
need to know the areas of competence for their role so they 
can accurately identify their learning needs. In essence, they 
need to know what it is they need to be able to do [13-15]. 
Competency frameworks can provide this, and are based 
on real life roles and experience; experiential or applied 
learning is essential for the development of competence.
Perhaps a shift should be made towards Continuing 
Professional Education (CPE), a more fit-forpurpose and 
competent practitioner according to the specificity of the 
country or sector needs. There is a need to globally define 
a career pathway, since there is no seamless evolution 
of the practitioner.
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Figure 4.4. Schools of pharmacy by population and by WHO region 
(n=61 countries and territories)
Figure 4.5. Comparative frequencies for pharmacy schools and pharmacy technician
 training schools (logarithmic scale to enable case comparison)
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A key challenge in addressing the global health workforce 
shortage is that countries in Africa tend to have fewer trained 
pharmacy personnel and fewer training institutions within the 
country infrastructure. Physical resource and supply capacity 
therefore remain an important issue for FIPEd.
4.3 Quality assurance
While virtually all countries have established systems for 
oversight and quality assurance (QA) of education in general, 
fewer countries have QA systems specific to pharmacy 
education that are well developed. In some countries, such 
systems are emerging; in others, they are non-existent or, 
at best, rely on internal (institutional) QA processes.
Data from the Global Pharmacy Workforce Survey suggest 
that only one respondent country (Uruguay) did not have any 
pharmacy schools accredited and only one respondent 
country (Burundi) did not have any pharmacy technician 
training schools accredited. Eight (out of 49) countries have 
variance between the total number and the number of 
accredited pharmacy schools and five (out of 26) countries 
have variance between total number and the number of 
accredited pharmacy technician training schools; Forty-two 
countries have their full national compliment under a national 
accreditation system for pharmacy schools and 23 countries 
for pharmacy technician training schools.
Further study of national accreditation systems is needed to 
gain greater insights into how such systems impact the 
quality of pharmacy education; such research has been 
proposed by PET. Ideally, countries should have their own 
national QA system and standards for pharmacy education 
that reflect contemporary and emerging pharmacy practice 
and education and meet the specific needs of the country.
To support national efforts to improve systems and standards for 
QA of pharmacy education, FIP developed and adopted the Global 
Framework for Quality Assurance of Pharmacy Education [10].
The framework (available at www.fip.org/education_taskforce) 
provides the context for QA of pharmacy education, presents a 
framework for a national QA system, and offers quality criteria 
for pharmacy education. The Framework is intended to serve 
as a foundation that can be adapted and built upon to suit 
national needs, systems, and conditions; it focuses on the 
elements that need to be included and how these elements are 
applied in principle, rather than being specific or prescriptive.
The Framework does not advocate for any one overall model or 
QA system, but comments on different approaches that exist 
and outlines trends that are emerging globally [11].
In 2008, WHO and PET supported studies in Ghana and Zambia 
to undertake a preliminary examination of the potential 
relevance of the Framework for advancing quality assurance 
of pharmacy education through detailed stakeholder 
analysis. Content validity of the Framework was evaluated by 
the Department of Pharmacy at the University of Zambia and 
the Faculty of Pharmacy at the Kwame Nkrumah University of 
Science and Technology in Ghana. There was an overwhelming
acceptance of the concept by policy makers, regulators, 
educators, and practitioners who emphasized the need for 
broader stakeholder involvement in developing QA systems.
In 2009-10, the Framework underwent further validation involving 
expert reviewers (representing pharmacy practice, academia, 
regulation and quality assurance of pharmacy education) from 
24 participating countries. The survey instrument used examined 
the validity and national applicability of each component of the 
Framework. All sections of the Framework including the 
philosophy and purpose of quality assurance; structure, policies, 
and procedures for a national quality assurance system; 
and quality criteria for the outcomes, structure and processes 
of a pharmacy school and its professional degree program
achieved high percentage validity scores: 60 of the 62 elements 
rating greater than 90%. Data and comments from the validation 
exercise are being used to inform the revision of the Framework, 
and release of the updated version is anticipated in 2013.
The quality assurance domain of PET is collaborating with 
WHO to develop an instrument that institutions can use 
for self-assessment and quality improvement of their 
academic program in pharmacy. The instrument, which uses 
the quality criteria of the Framework, has been piloted in
Nigeria and the findings and conclusions from that exercise 
will inform its revision. It is planned that the updated 
instrument will be further tested and validated in several 
additional countries prior to final adoption. Also under 
consideration is adaptation of the instrument for use with 
other health professional education.
4.4 Practitioner development approaches 
in professional education
Over the last ten years, competency frameworks in health 
care have become increasingly popular due to the need for 
transparency in the training, development, and accreditation 
of health care professionals [12]. Continuing Professional 
Development (CPD) is advocated as a means of ensuring
the competence of health care professionals and is now 
mandatory for many of the health care professions. 
In order for CPD to be meaningful, health care professionals 
need to know the areas of competence for their role so they 
can accurately identify their learning needs. In essence, they 
need to know what it is they need to be able to do [13-15]. 
Competency frameworks can provide this, and are based 
on real life roles and experience; experiential or applied 
learning is essential for the development of competence.
Perhaps a shift should be made towards Continuing 
Professional Education (CPE), a more fit-forpurpose and 
competent practitioner according to the specificity of the 
country or sector needs. There is a need to globally define 
a career pathway, since there is no seamless evolution 
of the practitioner.
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Figure 4.4. Schools of pharmacy by population and by WHO region 
(n=61 countries and territories)
Figure 4.5. Comparative frequencies for pharmacy schools and pharmacy technician
 training schools (logarithmic scale to enable case comparison)
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The vision and competency project team has developed an 
initial construct towards an “educational roadmap” to guide 
efforts in and mechanisms for pharmacy education [16]. 
Countries, particularly those marginalised by the human 
resources for health crisis, can use the evidence gathered to 
develop their workforce and to track the results of their 
efforts. The scaling up, quality assurance, and quality 
improvement of global pharmacy education are prerequisites 
for addressing workforce shortages and service development.
Since publication of the 2009 Workforce Report, a revision of 
the literature, discussion panels, respondent validation, and an 
online validation survey were conducted that supported the
development of the first Global Competency Framework 
(GbCF) for services provided by members of  the pharmacy 
workforce. The Global Competency Framework (GbCF) Version 
1 contains a core set of behavioural competencies
(www.fip.org/education_taskforce).
The GbCF Version 1 can be a starting point to provide guidance 
for foundation level practice, not only at an individual level 
but also for further development into advanced practice. 
It can also be an aid in providing an overview of how practice 
at a foundation level can be translated into ‘what’ and ‘how’ 
students should learn and interact with pharmaceutical care 
skills during their initial degree, always with country 
specifications in mind (the GbCF does not imply that there 
should be a ‘single’ global curriculum that would fit all 
countries). Table 4.1 indicates the terminology used by PET 
regarding the theme of competence.
Table 4.1. Terminology used by PET [17]
Acting as a mapping tool for the creation of country specific 
needs for the development of practice and practitioner 
professional development, the GbCF can be attached to an 
assessment grid and, together with appropriate assessment 
tools, can aid countries that do not currently have a 
competency framework but wish to develop one. By creating 
a portfolio, in synergy with other assessment tools, countries 
can implement the GbCF into practice, developing education 
and training infrastructures for their practitioners.
Table 4.2. Prevalence of practitioner development (or competency) framework 
Data gathered from the global workforce report survey in 2012 
indicate that 27 countries (33%) have a competency framework 
for pharmacists, 17 countries (21%) are currently developing one 
and 37 countries (46%) do not have one in place. For pharmacy 
technicians, 18 countries (24%) reported having a competency 
framework, 8 countries (11%) reported they are developing one 
and 48 countries (65%) reported that they do not have a 
competency framework. As stated in Table 4.2, despite an increase 
in number of respondents, there has been no significant increase 
in the number of countries that have reported using or 
developing a national competency framework since 2009.
The data also support the growing body of evidence that 
suggests that frameworks that use a competency approach 
are being implemented by pharmacists and pharmacy 
technicians as a way of operationalising otherwise vague 
concepts of CPD and CPD policy. [18-22].
The GbCF is under development; there is further work to be done 
and more studies to be conducted to effectively define the core 
competencies for a foundation level framework across all 
pharmacy sectors that will improve the competence of the 
practitioners. Nonetheless, the findings provide evidence that 
at the core, a practitioner is the same globally (i.e. having similar 
expectations of competence). Practice is likewise similar, as 
practitioners are experts of medicines. This is a key moment in 
global education development and should form the basis for 
further research and development into advanced practice 
development strategies.
4.5 Pharmacy support workforce
FIP acknowledges that health care facilities cannot operate 
without medicines [14]. The availability of both medicines and 
a pharmacy workforce in adequate numbers with appropriate 
competencies is crucial to ensuring a well-functioning phar-
maceutical system [14].
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Single item of knowledge, skill or professional value.
A complete collection of competencies that are thought 
to be essential to performance.
Full repertoire of competencies.
The knowledge, skills, behaviours and attitudes 
that an individual accumulates, develops, and acquires through 
education, training, and work experience.
Effective and persistent behaviour.
A measure of performance against a speciﬁed criteria or standard.
The systems, procedures, and information used by 
the pharmacists in providing professional services that serve 
as a standard against which performance can be assessed.
Competency
Competency
Framework
Competence
Competencies
Performance 
Performance
Indicators
Practice 
Standards
Pharmacists
2009 Workforce Report (n=52)           2012 Workforce Report (n=81)
Yes                                        20 (38%)           Yes                                       27 (33%)
In development             13 (25%)           In development             17 (21%)
No                                         19 (37%)           No                                        37 (46%)
Pharmacy Technicians
2009 Workforce Report (n=41)           2012 Workforce Report (n=74)
Yes                                          8 (20%)           Yes                                        18 (24%)
In development                9 (22%)          In development                8 (11%)
No                                         24 (59%)           No                                        48 (65%)
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In low-income countries where a shortage of pharmacists and 
technologies exists, other cadres are required to have extended 
responsibilities. This reliance on mid-level cadres is consistent 
with global trends and often reflects the unavailability of more 
highly qualified health professionals in those countries 
[23, 24]. In middle to high-income countries, well-trained 
pharmacy support staff allow pharmacists more time for 
clinical activities, which can translate into improved patient 
health outcomes and savings in health expenditure [25-27].
The global distribution of the pharmacy support workforce is 
varied. Global Pharmacy Workforce Survey data for 2012 show 
the greatest reliance on pharmacy support workforce cadres 
to be in South East Asia (67.5%), with the Americas (28.4%) being 
least reliant on these cadres (Figure 4.6). Significant variation 
is, however, also evident between countries within regions.
Figure 4.6. Percentage of regional means for pharmacy and technician 
workforce (n=62 matched variable pairs)
Many terms are used to describe those working within the 
pharmacy support workforce (e.g.pharmacy technician, 
assistant, technologist, dispenser, assistant pharmacist) with 
a variety ofexpected competency patterns. It should be noted 
that the International Labour Organisation adopted a 
definition for pharmacy technicians “Pharmacy technicians 
and assistants perform a variety of tasks associated with 
dispensing medicinal products under the guidance of a 
pharmacist, or other health professional” [28]. However is not 
used consistently, with many countries requiring these cadres 
to work unsupervised (especially in rural environments) [29].
A better understanding of the pharmacy support workforce 
is required to meet their needs in regard to education, 
registration and other work related issues. In response to 
this need, a global pharmacy support workforce review for 
non-pharmacist roles is being undertaken to present a global 
picture of the diverse nature of this cadre. Preliminary data 
indicate the varied nature of workforce distribution, cadre 
names, competency expectations, supervision, regulation 
systems and education needs.
With a consistent call from countries for a greater focus on 
pharmacy support workforce cadres, future involvement in this 
sector of the pharmacy workforce is to be encouraged. Any global 
focus should seek to address local country needs with the larger 
aim of ensuring safe use of quality medicines by patients.
4.6 Developing educational leadership
As pharmacy roles continue to evolve and the number of 
health providers rises to better meet the health needs of a 
globalized society, transformative leadership is needed to 
ensure that educational systems continue to innovate while 
remaining harmonized with workforce planning. The same 
globalization that has increased economic, social, technical 
and political interdependence between nations has also 
influenced education. International trade, cultural exchange, 
and the use of webbased communication systems have 
created opportunities for more robust discussions of 
collaborative but needs-based educational models for 
pharmacy services [30]. Taking full advantage of these 
opportunities will require new insights, skills, and 
perspectives at every leadership level.
However, for these discussions to be transformative, there must 
be a better understanding of how culture affects leadership.
Advancing educational leadership will require the profession 
to purposefully study the evidence from health care, 
education, and leadership. Some educational systems have 
prioritized leadership development as a critical part of the 
training programs required of pharmacists and pharmacy 
staff. Accreditation bodies (e.g., the US-based Accreditation 
Council for Pharmacy Education’s Standards and Guidelines 
[31]) increasingly value inclusion of leadership instruction. 
Some professional organizations have created special interest 
groups and frameworks (e.g., the Royal Pharmaceutical Society 
Leadership Competency Framework [32]) to support 
leadership development across the career of the pharmacy 
professional. Such models tend to be focused on a single 
system or population, however, and additional work is needed 
to determine the potential for cross applicability. Further, as 
educational systems continue to connect, there is a need for 
specific training for leaders to become competent in 
cross-cultural awareness and practices.
Although there are numerous local, regional, and national 
efforts for leadership communication, development and 
recognition, some resources with an international focus 
include, but are not limited, to:
• International Leadership Association - http://www.ila-net.org/  
   This association is a global network for all those who 
   practice, study and teach leadership.
• The Leadership Quarterly  - http://www.sciencedirect.com/
   science/journal/10489843 | This journal brings together a focus    
   on leadership for scholars, managers, and administrators, as  
   well as university academic staff across the world who teach  
   leadership courses.
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The vision and competency project team has developed an 
initial construct towards an “educational roadmap” to guide 
efforts in and mechanisms for pharmacy education [16]. 
Countries, particularly those marginalised by the human 
resources for health crisis, can use the evidence gathered to 
develop their workforce and to track the results of their 
efforts. The scaling up, quality assurance, and quality 
improvement of global pharmacy education are prerequisites 
for addressing workforce shortages and service development.
Since publication of the 2009 Workforce Report, a revision of 
the literature, discussion panels, respondent validation, and an 
online validation survey were conducted that supported the
development of the first Global Competency Framework 
(GbCF) for services provided by members of  the pharmacy 
workforce. The Global Competency Framework (GbCF) Version 
1 contains a core set of behavioural competencies
(www.fip.org/education_taskforce).
The GbCF Version 1 can be a starting point to provide guidance 
for foundation level practice, not only at an individual level 
but also for further development into advanced practice. 
It can also be an aid in providing an overview of how practice 
at a foundation level can be translated into ‘what’ and ‘how’ 
students should learn and interact with pharmaceutical care 
skills during their initial degree, always with country 
specifications in mind (the GbCF does not imply that there 
should be a ‘single’ global curriculum that would fit all 
countries). Table 4.1 indicates the terminology used by PET 
regarding the theme of competence.
Table 4.1. Terminology used by PET [17]
Acting as a mapping tool for the creation of country specific 
needs for the development of practice and practitioner 
professional development, the GbCF can be attached to an 
assessment grid and, together with appropriate assessment 
tools, can aid countries that do not currently have a 
competency framework but wish to develop one. By creating 
a portfolio, in synergy with other assessment tools, countries 
can implement the GbCF into practice, developing education 
and training infrastructures for their practitioners.
Table 4.2. Prevalence of practitioner development (or competency) framework 
Data gathered from the global workforce report survey in 2012 
indicate that 27 countries (33%) have a competency framework 
for pharmacists, 17 countries (21%) are currently developing one 
and 37 countries (46%) do not have one in place. For pharmacy 
technicians, 18 countries (24%) reported having a competency 
framework, 8 countries (11%) reported they are developing one 
and 48 countries (65%) reported that they do not have a 
competency framework. As stated in Table 4.2, despite an increase 
in number of respondents, there has been no significant increase 
in the number of countries that have reported using or 
developing a national competency framework since 2009.
The data also support the growing body of evidence that 
suggests that frameworks that use a competency approach 
are being implemented by pharmacists and pharmacy 
technicians as a way of operationalising otherwise vague 
concepts of CPD and CPD policy. [18-22].
The GbCF is under development; there is further work to be done 
and more studies to be conducted to effectively define the core 
competencies for a foundation level framework across all 
pharmacy sectors that will improve the competence of the 
practitioners. Nonetheless, the findings provide evidence that 
at the core, a practitioner is the same globally (i.e. having similar 
expectations of competence). Practice is likewise similar, as 
practitioners are experts of medicines. This is a key moment in 
global education development and should form the basis for 
further research and development into advanced practice 
development strategies.
4.5 Pharmacy support workforce
FIP acknowledges that health care facilities cannot operate 
without medicines [14]. The availability of both medicines and 
a pharmacy workforce in adequate numbers with appropriate 
competencies is crucial to ensuring a well-functioning phar-
maceutical system [14].
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No                                         24 (59%)           No                                        48 (65%)
.................................................................................
In low-income countries where a shortage of pharmacists and 
technologies exists, other cadres are required to have extended 
responsibilities. This reliance on mid-level cadres is consistent 
with global trends and often reflects the unavailability of more 
highly qualified health professionals in those countries 
[23, 24]. In middle to high-income countries, well-trained 
pharmacy support staff allow pharmacists more time for 
clinical activities, which can translate into improved patient 
health outcomes and savings in health expenditure [25-27].
The global distribution of the pharmacy support workforce is 
varied. Global Pharmacy Workforce Survey data for 2012 show 
the greatest reliance on pharmacy support workforce cadres 
to be in South East Asia (67.5%), with the Americas (28.4%) being 
least reliant on these cadres (Figure 4.6). Significant variation 
is, however, also evident between countries within regions.
Figure 4.6. Percentage of regional means for pharmacy and technician 
workforce (n=62 matched variable pairs)
Many terms are used to describe those working within the 
pharmacy support workforce (e.g.pharmacy technician, 
assistant, technologist, dispenser, assistant pharmacist) with 
a variety ofexpected competency patterns. It should be noted 
that the International Labour Organisation adopted a 
definition for pharmacy technicians “Pharmacy technicians 
and assistants perform a variety of tasks associated with 
dispensing medicinal products under the guidance of a 
pharmacist, or other health professional” [28]. However is not 
used consistently, with many countries requiring these cadres 
to work unsupervised (especially in rural environments) [29].
A better understanding of the pharmacy support workforce 
is required to meet their needs in regard to education, 
registration and other work related issues. In response to 
this need, a global pharmacy support workforce review for 
non-pharmacist roles is being undertaken to present a global 
picture of the diverse nature of this cadre. Preliminary data 
indicate the varied nature of workforce distribution, cadre 
names, competency expectations, supervision, regulation 
systems and education needs.
With a consistent call from countries for a greater focus on 
pharmacy support workforce cadres, future involvement in this 
sector of the pharmacy workforce is to be encouraged. Any global 
focus should seek to address local country needs with the larger 
aim of ensuring safe use of quality medicines by patients.
4.6 Developing educational leadership
As pharmacy roles continue to evolve and the number of 
health providers rises to better meet the health needs of a 
globalized society, transformative leadership is needed to 
ensure that educational systems continue to innovate while 
remaining harmonized with workforce planning. The same 
globalization that has increased economic, social, technical 
and political interdependence between nations has also 
influenced education. International trade, cultural exchange, 
and the use of webbased communication systems have 
created opportunities for more robust discussions of 
collaborative but needs-based educational models for 
pharmacy services [30]. Taking full advantage of these 
opportunities will require new insights, skills, and 
perspectives at every leadership level.
However, for these discussions to be transformative, there must 
be a better understanding of how culture affects leadership.
Advancing educational leadership will require the profession 
to purposefully study the evidence from health care, 
education, and leadership. Some educational systems have 
prioritized leadership development as a critical part of the 
training programs required of pharmacists and pharmacy 
staff. Accreditation bodies (e.g., the US-based Accreditation 
Council for Pharmacy Education’s Standards and Guidelines 
[31]) increasingly value inclusion of leadership instruction. 
Some professional organizations have created special interest 
groups and frameworks (e.g., the Royal Pharmaceutical Society 
Leadership Competency Framework [32]) to support 
leadership development across the career of the pharmacy 
professional. Such models tend to be focused on a single 
system or population, however, and additional work is needed 
to determine the potential for cross applicability. Further, as 
educational systems continue to connect, there is a need for 
specific training for leaders to become competent in 
cross-cultural awareness and practices.
Although there are numerous local, regional, and national 
efforts for leadership communication, development and 
recognition, some resources with an international focus 
include, but are not limited, to:
• International Leadership Association - http://www.ila-net.org/  
   This association is a global network for all those who 
   practice, study and teach leadership.
• The Leadership Quarterly  - http://www.sciencedirect.com/
   science/journal/10489843 | This journal brings together a focus    
   on leadership for scholars, managers, and administrators, as  
   well as university academic staff across the world who teach  
   leadership courses.
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Key considerations for educational leadership going forward 
include an increased recognition of the value of and need for 
interprofessional leadership training. Just as pharmacists must 
learn to lead across cultures, we must also learn to affect change 
across and within multiple health professions. In this respect, 
the countries where the education of pharmacists and pharmacy 
staff is only now emerging (e.g., Namibia) have a real opportunity 
to develop models that may be adaptable for others.
4.7 Publishing pharmacy education research 
and development
The pharmacy academic and education sector is growing to 
meet the human resource demands in settings where 
pharmacy education is developed, but also notably in regions 
such as sub-Saharan Africa where there is the greatest 
shortage of pharmacy personnel [14]. Pharmacy education is 
perhaps the only way to provide a sustainable approach to 
workforce solutions in ensuring quality medicines supply and 
pharmaceutical care. Research suggests that even in 
developed settings, educators will be in increased demand
in the coming decade [33].
An essential part of this is demand is to ensure that these 
activities are well reported in the literature including journals 
such as Pharmacy Education.
Pharmacy Education is an online open-access international 
journal hosted, published by FIP and endorsed by the WHO, 
and focus on issues in pharmacy education. With a new 
editorial team who started at the end of 2011, including 
representation from the African region, a review was 
conducted sof the content of the journal, soon to be published 
in Pharmacy Education. This review confirmed that Pharmacy 
Education historically represents research and reports 
primarily from Europe (Figure 4.7). The journal is now 
engaging to a greater extent with the international audience 
by encouraging research manuscript submissions and inviting 
peer reviewers specifically from other regions. 
An editorial decision was also made in 2012 to focus 
particularly on the main areas of publishing including original 
research, programme and assessment descriptions, and short 
reports (Figure 4.8). Pharmacy Education will no longer publish 
opinion pieces, essays, book reviews, or keynote lectures, but 
will continue to support conferences and symposia through 
the publication of abstracts. There will be continued efforts to 
ensure the quality of published works and support especially 
for new authors and researchers and those from the practice 
settings where formal education increasingly takes place.
Figure 4.7. First author reporting in Pharmacy Education since inception 
of the journal by WHO region (2000-2011)
Figure 4.8. Volume of published articles by article type (2000- 2011)
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4.8 Summary and future steps
• FIPEd is a global forum where educators, practitioners, 
   policy makers and educational planners come together 
   to share experiences, build consensus and drive global 
   advocacy and policy for the transformation and 
   development of pharmacy education.
• PET aims to advocate, facilitate and design support tools 
   for pharmacy education that are needs-based in their 
   approach [34]. This will include post-registration in addition    
   to preservice education.
• Education strategies need to be flexible for the pre-existing    
   and future needs of the community in order to optimise 
   effectiveness. This further supports the importance of the   
   adoption of a vision and action plan for global pharmacy 
   education that is founded in local, regional, national and   
   international needs for health care.
• Future PET activities include the finalisation in 2013 of the 
   FIP-WHO Global Survey of Pharmacy Schools, launch of the 
   first resources made available through the ‘UNITWIN Network 
   in Global Pharmacy Education Development (GPhED)’, the  
   publication of an updated version of the FIP Quality 
   Assurance Framework for Pharmacy Education, further   
   validation and development of the GbCF, finalisation of the    
   pharmacy support workforce competency survey and the   
   compilation of leadership development resources.
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Key considerations for educational leadership going forward 
include an increased recognition of the value of and need for 
interprofessional leadership training. Just as pharmacists must 
learn to lead across cultures, we must also learn to affect change 
across and within multiple health professions. In this respect, 
the countries where the education of pharmacists and pharmacy 
staff is only now emerging (e.g., Namibia) have a real opportunity 
to develop models that may be adaptable for others.
4.7 Publishing pharmacy education research 
and development
The pharmacy academic and education sector is growing to 
meet the human resource demands in settings where 
pharmacy education is developed, but also notably in regions 
such as sub-Saharan Africa where there is the greatest 
shortage of pharmacy personnel [14]. Pharmacy education is 
perhaps the only way to provide a sustainable approach to 
workforce solutions in ensuring quality medicines supply and 
pharmaceutical care. Research suggests that even in 
developed settings, educators will be in increased demand
in the coming decade [33].
An essential part of this is demand is to ensure that these 
activities are well reported in the literature including journals 
such as Pharmacy Education.
Pharmacy Education is an online open-access international 
journal hosted, published by FIP and endorsed by the WHO, 
and focus on issues in pharmacy education. With a new 
editorial team who started at the end of 2011, including 
representation from the African region, a review was 
conducted sof the content of the journal, soon to be published 
in Pharmacy Education. This review confirmed that Pharmacy 
Education historically represents research and reports 
primarily from Europe (Figure 4.7). The journal is now 
engaging to a greater extent with the international audience 
by encouraging research manuscript submissions and inviting 
peer reviewers specifically from other regions. 
An editorial decision was also made in 2012 to focus 
particularly on the main areas of publishing including original 
research, programme and assessment descriptions, and short 
reports (Figure 4.8). Pharmacy Education will no longer publish 
opinion pieces, essays, book reviews, or keynote lectures, but 
will continue to support conferences and symposia through 
the publication of abstracts. There will be continued efforts to 
ensure the quality of published works and support especially 
for new authors and researchers and those from the practice 
settings where formal education increasingly takes place.
Figure 4.7. First author reporting in Pharmacy Education since inception 
of the journal by WHO region (2000-2011)
Figure 4.8. Volume of published articles by article type (2000- 2011)
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4.8 Summary and future steps
• FIPEd is a global forum where educators, practitioners, 
   policy makers and educational planners come together 
   to share experiences, build consensus and drive global 
   advocacy and policy for the transformation and 
   development of pharmacy education.
• PET aims to advocate, facilitate and design support tools 
   for pharmacy education that are needs-based in their 
   approach [34]. This will include post-registration in addition    
   to preservice education.
• Education strategies need to be flexible for the pre-existing    
   and future needs of the community in order to optimise 
   effectiveness. This further supports the importance of the   
   adoption of a vision and action plan for global pharmacy 
   education that is founded in local, regional, national and   
   international needs for health care.
• Future PET activities include the finalisation in 2013 of the 
   FIP-WHO Global Survey of Pharmacy Schools, launch of the 
   first resources made available through the ‘UNITWIN Network 
   in Global Pharmacy Education Development (GPhED)’, the  
   publication of an updated version of the FIP Quality 
   Assurance Framework for Pharmacy Education, further   
   validation and development of the GbCF, finalisation of the    
   pharmacy support workforce competency survey and the   
   compilation of leadership development resources.
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This part presents nine case studies on pharmacy workforce 
planning, management, and development from Afghanistan, 
Costa Rica, Ghana, Great Britain, Japan, the Pacific Island 
Countries, Singapore, South Africa, and Tanzania. Sourced from 
different regions, each case study describes a unique set of 
pharmacy workforce challenges and issues. The particular 
focus on Africa, with three case studies from Ghana, South 
Africa, and Tanzania, reflect the broad changes taking place in 
this region that is still most affected by the severe 
shortage of health care professionals. The case studies provide 
an overview of strategies employed to address key workforce 
challenges, associated outcomes and lessons learnt.
5.1 Country Case Study: Afghanistan
Authors
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Summary
• There are seven times more pharmaceutical establishments   
   than the total number of pharmacists and pharmacy 
   assistants in Afghanistan.
• Evidence and multi-stakeholder collaboration are required to   
   inform needs-based pharmaceutical human resources planning.
• In 2011, the Ministry of Public Health conducted a comprehensive 
   assessment of pharmaceutical human resources at the national,   
   provincial, facility, and individual levels to identify key issues and 
   to provide data to inform planning.
• Through multi-stakeholder processes, the Ministry of 
   Public Health has developed a draft Pharmaceutical Human 
   Resources Strategic Framework describing strategic 
   objectives and strategies to address priority issues.
5.1.1. Background
The Islamic Republic of Afghanistan is a landlocked country 
with an estimated population of more than 30 million, of 
which almost 80% reside in rural areas and 36% live below the 
poverty line. Life expectancy is 48 years and while mortality 
rates have declined significantly over the last 10 years, they 
remain high with an under-five child mortality rate of 149 per 
1,000 live births and a maternal mortality ratio of 449 
per 100,000 live births [1].
With approximately 1,163 pharmacists and 822 pharmacy 
assistants in the country, this workforce is outnumbered 
seven-fold by the 10,131 private pharmacies, 2,082 public sector 
pharmacies, 677 pharmaceutical wholesalers, and 17 
pharmaceutical manufacturers [2]. These figures are especially 
concerning given the vital role the pharmacy workforce plays 
in the health system, providing services ranging from 
manufacturing and regulating medicines to distributing and 
dispensing medicines. The number of new pharmacists is 
limited, as there is only one training institution in Afghanistan 
(the Faculty of Pharmacy at Kabul University). However the 
number of schools training pharmacy assistants has increased 
recently to 21; all but one of these schools are public.
Stakeholders identified eight major areas of services across 
the public and private pharmaceutical sector in 2010 
(described in the Competency Framework for Pharmaceutical 
Services in Afghanistan):
1- Policy and planning
2- Laws and regulation
3- Quality assurance systems
4- Production/manufacturing
5- Procurement
6- Supply chain management
7- Dispensing: Outpatient hospital and private pharmacy
8- Hospital inpatient dispensing (hospital)
The Ministry of Public Health (MoPH), together with various 
partners, is actively rebuilding the pharmaceutical system 
after more than 30 years of conflict to provide safe, 
affordable, and equitable access to medicines. These efforts 
include strengthening regulatory and quality assurance 
mechanisms, implementing strategies and policies to improve 
rational use of medicines, and supporting the development 
and reform of pre-service education-all of which require 
stronger pharmaceutical human resources to ensure the 
sustainabilityof these efforts.
The General Directorate of Pharmaceutical Affairs (GDPA) and 
the General Directorate of Human Resources (GDHR) within 
the MoPH, together with other institutions, are responsible for 
all activities related to creating and maintaining a sustainable 
workforce in the pharmaceutical sector. In 2010, the GDPA and 
GDHR formed a core team with the support of the U.S. Agency 
for International Development’s (USAID’s) Strengthening 
Pharmaceutical Systems (SPS) Project. This core team steered 
the development and implementation of a comprehensive 
pharmaceutical human resources assessment in 2011, 
analyzed and presented findings from the assessment, and 
facilitated the development of a pharmaceutical human 
resources strategic framework in 2012 (Figure 5.1.1).
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in the health system, providing services ranging from 
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dispensing medicines. The number of new pharmacists is 
limited, as there is only one training institution in Afghanistan 
(the Faculty of Pharmacy at Kabul University). However the 
number of schools training pharmacy assistants has increased 
recently to 21; all but one of these schools are public.
Stakeholders identified eight major areas of services across 
the public and private pharmaceutical sector in 2010 
(described in the Competency Framework for Pharmaceutical 
Services in Afghanistan):
1- Policy and planning
2- Laws and regulation
3- Quality assurance systems
4- Production/manufacturing
5- Procurement
6- Supply chain management
7- Dispensing: Outpatient hospital and private pharmacy
8- Hospital inpatient dispensing (hospital)
The Ministry of Public Health (MoPH), together with various 
partners, is actively rebuilding the pharmaceutical system 
after more than 30 years of conflict to provide safe, 
affordable, and equitable access to medicines. These efforts 
include strengthening regulatory and quality assurance 
mechanisms, implementing strategies and policies to improve 
rational use of medicines, and supporting the development 
and reform of pre-service education-all of which require 
stronger pharmaceutical human resources to ensure the 
sustainabilityof these efforts.
The General Directorate of Pharmaceutical Affairs (GDPA) and 
the General Directorate of Human Resources (GDHR) within 
the MoPH, together with other institutions, are responsible for 
all activities related to creating and maintaining a sustainable 
workforce in the pharmaceutical sector. In 2010, the GDPA and 
GDHR formed a core team with the support of the U.S. Agency 
for International Development’s (USAID’s) Strengthening 
Pharmaceutical Systems (SPS) Project. This core team steered 
the development and implementation of a comprehensive 
pharmaceutical human resources assessment in 2011, 
analyzed and presented findings from the assessment, and 
facilitated the development of a pharmaceutical human 
resources strategic framework in 2012 (Figure 5.1.1).
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Figure 5.1.1. Overview of the assessment and strategic framework 
development process
5.1.2. Key Issues
Major pharmaceutical human resources issues in Afghanistan 
include:
Gaps in information and information flow
Prior to 2010, there was limited information available about 
the pharmaceutical human resources in Afghanistan with 
regards to density, distribution, roles, competency 
development needs, or projected human resources 
requirements. Information on pharmaceutical human 
resources was also not disaggregated by cadres. Information 
regarding pharmacist and pharmacy assistant graduates and 
vacancies did not systematically flow among training 
institutions, GDPA, and GDHR. The lack of a licensing renewal 
mechanism meant that information kept by GPDA on the 
number of pharmacists was out of date, and the directorate 
had no way of knowing which of pharmacists were in-country 
and actively working in the pharmaceutical sector. All of these 
factors made it difficult to maintain an up-to-date and 
accurate human resources information system to inform 
human resources for health (HRH) planning. There was also 
limited interaction, information flow, and coordination among 
MoPH, training institutions, employers, and development 
partners on pharmaceutical human resources issues. Although 
stakeholders recognized the importance of these issues, there 
was an absence of pharmaceutical human resources strategies 
and plans designed to address them.
Pharmaceutical human resources shortage 
and distribution imbalance
The last few decades have seen rapid growth in the number 
of private sector pharmacies in Afghanistan, particularly in 
urban areas, as a result of demand and weakened regulatory 
mechanisms. Over time, the number of private pharmacies has 
far exceeded the supply of pharmaceutical human resources 
in the labor market. Increasingly, other health workers and lay
workers provide pharmaceutical services in both private and 
public sectors. Of the 136 private pharmacy personnel 
participating in the assessment, only 11% were pharmacists 
and 21% were pharmacy assistants; the majority were other 
cadres including nurses, physician assistants, teachers, school 
students, and lay workers. Although pharmaceutical 
establishments outnumber the pharmaceutical workforce, 
only 57% of pharmacists who graduated between 2009 and 
2010 worked in the pharmaceutical sector, and 20% were 
unemployed at the time of the graduate tracking survey in 
February 2012.
The survey also found maldistribution of pharmacists and
pharmacy assistants, with the density varying from zero to 
more than three per 10,000 population in different provinces 
(Figure 5.1.2).
Figure 5.1.2. Density of pharmacists and pharmacy assistants per 10,000, 
by province (Provincial Health Authorities, 2011)
Aside from provincial distribution imbalances, the graduate 
tracking survey also found a lack of pharmaceutical human 
resources in rural areas of each province; rural areas in some 
provinces lacked pharmaceutical staff entirely (Figure 5.1.3).
Figure 5.1.3. Proportion of pharmacists and pharmacy assistants in rural 
areas, by province (Provincial Health Authorities, 2011)
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In a February 2012 workshop, key stakeholders voiced their 
concern regarding the growth in the proportion of non 
pharmaceutical cadres and informal workers, stressing that 
it posed major risks to the public and reduced the number of 
available positions for pharmacy graduates. The assessment
showed that physician assistants had a major role in the pro-
vision of pharmaceutical services in health facilities –the pro-
portion of health facilities for which they were responsible for 
dispensing was comparable to that of pharmacy assistants.
The assessment also identified key competency gaps. Of the 
surveyed individuals:
• 40% did not have any or only had very little knowledge of 
   formularies and essential drug lists,
• 36% did not have or had very limited ability to arrange 
   pharmaceutical products based on storage guidelines, and
• 24% indicated being able to fully evaluate the appropriate-
   ness of prescribed medicines.
Low salaries
The average pharmacist and pharmacy assistant earn similar 
salaries (around 5,500 to 7,500 Afghanis per month or US$115 
to 155). With the increasing cost of living in Afghanistan, these 
salaries make it difficult for pharmaceutical human resources 
to earn a living.
5.1.3. Strategies used and lessons learned
This section describes the strategies applied through the 
pharmaceutical human resources assessment and strategic 
framework development processes and key lessons learned 
and summarises the strategic objectives in the human 
resources framework. 
Needs-based approach
The needs in Afghanistan are unique, particularly given the 
conditions, history, and trends in the pharmaceutical sector. 
The core team first identified what information they would 
need in order to develop a strategic plan, and from this they 
identified a set of assessment objectives. They used these 
assessment objectives to guide processes to adapt existing 
WHO tools [3] or to develop required tools (e.g., graduate 
tracking tool, competency assessment tool).
The assessment thus set out to address specific information 
needs, generating data to inform the development of a 
strategic plan that addresses priority pharmaceutical human 
resources issues. Specific assessment objectives and their 
purposes at each level are summarized in Table 5.1.1.
Table 5.1.1. Purpose of assessments at each level
The integration of the assessment and strategic framework 
development processes into broader MoPH efforts was 
critical, as was ensuring alignment with existing strategic plans 
such as the Human Resources Management and Development 
strategic objectives and priority interventions described in the 
MoPH Strategic Plan 2011–2015.
Multi-stakeholder engagement
Pharmaceutical human resources is a relatively new focus area, 
and this assessment and strategic framework  development 
process provided opportunities for key  stakeholders to engage 
in discussions and share information and insights required to 
see different dimensions of complex and challenging issues. 
Before the first stakeholders’ forum in 2010, the core team 
conducted a stakeholder analysis to identify priority 
stakeholders to engage. Throughout the  process, a broad 
range of stakeholders that influence  pharmaceutical human 
resources planning, management, or development were kept 
informed and invited to contribute to the development of the 
strategic framework. Such engagement was also key to gaining 
the commitment of stakeholders throughout the process, 
including stakeholders outside of the MoPH and 
pharmaceutical sector who hold decision-making authority 
over strategies described in the strategic framework.
Evidence-based approach
Prior to 2010, there was a lack of information on pharmaceutical 
human resources and a lack of data that described priority 
issues. The pharmaceutical human resources assessment provided 
muchneeded information to inform human resources planning, 
management, and development. The assessment was carried out 
at the national, provincial, facility, and individual levels. 
The national and provincial level assessments were conducted 
in the first phase, and consisted of a review of existing policy 
documents and records. Facility-and individual-level assessments 
were conducted in four provinces (Kabul, Hirat, Nangahar, and 
Balkh) across 205 randomly selected facilities (Table 5.1.2). A total 
of 265 personnel providing pharmaceutical services filled out an 
.................................................................................
Assessment 
levels
National
Provincial
Facility
Individual
Purpose
To identify total number of pharmaceutical personnel, data 
sources for information on pharmaceutical human resources, 
and current policies and strategies for pharmaceutical human 
resources.
To identify number of facilities providing pharmaceutical 
services and total pharmaceutical human resources and 
distribution, and to gather facility lists.
To determine employee demographics, cadres providing 
pharmaceutical services, and human resources policies 
in each facility. 
To examine the work environment, supervisory support 
provided and received, support for training received, and 
competencies of cadres providing pharmaceutical services.
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Figure 5.1.1. Overview of the assessment and strategic framework 
development process
5.1.2. Key Issues
Major pharmaceutical human resources issues in Afghanistan 
include:
Gaps in information and information flow
Prior to 2010, there was limited information available about 
the pharmaceutical human resources in Afghanistan with 
regards to density, distribution, roles, competency 
development needs, or projected human resources 
requirements. Information on pharmaceutical human 
resources was also not disaggregated by cadres. Information 
regarding pharmacist and pharmacy assistant graduates and 
vacancies did not systematically flow among training 
institutions, GDPA, and GDHR. The lack of a licensing renewal 
mechanism meant that information kept by GPDA on the 
number of pharmacists was out of date, and the directorate 
had no way of knowing which of pharmacists were in-country 
and actively working in the pharmaceutical sector. All of these 
factors made it difficult to maintain an up-to-date and 
accurate human resources information system to inform 
human resources for health (HRH) planning. There was also 
limited interaction, information flow, and coordination among 
MoPH, training institutions, employers, and development 
partners on pharmaceutical human resources issues. Although 
stakeholders recognized the importance of these issues, there 
was an absence of pharmaceutical human resources strategies 
and plans designed to address them.
Pharmaceutical human resources shortage 
and distribution imbalance
The last few decades have seen rapid growth in the number 
of private sector pharmacies in Afghanistan, particularly in 
urban areas, as a result of demand and weakened regulatory 
mechanisms. Over time, the number of private pharmacies has 
far exceeded the supply of pharmaceutical human resources 
in the labor market. Increasingly, other health workers and lay
workers provide pharmaceutical services in both private and 
public sectors. Of the 136 private pharmacy personnel 
participating in the assessment, only 11% were pharmacists 
and 21% were pharmacy assistants; the majority were other 
cadres including nurses, physician assistants, teachers, school 
students, and lay workers. Although pharmaceutical 
establishments outnumber the pharmaceutical workforce, 
only 57% of pharmacists who graduated between 2009 and 
2010 worked in the pharmaceutical sector, and 20% were 
unemployed at the time of the graduate tracking survey in 
February 2012.
The survey also found maldistribution of pharmacists and
pharmacy assistants, with the density varying from zero to 
more than three per 10,000 population in different provinces 
(Figure 5.1.2).
Figure 5.1.2. Density of pharmacists and pharmacy assistants per 10,000, 
by province (Provincial Health Authorities, 2011)
Aside from provincial distribution imbalances, the graduate 
tracking survey also found a lack of pharmaceutical human 
resources in rural areas of each province; rural areas in some 
provinces lacked pharmaceutical staff entirely (Figure 5.1.3).
Figure 5.1.3. Proportion of pharmacists and pharmacy assistants in rural 
areas, by province (Provincial Health Authorities, 2011)
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In a February 2012 workshop, key stakeholders voiced their 
concern regarding the growth in the proportion of non 
pharmaceutical cadres and informal workers, stressing that 
it posed major risks to the public and reduced the number of 
available positions for pharmacy graduates. The assessment
showed that physician assistants had a major role in the pro-
vision of pharmaceutical services in health facilities –the pro-
portion of health facilities for which they were responsible for 
dispensing was comparable to that of pharmacy assistants.
The assessment also identified key competency gaps. Of the 
surveyed individuals:
• 40% did not have any or only had very little knowledge of 
   formularies and essential drug lists,
• 36% did not have or had very limited ability to arrange 
   pharmaceutical products based on storage guidelines, and
• 24% indicated being able to fully evaluate the appropriate-
   ness of prescribed medicines.
Low salaries
The average pharmacist and pharmacy assistant earn similar 
salaries (around 5,500 to 7,500 Afghanis per month or US$115 
to 155). With the increasing cost of living in Afghanistan, these 
salaries make it difficult for pharmaceutical human resources 
to earn a living.
5.1.3. Strategies used and lessons learned
This section describes the strategies applied through the 
pharmaceutical human resources assessment and strategic 
framework development processes and key lessons learned 
and summarises the strategic objectives in the human 
resources framework. 
Needs-based approach
The needs in Afghanistan are unique, particularly given the 
conditions, history, and trends in the pharmaceutical sector. 
The core team first identified what information they would 
need in order to develop a strategic plan, and from this they 
identified a set of assessment objectives. They used these 
assessment objectives to guide processes to adapt existing 
WHO tools [3] or to develop required tools (e.g., graduate 
tracking tool, competency assessment tool).
The assessment thus set out to address specific information 
needs, generating data to inform the development of a 
strategic plan that addresses priority pharmaceutical human 
resources issues. Specific assessment objectives and their 
purposes at each level are summarized in Table 5.1.1.
Table 5.1.1. Purpose of assessments at each level
The integration of the assessment and strategic framework 
development processes into broader MoPH efforts was 
critical, as was ensuring alignment with existing strategic plans 
such as the Human Resources Management and Development 
strategic objectives and priority interventions described in the 
MoPH Strategic Plan 2011–2015.
Multi-stakeholder engagement
Pharmaceutical human resources is a relatively new focus area, 
and this assessment and strategic framework  development 
process provided opportunities for key  stakeholders to engage 
in discussions and share information and insights required to 
see different dimensions of complex and challenging issues. 
Before the first stakeholders’ forum in 2010, the core team 
conducted a stakeholder analysis to identify priority 
stakeholders to engage. Throughout the  process, a broad 
range of stakeholders that influence  pharmaceutical human 
resources planning, management, or development were kept 
informed and invited to contribute to the development of the 
strategic framework. Such engagement was also key to gaining 
the commitment of stakeholders throughout the process, 
including stakeholders outside of the MoPH and 
pharmaceutical sector who hold decision-making authority 
over strategies described in the strategic framework.
Evidence-based approach
Prior to 2010, there was a lack of information on pharmaceutical 
human resources and a lack of data that described priority 
issues. The pharmaceutical human resources assessment provided 
muchneeded information to inform human resources planning, 
management, and development. The assessment was carried out 
at the national, provincial, facility, and individual levels. 
The national and provincial level assessments were conducted 
in the first phase, and consisted of a review of existing policy 
documents and records. Facility-and individual-level assessments 
were conducted in four provinces (Kabul, Hirat, Nangahar, and 
Balkh) across 205 randomly selected facilities (Table 5.1.2). A total 
of 265 personnel providing pharmaceutical services filled out an 
.................................................................................
Assessment 
levels
National
Provincial
Facility
Individual
Purpose
To identify total number of pharmaceutical personnel, data 
sources for information on pharmaceutical human resources, 
and current policies and strategies for pharmaceutical human 
resources.
To identify number of facilities providing pharmaceutical 
services and total pharmaceutical human resources and 
distribution, and to gather facility lists.
To determine employee demographics, cadres providing 
pharmaceutical services, and human resources policies 
in each facility. 
To examine the work environment, supervisory support 
provided and received, support for training received, and 
competencies of cadres providing pharmaceutical services.
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individual-level assessment tool, providing data on their 
background, working conditions, and competency 
development needs.
Table 5.1.2. Pharmaceutical human resources assessment: Facilities
The findings helped to inform in-depth discussions during a 
stakeholder consultation hosted by MoPH in February 2012 to 
develop a draft pharmaceutical human resources strategic 
framework. These findings provided data that at times challenged 
the perceived nature of problems and helped multiple 
stakeholders arrive at a shared understanding of key issues and 
their underlying causes. The assessment findings were published 
as a factsheet, and small group discussions were held to identify 
key issues and their causes, in order to propose strategic 
objectives and determine appropriate strategies (Table 5.1.3).
Table 5.1.3. Pharmaceutical human resources strategic framework objectives
5.1.4. Outcomes
Stakeholders in Afghanistan successfully developed a 
competency framework, applied this framework to assess the 
competency development needs of individuals providing 
pharmaceutical services across both the public and private 
sector, identified information needs, defined assessment 
objectives, adapted and developed assessment tools to meet these 
objectives, and completed the assessment to provide an evidence 
base to inform pharmaceutical human resources planning.
The MoPH convened stakeholders in February 2012 to review 
findings and draft a pharmaceutical human resources strategic 
framework. This strategic framework outlines strategic objectives 
for workforce planning, management, and development, along 
with strategies, opportunities, barriers, and stakeholder roles. 
Following widespread consultation on the draft strategic
framework with 38 national and international stakeholder 
groups, consensus on the strategic framework was achieved on 
2nd July. The framework will be used to inform the MoPH 
operational planning process to determine how priority 
pharmaceutical human resources strategic objectives can 
be implemented going forward.
The pharmaceutical human resources strategic framework seeks 
to outline a national strategy for the planning, management, and 
development of pharmaceutical human resources in the public 
and private sectors in Afghanistan. It will inform the wider Human 
Resources for Health strategic and operational plans, and will 
bring stakeholders together around a common framework for 
action to strengthen pharmaceutical human resources.
The MoPH will be working together with stakeholders and 
development partners on priority strategic objectives over the next 
three years. Efforts include developing pharmaceutical human 
resources projections, strengthening the pharmaceutical human 
resources information system, scaling up community pharmacy 
assistant training programmes, reviewing and revising pre-service 
curriculum, forming a Pharmacy Council to license and regulate 
pharmacists and pharmacy assistants, improving basic 
pharmaceutical service competencies, and advocating for
 increases in private and public sector salaries.
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FACILITY TYPE                                              NUMBER OF FACILITIES
Manufacturers                 4
Wholesalers                10
Private hospitals                9
Private pharmacies              125
Public hospitals               46
Governmental pharmacies                8
Other: Government directorates,     3 
Quality Control Lab
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Z^ac`gV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individual-level assessment tool, providing data on their 
background, working conditions, and competency 
development needs.
Table 5.1.2. Pharmaceutical human resources assessment: Facilities
The findings helped to inform in-depth discussions during a 
stakeholder consultation hosted by MoPH in February 2012 to 
develop a draft pharmaceutical human resources strategic 
framework. These findings provided data that at times challenged 
the perceived nature of problems and helped multiple 
stakeholders arrive at a shared understanding of key issues and 
their underlying causes. The assessment findings were published 
as a factsheet, and small group discussions were held to identify 
key issues and their causes, in order to propose strategic 
objectives and determine appropriate strategies (Table 5.1.3).
Table 5.1.3. Pharmaceutical human resources strategic framework objectives
5.1.4. Outcomes
Stakeholders in Afghanistan successfully developed a 
competency framework, applied this framework to assess the 
competency development needs of individuals providing 
pharmaceutical services across both the public and private 
sector, identified information needs, defined assessment 
objectives, adapted and developed assessment tools to meet these 
objectives, and completed the assessment to provide an evidence 
base to inform pharmaceutical human resources planning.
The MoPH convened stakeholders in February 2012 to review 
findings and draft a pharmaceutical human resources strategic 
framework. This strategic framework outlines strategic objectives 
for workforce planning, management, and development, along 
with strategies, opportunities, barriers, and stakeholder roles. 
Following widespread consultation on the draft strategic
framework with 38 national and international stakeholder 
groups, consensus on the strategic framework was achieved on 
2nd July. The framework will be used to inform the MoPH 
operational planning process to determine how priority 
pharmaceutical human resources strategic objectives can 
be implemented going forward.
The pharmaceutical human resources strategic framework seeks 
to outline a national strategy for the planning, management, and 
development of pharmaceutical human resources in the public 
and private sectors in Afghanistan. It will inform the wider Human 
Resources for Health strategic and operational plans, and will 
bring stakeholders together around a common framework for 
action to strengthen pharmaceutical human resources.
The MoPH will be working together with stakeholders and 
development partners on priority strategic objectives over the next 
three years. Efforts include developing pharmaceutical human 
resources projections, strengthening the pharmaceutical human 
resources information system, scaling up community pharmacy 
assistant training programmes, reviewing and revising pre-service 
curriculum, forming a Pharmacy Council to license and regulate 
pharmacists and pharmacy assistants, improving basic 
pharmaceutical service competencies, and advocating for
 increases in private and public sector salaries.
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5.2 Country Case Study: Costa Rica
Authors
Freddy Arias Mora, Professor, Faculty of Pharmacy, University 
of Costa Rica and Fiscal, the Colegio de Farmacéuticos de Costa 
Rica, freddy.arias_m@ucr.ac.cr; and Beatriz Badilla Baltodano, 
Professor, Faculty of Pharmacy, University of Costa Rica, 
beatriz.badilla@ucr.ac.cr
Summary
• The Colegio de Farmacéuticos de Costa Rica (Costa Rica’s 
   Pharmacists Association) has regulated general pharmacist 
   practice since 1902 and, since 1986, the registration of specialists 
   in various areas of pharmacy practice.
• Currently, Costa Rica has no specific policy regarding pharmaceutical 
    human resources planning to address the needs of the nation.
• There are 3,378 active pharmacists registered as of March 2012 
   (78.5 active pharmacists per 100,000 population).
• The majority of pharmacists practice in two main areas: health   
   care pharmacy (64.60%) and the pharmaceutical industry (31.68%).
• On average, there is one private pharmacy for every 4,454 
   inhabitants, although the geographical distribution is unequal; 
   there is an average of one public (state) pharmacy for every 
   15,390 inhabitants.
• There is a need to further develop leadership among pharmacy 
   professionals to become empowered in their profession and 
   capable of facing current and future challenges.
5.2.1. Background
Costa Rica is a country covering an area of 51,100 km2 located 
in Central America with a population of 4.6 million inhabitants 
[1]. Since 1941, there has been a supportive social security 
system (Caja Costarricense de Seguro Social), which provides 
comprehensive health services to all inhabitants in the 
country without discrimination [2].
Pharmaceutical human resources 
in the country
The number of active pharmacists in Costa Rica in March 2012 is 
3,378, of which 69% are female and 28% male. Half are under 35 
years of age. The number of active pharmacists per 100,000 
inhabitants in the country in 2012 is 78.5. There are no unemployed 
pharmacists in the country [3]. There are no certified pharmacist 
assistants, as this training is not provided in Costa Rica. 
Distribution and human resources roles of 
pharmacists
The majority of professionals practice in two main areas, in the 
health care pharmacy area (64.60%) and the pharmaceutical 
industry area (22.36%). The health care pharmacy area includes 
professionals working in community pharmacies and hospital 
pharmacies, both public and private.
Roles in the pharmaceutical industry area include medical 
representatives, regents of pharmaceutical distributors, 
regulatory affairs, pharmaceutical industry and clinical 
research. In addition, 1.24% of pharmacists have roles in 
teaching and research. Figure 5.2.1 describes the distribution 
of areas of practice of pharmacists working in the country.
Figure 5.2.1. Distribution of pharmacy practice areas
Source: Data obtained from the Colegio de Farmacéuticos de Costa Rica, 2012.
Community pharmacies and hospitals are divided between the 
public and private sectors. The roles developed in this area of 
practice include: dispensing, pharmaceutical advice, 
pharmacovigilance, and pharmaceutical care-all activities carried 
out under the standards and regulations issued by the Ministry of 
Health of Costa Rica [4]. In a study conducted in 2009, it was found 
that the main services offered in pharmacies include providing 
written information for promoting health and providing 
injections, blood pressure, and blood glucose measurement [5].
The roles of pharmacists in the pharmaceutical industry 
are indispensable, as national legislation requires that all 
pharmaceutical companies and medicines distribution 
companies must have a professional pharmacist who is in 
charge. Even the roles of medical representatives must be 
performed by a pharmacist or a physician.
To practice as a pharmacist in Costa Rica, enrollment in the
Colegio de Farmacéuticos de Costa Rica and possessing a 
degree in pharmacy is required; however there is no 
pre-regitration exam.
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Distribution of pharmaceutical facilities
In Costa Rica there are three types of pharmaceutical facilities 
establishments that require management by pharmacists: 1) 
public and private pharmacies, 2) pharmaceutical manufacturing 
laboratories, and 3) pharmaceutical distributors. The country has 
337 pharmaceutical distributors and 75 pharmaceutical 
manufacturing laboratories. Table 5.2.1 shows the distribution 
of pharmacies and the number of inhabitants per pharmacy, 
according to the seven provinces that constitute the country. 
On average, there is one private pharmacy for every 4,454 
inhabitants, although geographical distribution is unequal. 
In public (state) pharmacies there is an average 15,390 
inhabitants per pharmacy.
Table 5.2.1. Distribution of pharmacies
Source: Data obtained from, and used with the permission of, the Colegio de 
Farmacéuticos de Costa Rica, 2012.
Regulation of professional practice
In Costa Rica, professional practice is regulated by the Colégio 
de Farmacéuticos, which is delegated by the State to do so. 
The Colegio works to ensure the proper implementation of 
national legislation in pharmaceutical establishments, to 
monitor the professional authority in such facilities, and to
respond to societal demands. An essential tool for effective 
regulation of professional practice is to propose amendments 
to the laws and regulations related to medicines. However, 
it is a lengthy process to amend regulations.
Pharmaceutical education
From 1940 to 1998, the state university, University of Costa 
Rica (UCR), was the only institution that offered a pharmacy 
degree. In 1998, however, the first pharmacists graduated from 
a private university, which had a shorter degree than the state 
university and a different curriculum. Curricula and general 
activities of private universities are designed according to 
the legislation established by the National Council of Private 
Higher Education (CONESUP) within the Ministry of Education, 
as opposed to the public universities, which are governed by 
the National Council of Deans (CONARE).
To date, aside from UCR, there are four private universities that 
offer pharmacy degrees: La Universidad Interamericana de las 
Américas (UIA), La Universidad Iberoamericana (UNIBE), 
Number of public 
pharmacies
Population per public
pharmacy
Number of private 
pharmacies
Population per private 
pharmacy
Province
ALAJUELA        57        16085                156                    3486
     
CARTAGO        22        19295                77                    2948
     
GUANACASTE       29         7698                 70                    1744
   
HEREDIA        22        19551               123                    2140
LIMÓN        30        13548                42                    6889
PUNTARENAS       46         5503                66                    2388
     
SAN JOSÉ        59        26051               407                    2080
     
Total       265        15816               941                    4454
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La Universidad de Ciencias Médicas (UCIMED) and Universidad 
Latina (ULATINA), which opened in 2011 with no graduates 
to date. Table 5.2.2 presents the number of professionals 
registered in the Colegio de Farmacéuticos, according to their 
university of origin, between 2001 and 2011. In this period,
2,092 new professionals were registered. The number of 
pharmacy professionals doubled in a decade, for the first time 
in 100 years.
Table 5.2.2. Registrants in the Colegio de Farmacéuticos de Costa Rica, 
by university of origin and year of registration, from 2001 to 2011
Source: Data obtained from, and used with the permission of, Colegio de 
Farmacéuticos de Costa Rica. 2012
There are also postgraduate programmes for pharmacists 
offered only at UCR, which has academic expertise in: analysis 
and quality control of medicines and a recently-established 
master’s degree in pharmaceutical care. There are also 
postgraduate programmes in administration, finance, 
marketing, and other areas of interest.
Development of pharmaceutical specialties
Pharmacists also have the opportunity to specialize in areas 
of practice, such as public health, pharmacology, biochemistry, 
physiology, pharmacoeconomics and health services 
administration. The Colegio de Farmacéuticos has regulated 
the registration of specialists from both academic and 
vocational training since 1986. Currently the institution has 
enrolled 261 professionals, most of whom are specialists in 
management health facilities (96), followed by specialists in 
the analysis and quality control of medicines (26) [6].
5.2.2. Key challenges
Variation in pharmacy education provision
The pharmacy curriculum varies between universities due to 
differences in the content and depth provided for different 
subjects. Courses in biopharmaceuticals, pharmacokinetics, 
pharmaceutical care and pharmaceutical marketing are not 
always found in the curriculum, despite being important 
areas of practice.
There is also a major disparity regarding the duration of degree 
programmes. At UNIBE, completing coursework for the pharmacy 
bachelor’s degree takes 3.3 years; at UCIMED, 4.5 years; at LATINA 
and UIA, 4 years; and in the UCR, 5.5 years. With regards to 
community service, students from UCR have to provide 300 hours 
of community work, whereas the remaining universities only 
require 150 hours, as set by CONESUP. Humanies and other 
non-degree related courses are only taught at UCR.
Year
University       2001        2002        2003        2004        2005        2006         2007        2008        2009        2010        2011        Total
UIA         16              58            114            73             22             42               35             54             58             42               77           591
UNIBE                33              33             42             40             54             56               74             89              43            75              113          652
UCIMED             0               11                7              46            13             18                8               33              10            21               19           186
UCR                    77              94              75             77            50             34               56             43              55            44               58            663
Total                 126            196           238          236          139          150             173          219           166          182            267         2092
34 35
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Summary
• The Colegio de Farmacéuticos de Costa Rica (Costa Rica’s 
   Pharmacists Association) has regulated general pharmacist 
   practice since 1902 and, since 1986, the registration of specialists 
   in various areas of pharmacy practice.
• Currently, Costa Rica has no specific policy regarding pharmaceutical 
    human resources planning to address the needs of the nation.
• There are 3,378 active pharmacists registered as of March 2012 
   (78.5 active pharmacists per 100,000 population).
• The majority of pharmacists practice in two main areas: health   
   care pharmacy (64.60%) and the pharmaceutical industry (31.68%).
• On average, there is one private pharmacy for every 4,454 
   inhabitants, although the geographical distribution is unequal; 
   there is an average of one public (state) pharmacy for every 
   15,390 inhabitants.
• There is a need to further develop leadership among pharmacy 
   professionals to become empowered in their profession and 
   capable of facing current and future challenges.
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Latina (ULATINA), which opened in 2011 with no graduates 
to date. Table 5.2.2 presents the number of professionals 
registered in the Colegio de Farmacéuticos, according to their 
university of origin, between 2001 and 2011. In this period,
2,092 new professionals were registered. The number of 
pharmacy professionals doubled in a decade, for the first time 
in 100 years.
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There are also postgraduate programmes for pharmacists 
offered only at UCR, which has academic expertise in: analysis 
and quality control of medicines and a recently-established 
master’s degree in pharmaceutical care. There are also 
postgraduate programmes in administration, finance, 
marketing, and other areas of interest.
Development of pharmaceutical specialties
Pharmacists also have the opportunity to specialize in areas 
of practice, such as public health, pharmacology, biochemistry, 
physiology, pharmacoeconomics and health services 
administration. The Colegio de Farmacéuticos has regulated 
the registration of specialists from both academic and 
vocational training since 1986. Currently the institution has 
enrolled 261 professionals, most of whom are specialists in 
management health facilities (96), followed by specialists in 
the analysis and quality control of medicines (26) [6].
5.2.2. Key challenges
Variation in pharmacy education provision
The pharmacy curriculum varies between universities due to 
differences in the content and depth provided for different 
subjects. Courses in biopharmaceuticals, pharmacokinetics, 
pharmaceutical care and pharmaceutical marketing are not 
always found in the curriculum, despite being important 
areas of practice.
There is also a major disparity regarding the duration of degree 
programmes. At UNIBE, completing coursework for the pharmacy 
bachelor’s degree takes 3.3 years; at UCIMED, 4.5 years; at LATINA 
and UIA, 4 years; and in the UCR, 5.5 years. With regards to 
community service, students from UCR have to provide 300 hours 
of community work, whereas the remaining universities only 
require 150 hours, as set by CONESUP. Humanies and other 
non-degree related courses are only taught at UCR.
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Accreditation 
Only two universities have degrees that are currently 
accredited by the National System of Higher Education 
Accreditation (SINAES), established in 1992, in order to promote 
and certify quality assurance in both public and private higher 
education institutions [7]. Accreditation is voluntary and is 
valid for four years, after which the curriculum must undergo 
the process of evaluation by the accrediting staff to obtain 
re-accreditation. The accreditation applies to courses or
programmes, not to the schools or academic institutions.
Pharmaceutical human resources planning
Costa Rica has no specific policy regarding pharmaceutical 
human resources planning to address the needs of the nation. 
Pharmacy education responds to market needs by providing 
professionals that the country needs at the moment.
Due to the need for an education model that best meets 
professional and societal requirements, international 
benchmarks have issued guidelines or called for the need to 
target training to necessary skills and competencies. 
Badilla and Bolaños [8] propose, along with the harmonization 
of course content, a list of generic competencies that must 
be obtained by students. This work is complemented by the 
work undertaken by agencies such as Pan American Health 
Organization (PAHO)/World Health Organization (WHO) in the 
establishment of specific skill sets in pharmacy. This new 
approach responds to the global need for change. 
The challenge for the universities is to provide teachers with 
the appropriate tools for specific skills training, including the 
assessment of these skills.
Systematic evaluations of professional 
performance
There are no systematic evaluations of professional 
performance in the country and no mandatory recertification
or other systems that mandate the professional to keep 
up-to-date. If a practitioner harms a patient or society, the only 
action that can be taken is to bring the matter to professional 
or legal courts.
5.2.3. Strategies and outcomes
Continuing education and recertification 
for pharmacists
Several strategies are used to promote continuous professional 
education, primarily through the Colegio de Farmacéuticos 
and universities. The universities offer courses for practicing 
professionals as well as conferences in specific areas of
practice such as in pharmaceutical care and toxicology. It is the 
responsibility of the university to offer postgraduate studies.
The Colegio de Farmacéuticos has a professional recertification 
programme, which is voluntary and charges an annual fee to the 
professional who wants to participate. This programme aims to 
encourage the participation of pharmacists in professional 
development activities and, through the commission of 
recertification and continuing education committee, manages 
to systematize and evaluate educational activities. In order to 
adequately address the educational proposals, a survey for 
education needs is conducted every two years.
Through the strategies used and the range of activities aimed 
at the needs of professionals, there has been an increased 
participation in the recertification programme, from an initial 
10% in 2004 to 30% in 2012.
There has been a wide range of education activities provided 
by the pharmaceutical industry, professional associations, and 
private companies. The Social Security System recognizes this 
recertification programme and offers a higher salary for 
recertified professionals working in the public sector; however, 
this recognition has not yet been achieved in the private sector.
Accreditation
Since only two of the five universities offering the Degree of 
Pharmacist (UCR and the University of Medical Sciences) are 
accredited, the Colegio de Farmacéuticos, along with SINAES 
are working to establish specific criteria for the accreditation 
of pharmacy degrees [9].
Development of general skills
International organizations such as WHO have pointed out 
the need of developing skills in pharmacists that help them to 
implement pharmaceutical services focused on the individual, 
family, and community. Pharmacy schools are considering 
these recommendations to improve their curricula.
Implementation of the Renewed Primary 
Health Care initiative (PHC-R) by pharmacists
A national working committee on PHC-R has recently been 
established. It will operationalize and take action to overturn 
the widespread view of private pharmacies as mere 
commercial establishments and turn them into true health 
care centers. Also it is intended that public pharmacies 
become health care centers. The aim is to achieve the highest 
quality of service from the patient’s first contact with the 
pharmacist [10].
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Development of pharmaceutical specialties
Two major achievements are the consolidation of pharmaceutical 
specialties and the development of an objective system for
 registering and regulating specialties. These specialties are 
recognized by the Social Security system, with those registered 
and working in the public sector receiving a salaried incentive.
5.2.4. Conclusion
It is necessary to further develop pharmacy leadership in Costa 
Rica, enabling professionals to become empowered in their 
profession and capable of facing current and future challenges.
To advance the profession, it is necessary to promote the 
importance of recertification to the profession and to increase 
the number of specialists and the types of recognized 
specialties in the pharmaceutical field. It is also important to 
provide more support to pharmacy education, particularly in 
private universities.
In the area of pharmaceutical care, it is necessary to: promote 
services that a pharmacy must provide or develop, according 
to the PHC-R criteria; to update domestic policies on pharmacy 
practice; to create a plan for long-term development of 
pharmacies as health care centers; to identify the education 
that professionals require for these new services in professional 
practice; and to work with academic institutions to educate 
future professionals in both the technical and humanistic 
skills required by this new service approach.
In the absence of comprehensive human resource planning, 
it is necessary that national policies consider the pharmacy 
workforce, taking into account the current and emerging areas 
of work and the needs of the society and country.
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Summary
• Access to good quality medicines and competent health  
  care providers are fundamental aspects of the health care 
  system. Pharmaceutical human resources are responsible   
  for ensuring the uninterrupted supply of quality medicines to  
  the population, their management, and rational use, all these 
  being vital components of the architecture to improve access 
  to medicines. The human resources for health crisis affects 
  57 countries worldwide, including Ghana.
• In 2009, an assessment of pharmaceutical human resources 
  was undertaken in Ghana (funded by the WHO and the 
  European Commission), and the findings provided the 
  evidence, which informed a human resources strategic 
  framework and strategic pharmaceutical workforce plan. 
  The plan was developed by key stakeholders with the 
  intention of being integrated into the broader national 
  human resources plan for health. Some of the key findings   
  of the assessment were significant pharmaceutical human   
  resources shortages, inequitable distribution, skill mix 
  imbalances, and limited training capacity.
• Even though Ghana training institutions had produced over  
   2,500 pharmacists since 2009, only a little over 1,500 were 
   actively practicing in Ghana. Anecdotal evidence from the   
   Pharmacy Council of Ghana identified workforce retention 
   as the greatest challenge contributing to the key findings 
   observed. The following strategies were adopted to address   
   the workforce challenges, namely: expansion of training 
   institutions, improved remuneration packages in the public   
   sector, and the development and implementation of the   
   Doctor of Pharmacy (Pharm D) degree and other continuous   
   professional development (CPD) programmes.
5.3.1. Background
The introduction of pharmacy practice in the Gold Coast 
(now Ghana) in the 1930s was associated with the 
development of Western-type medical services in the country. 
Pharmacy has generally undergone tremendous changes both 
in concept and practice since then-major changes resulting 
in an emphasis on patients rather than medicines.
Pharmaceutical human resources in Ghana are required 
to provide services as diverse as medicines selection, 
procurement, compounding, dispensing, medicines 
information and advice, therapeutic drug monitoring, 
pharmacovigilance, manufacturing, training, and research.
Although Ghana has a register of 2969 pharmacists, 2139 
technicians and 4250 medicine counter assistants, only a total 
of 1,966 are actively practicing pharmacists (0.81 per 10,000 
population), 1,075 actively practicing pharmacy technicians 
(0.44 per 10,000), and 3,000 medicine counter assistants 
(1.24 per 10,000). In 2011, public and private sectors employed 
35% and 65% of pharmacists, respectively, compared to 26% 
and 74% in 2009. The pharmaceutical manufacturing industry 
only employs 4% of the pharmacy workforce; however, this 
sector is expanding with the establishment of new 
manufacturing sites and growth of existing companies.
Table 5.3.1. Number of pharmacists per employment sector
Data source: Assessment of Pharmaceutical Human Resources 2011(1).
*Pharmacists are allowed to work in more than one sector of employment.
Table 5.3.2. Total number of premises providing pharmaceutical services
Data source: Pharmacy Council Register of Pharmaceutical Facilities 2011
5.3.2. Key issues
Challenges affecting pharmacy workforce planning, 
management, and/or development.
1. Distribution imbalance of pharmaceutical personnel 
     between rural and urban areas
2. Needs-based pre-service pharmacy education
3. Poorly-defined roles of pharmaceutical personnel
4. CPD and career development: Lack of needs-based 
     CPD programmes
.................................................................................
 No. of pharmacists 
 (N=1,966)          
% Sector
Private Hospitals & Clinics                                                            16                    0.8
Private retail/wholesale pharmacies*                               1,931                   98.2
Pharmaceutical manufacturers                                   80                    4.0
Academia/teaching                                                    60                    3.0
Multilateral/bilateral/NGOs                                               6                    0.3
Not currently working                                                 N/A                   N/A
Public Health
Institucions
Public Hospitals & Christian Health
Association of Ghana (CHAG)                                        
505
Quasi Gov’t Hospitals                65
Regulatory                 75     33.0
                    Types of premise                                Number          Percentage          Number of pharmacists
Public hospital pharmacies         172                        1.3                                         570
Private hospitals/clinics dispensaries        925                        6.7                                          16
Private retail/wholesale pharmacies      2,007                14.6                                      1,931
Licensed Chemical Sellers      10,602                77.4                    N/A
                                 Total      13,706              100.0
.................................................................................
5. Recruitment: Significant delays in the recruitment of 
     personnel to the public sector (takes up to one year), which  
     serves as a barrier to increasing public sector workforce levels
6. Incentives for attracting personnel to work in rural areas 
     are not enforced
Projection and supply
Rural areas are the most affected when it comes to pharmaceutical 
personnel. There is a concentration of pharmacy personnel in 
urban areas due to lack of amenities and infrastructure such as 
quality public and private schools that act as a disincentive to 
working in the rural areas. Pharmaceutical cadres are concentrated 
in urban regions with the ratio of pharmacy personnel in each region 
ranging between 0.14-3.17 per 10,000 population for pharmacists 
(Table 5.3.3) and 0.12-0.52 for pharmacy technicians. This disparity has 
led to inequitable service provision. To ensure that only 
quality products are made available to the population, functional 
and well-resourced pharmaceutical supply and regulatory systems 
are required, with adequate numbers of trained personnel.
Table 5.3.3. Regional Distribution of Health facilities and Pharmacy Work-
force 2011
Figure 5.3.1. Comparative frequencies for density of pharmacists per 10,000 
and density of pharmacies per 10,000 in the different regions of Ghana 
(logarithmic scale to enable region comparison)
Sources: Ghana Statistical Service, 2010 Population and Housing Census; 
Private Hospitals and Maternity Homes Board Report, 2011; Pharmacy Unit 
MoH/Ghana Health Service (GHS) November 2011; Pharmacy Council, 2011
Education capacity, skill mix
There are currently three universities undertaking 
the training of pharmacists (Bachelor of Pharmacy degree) 
with a combined annual intake of 240 students in 2009; 
one pharmacy technician training school (Higher National 
Diploma) enrolling 90; and 21 Medicines Counter Assistants 
(MCA) programmes enrolling 600 students every six months. 
To date, there are no formalised training requirements for 
Licensed Chemical Sellers (LCS). However the Pharmacy 
Council (PC) organises annual training programmes for LCS 
and CPD programmes for pharmacists.
The curriculum for pharmacy education has also been revised 
to a Doctor of Pharmacy (Pharm. D) programme to improve 
patient-pharmacist interaction, address job satisfaction and 
career development challenges, and also bridge the wide gap 
between academia and practice to reflect emerging trends in 
health care delivery in other countries.
The Specialist Health Training and Plant Research Act [3] 
which establishes the College of Pharmacists is also being 
implmented to provide further opportunities for 
post-graduate and specialist training locally.
.................................................................................
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health facilities 
No. of private 
hospitals, clinics 
& maternity 
homes (PHCM)
Pharmacists % 
change 2009-11
Technicians % 
change 2009-11
Density 
pharmacists
/10,000 
population
Density 
pharmacies
/10,000 
population
Region
Greater               1238                       1328                              34                51           18.9     28.6                  3.17       3.40
Accra
Volta                       30   25                175                               55            7.1      2.4                  0.14       0.12
Region
Eastern              60    62                357               26           34.8     0.0                   0.23       0.24
Central                  46   44                106                84            2.2      8.1                  0.22       0.21
Region
Western              58        50                110              242            3.6      0.0                  0.25       0.21
Ashanti                 400       420                159              269           21.2      9.6                  0.85       0.89
Region
Brong                  58    48                 82               130           38.1      0.0                  0.25       0.21 
Ahafo
Northern              47   18                196               15                  67.9    42.1                  0.19       0.07
Region
Upper                  47   18                196               15           67.9    42.1                 0.19       0.07
East
Upper                 12     6                  57                2           50.0      0.0                 0.18       0.09
West
TOTALs           1966                      2007               1310              925              20.1   15.6                 0.81       0.83
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led to inequitable service provision. To ensure that only 
quality products are made available to the population, functional 
and well-resourced pharmaceutical supply and regulatory systems 
are required, with adequate numbers of trained personnel.
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Sources: Ghana Statistical Service, 2010 Population and Housing Census; 
Private Hospitals and Maternity Homes Board Report, 2011; Pharmacy Unit 
MoH/Ghana Health Service (GHS) November 2011; Pharmacy Council, 2011
Education capacity, skill mix
There are currently three universities undertaking 
the training of pharmacists (Bachelor of Pharmacy degree) 
with a combined annual intake of 240 students in 2009; 
one pharmacy technician training school (Higher National 
Diploma) enrolling 90; and 21 Medicines Counter Assistants 
(MCA) programmes enrolling 600 students every six months. 
To date, there are no formalised training requirements for 
Licensed Chemical Sellers (LCS). However the Pharmacy 
Council (PC) organises annual training programmes for LCS 
and CPD programmes for pharmacists.
The curriculum for pharmacy education has also been revised 
to a Doctor of Pharmacy (Pharm. D) programme to improve 
patient-pharmacist interaction, address job satisfaction and 
career development challenges, and also bridge the wide gap 
between academia and practice to reflect emerging trends in 
health care delivery in other countries.
The Specialist Health Training and Plant Research Act [3] 
which establishes the College of Pharmacists is also being 
implmented to provide further opportunities for 
post-graduate and specialist training locally.
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Performance management
The issue of workforce productivity remains a high priority 
for the Ministry of Health (MoH) as well as its agencies in the 
service and regulatory units. There appears to be no clear 
direction as to what constitutes health workforce productivity 
[1]. However, with the salary enhancement, the issue of 
signing performance contracts at all levels was revisited. 
The MoH and its agencies are presently working on the criteria 
for the performance contract. Health worker productivity and 
performance covers performance management, motivation, 
welfare, training, and continuing professional development.
There is currently no comprehensive system for performance 
management for the MoH. Staff appraisal appears to be the 
main performance management tool employed by all age cies. 
However, there is no objectivity in the performance appraisal 
process. There is no recognition/award or sanctions for good 
or poor performance. The appraisals are completed annually, 
and the process focuses mainly on promotions. There is lack of 
adequate training for staff and managers on the performance 
management.
Workforce distribution and retention
The retirement age for all workers in Ghana is sixty years, and 
this is seen as an area that contributes to the loss of skilled 
and experienced health professionals in the health system. 
It appears from available information and data that the overall 
attrition of professional health workers is on the decline due 
to the several positive interventions undertaken by 
government between 2001 and 2007, including the recent 
upsurge in production interventions. The recent public payroll 
analysis also confirms a general decline in attrition 
particularly after 2006. However, a recent MoH analysis 
indicates that retirement from the sector stands as the most 
consequential reason for attrition between 2004 and 2008.
Regulation, practice standards, 
and competency development
The pharmacy workforce is organized into groups whose 
practices are regulated by the Pharmacy Council, a statutory 
regulatory body. This is intended to ensure and maintain 
quality in practice and to safeguard the wellbeing of the 
public. There is disconnection among workforce needs, health 
sector policies, and strategies adopted by Ministry of 
Education (MoE) and private training institutions. As a result, 
training institutions under the MoE appear to be slow in 
responding to human resources plans under various 
programmes of work (POW) and the need to scale up the 
production of health workers. The legal and regulatory 
framework for educating health workers is equally splintered, 
and has emerged in an ad hoc manner. Although this is not 
unusual in terms of international practice, it creates a 
challenging regulatory environment and is prone to 
coordination problems. The introduction of the Health 
Workforce Observatory by the MoH is expected to address
this challenge as the technical committee on training has 
membership of all stakeholders in training.
Policy development and implementation
One key ingredient in ensuring equitable human resources 
distribution is the existence of a system for identifying and 
tracking the movement of personnel. Over the years, there 
have been various efforts aimed at setting up and 
implementing a human resources system. These efforts were 
mostly fragmented and region-based, lacking standardization 
and continuity nationwide. In collaboration with West African 
Health Organization (WAHO) and Capacity Plus, the MoH has 
initiated the process of implementing an effective human 
resource information system to guide relevant decision-
making. The system, when fully implemented, will have the 
components for planning regulation and management 
of human resource data that will go a long way to ensure 
effective distribution of staff. The system will serve as the 
human resources information system of a sub-regional body 
called the Economic Community of West African States.
................................................................................. .................................................................................
5.3.3. Strategies used and lessons learnt
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Table 5.3.4. Strategies used and lessons learnt
1.0 To integrate pharmaceutical human 
resources planning with broader human 
resources for health planning
2.0 To reduce delays in recruitment 
and improve retention of public sector
pharmaceutical  personnel
3.0 To further develop, review and 
dissemina te a comprehensive set
of practice standards for both 
the public and private sector
4.0 To review and reform curriculum
of preservice education to be 
needs-based, practiceoriented and linked 
to required competencies within 
the scope of practice for each cadre
5.0 To strengthen the academic 
capacity of training institutions
Opportunities
a. Pharmaceutical human resources 
planning already institutionalised within 
the Ministry of Health and its agencies
b. WAHO to pilot internet based human 
resource information system for the
pharmaceutical  sector
c. Pharmaceutical human resource
indicators included  in the District Health
Management Information System (DHMIS)
Barriers
a. Inadequate funding for human 
resource development
b. Lack of clarity on processes to request 
public sector funding for pharmaceutical
human resource development
Opportunities
a. Two new schools of pharmacy to 
increase intake
b. Commonwealth scholarships available 
for further study
c. The MoH ensures that only programmes 
that are not available in the country are
granted external fellowships
Barriers
a. Lack of well developed career pathway 
for pharmaceutical cadres
b. Lack of practice oriented post-graduate 
training programs
c. Annual fellowship plans are not fully 
implemented because the budgetary
allocation
Opportunities
a. Public and private sector facilities are
sponsoring upgrade training (eg, pharmacy 
technicians  to undergo BPharm program)
b. Pharmacy Council (PC) has an existing
website which can be improved and used 
to run online CPD programmes as well
as to disseminate information
Opportunities
a. Kwame Nkrumah University of Science 
and Technology (KNUST) is reviewing its 
BPharm curriculum to develop a PharmD 
programme
b. Pharmacy Council is developing a ﬁve 
year CPD programme plan for training of 
pharmacists, pharmacy technicians and
licensed chemical sellers
Opportunities
a. The establishment of Advisory Boards
composed of most key stakeholders for
holistic decision-making.
Ghana National Human Resource 
strategic plan  for the health 
sector been  revised to integrate
the pharmaceutical human resource
plan.
Public sector recruitment increased 
from 26% in 2009 to 35% in 2011.
Public sector salaries 
improved.
It is now more attractive to work
in the public sector than 
the private sector.
Practice standards for all categories 
of pharmacy workforce developed.
The PC in collaboration with KNUST 
and Ohio Northern University 
has developed the PharmD
curriculum.
KNUST to admit the ﬁrst batch 
of PharmD students this academic
year.
CPD programme for pharmacists
undertaken by the PC annually.
Similarly, LCS are trained annually.
KNUST has signed a memorandum
of understanding with other
international training institutions 
to develop faculty members 
and access to other training logistics.
1.1 To actively engage in the broader 
sectoral HRH planning processes of the  
MoH and GHS
1.2 To integrate the 2011 – 2016
pharmaceutical human resource plan into 
the  2011 – 2016 human resources for 
health plan
2.1 Pharmacy Council to build its capacity 
on pharmaceutical human resource issues 
by end 2012
2.2 To develop the capacity of  the 
technical working group to advocate, 
negotiate, and follow up on recruitment 
of pharmaceutical human resources
2.3 To negotiate  for improved 
remuneration and other incentive 
packages.
3.1 To form a review committee to examine 
existing practice standards documents
(Standards for Pharmaceutical Care, 
Practice Standards for Pharmacists, 
Licensed Chemical Sellers, Pharmacy 
Technicians and MCAs)
3.2 To develop one draft comprehensive 
standards document and circulate to all
stakeholders
4.1 To establish a pharmacy education 
reform working group
4.2 To evaluate existing tools for quality 
assurance and standardize them into 
single quality assurance tool
4.3 To conduct curriculum review and 
quality assessment  of all pre�service 
training programmes
4.4 To develop and implement plans for 
curriculum reform based on ﬁndings
5.1 To establish a working group on 
academic capacity development
5.2 To identify relevant postgraduate 
programmes and scholarships for 
academic staff
5.3 To build national and international 
exchange programmes between training
institutions as a mechanism for sharing 
and expanding academic capacity
5.4 To improve library capacities of training 
institutions and subscribe to databases 
and journals
Strategy                      Stakeholders Involved           Activity/Processes          Opportunities/Barriers                  Outcomes
Pharmaceutical human resources
technical working group, Human
Resource Development Directorate
(HRDD) GHS; Human Resource for Health 
and Development (HRHD)�MoH;
Human Resource for Health (HRH);
Teaching Hospitals,  WHO
Technical working group on
pharmaceutical human resource; 
Pharmacy Council;  Ghana Hospital
Pharmacist Association (GHOSPA),
Pharmacy Unit MoH; HRDD�GHS;
HRHD�MoH; Ministry of Finance and
Economic Planning (MOFEP)
PC, Pharmacy Unit/MoH, Ghana National 
Drugs Program, Pharmaceutical Society 
of Ghana (PSGH)
Training institutions, Pharmacy Council,
Pharmacy Unit/MoH, PSGH, HRHD/MoH,
HRDD/GHS, Ghana Education Service, 
MoE, World Health Organization (WHO)
MoE, Local and international training
Institutions; Private sector, Development
Partners; Ghana Education Trust Fund 
(GETFund)
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or poor performance. The appraisals are completed annually, 
and the process focuses mainly on promotions. There is lack of 
adequate training for staff and managers on the performance 
management.
Workforce distribution and retention
The retirement age for all workers in Ghana is sixty years, and 
this is seen as an area that contributes to the loss of skilled 
and experienced health professionals in the health system. 
It appears from available information and data that the overall 
attrition of professional health workers is on the decline due 
to the several positive interventions undertaken by 
government between 2001 and 2007, including the recent 
upsurge in production interventions. The recent public payroll 
analysis also confirms a general decline in attrition 
particularly after 2006. However, a recent MoH analysis 
indicates that retirement from the sector stands as the most 
consequential reason for attrition between 2004 and 2008.
Regulation, practice standards, 
and competency development
The pharmacy workforce is organized into groups whose 
practices are regulated by the Pharmacy Council, a statutory 
regulatory body. This is intended to ensure and maintain 
quality in practice and to safeguard the wellbeing of the 
public. There is disconnection among workforce needs, health 
sector policies, and strategies adopted by Ministry of 
Education (MoE) and private training institutions. As a result, 
training institutions under the MoE appear to be slow in 
responding to human resources plans under various 
programmes of work (POW) and the need to scale up the 
production of health workers. The legal and regulatory 
framework for educating health workers is equally splintered, 
and has emerged in an ad hoc manner. Although this is not 
unusual in terms of international practice, it creates a 
challenging regulatory environment and is prone to 
coordination problems. The introduction of the Health 
Workforce Observatory by the MoH is expected to address
this challenge as the technical committee on training has 
membership of all stakeholders in training.
Policy development and implementation
One key ingredient in ensuring equitable human resources 
distribution is the existence of a system for identifying and 
tracking the movement of personnel. Over the years, there 
have been various efforts aimed at setting up and 
implementing a human resources system. These efforts were 
mostly fragmented and region-based, lacking standardization 
and continuity nationwide. In collaboration with West African 
Health Organization (WAHO) and Capacity Plus, the MoH has 
initiated the process of implementing an effective human 
resource information system to guide relevant decision-
making. The system, when fully implemented, will have the 
components for planning regulation and management 
of human resource data that will go a long way to ensure 
effective distribution of staff. The system will serve as the 
human resources information system of a sub-regional body 
called the Economic Community of West African States.
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Table 5.3.4. Strategies used and lessons learnt
1.0 To integrate pharmaceutical human 
resources planning with broader human 
resources for health planning
2.0 To reduce delays in recruitment 
and improve retention of public sector
pharmaceutical  personnel
3.0 To further develop, review and 
dissemina te a comprehensive set
of practice standards for both 
the public and private sector
4.0 To review and reform curriculum
of preservice education to be 
needs-based, practiceoriented and linked 
to required competencies within 
the scope of practice for each cadre
5.0 To strengthen the academic 
capacity of training institutions
Opportunities
a. Pharmaceutical human resources 
planning already institutionalised within 
the Ministry of Health and its agencies
b. WAHO to pilot internet based human 
resource information system for the
pharmaceutical  sector
c. Pharmaceutical human resource
indicators included  in the District Health
Management Information System (DHMIS)
Barriers
a. Inadequate funding for human 
resource development
b. Lack of clarity on processes to request 
public sector funding for pharmaceutical
human resource development
Opportunities
a. Two new schools of pharmacy to 
increase intake
b. Commonwealth scholarships available 
for further study
c. The MoH ensures that only programmes 
that are not available in the country are
granted external fellowships
Barriers
a. Lack of well developed career pathway 
for pharmaceutical cadres
b. Lack of practice oriented post-graduate 
training programs
c. Annual fellowship plans are not fully 
implemented because the budgetary
allocation
Opportunities
a. Public and private sector facilities are
sponsoring upgrade training (eg, pharmacy 
technicians  to undergo BPharm program)
b. Pharmacy Council (PC) has an existing
website which can be improved and used 
to run online CPD programmes as well
as to disseminate information
Opportunities
a. Kwame Nkrumah University of Science 
and Technology (KNUST) is reviewing its 
BPharm curriculum to develop a PharmD 
programme
b. Pharmacy Council is developing a ﬁve 
year CPD programme plan for training of 
pharmacists, pharmacy technicians and
licensed chemical sellers
Opportunities
a. The establishment of Advisory Boards
composed of most key stakeholders for
holistic decision-making.
Ghana National Human Resource 
strategic plan  for the health 
sector been  revised to integrate
the pharmaceutical human resource
plan.
Public sector recruitment increased 
from 26% in 2009 to 35% in 2011.
Public sector salaries 
improved.
It is now more attractive to work
in the public sector than 
the private sector.
Practice standards for all categories 
of pharmacy workforce developed.
The PC in collaboration with KNUST 
and Ohio Northern University 
has developed the PharmD
curriculum.
KNUST to admit the ﬁrst batch 
of PharmD students this academic
year.
CPD programme for pharmacists
undertaken by the PC annually.
Similarly, LCS are trained annually.
KNUST has signed a memorandum
of understanding with other
international training institutions 
to develop faculty members 
and access to other training logistics.
1.1 To actively engage in the broader 
sectoral HRH planning processes of the  
MoH and GHS
1.2 To integrate the 2011 – 2016
pharmaceutical human resource plan into 
the  2011 – 2016 human resources for 
health plan
2.1 Pharmacy Council to build its capacity 
on pharmaceutical human resource issues 
by end 2012
2.2 To develop the capacity of  the 
technical working group to advocate, 
negotiate, and follow up on recruitment 
of pharmaceutical human resources
2.3 To negotiate  for improved 
remuneration and other incentive 
packages.
3.1 To form a review committee to examine 
existing practice standards documents
(Standards for Pharmaceutical Care, 
Practice Standards for Pharmacists, 
Licensed Chemical Sellers, Pharmacy 
Technicians and MCAs)
3.2 To develop one draft comprehensive 
standards document and circulate to all
stakeholders
4.1 To establish a pharmacy education 
reform working group
4.2 To evaluate existing tools for quality 
assurance and standardize them into 
single quality assurance tool
4.3 To conduct curriculum review and 
quality assessment  of all pre�service 
training programmes
4.4 To develop and implement plans for 
curriculum reform based on ﬁndings
5.1 To establish a working group on 
academic capacity development
5.2 To identify relevant postgraduate 
programmes and scholarships for 
academic staff
5.3 To build national and international 
exchange programmes between training
institutions as a mechanism for sharing 
and expanding academic capacity
5.4 To improve library capacities of training 
institutions and subscribe to databases 
and journals
Strategy                      Stakeholders Involved           Activity/Processes          Opportunities/Barriers                  Outcomes
Pharmaceutical human resources
technical working group, Human
Resource Development Directorate
(HRDD) GHS; Human Resource for Health 
and Development (HRHD)�MoH;
Human Resource for Health (HRH);
Teaching Hospitals,  WHO
Technical working group on
pharmaceutical human resource; 
Pharmacy Council;  Ghana Hospital
Pharmacist Association (GHOSPA),
Pharmacy Unit MoH; HRDD�GHS;
HRHD�MoH; Ministry of Finance and
Economic Planning (MOFEP)
PC, Pharmacy Unit/MoH, Ghana National 
Drugs Program, Pharmaceutical Society 
of Ghana (PSGH)
Training institutions, Pharmacy Council,
Pharmacy Unit/MoH, PSGH, HRHD/MoH,
HRDD/GHS, Ghana Education Service, 
MoE, World Health Organization (WHO)
MoE, Local and international training
Institutions; Private sector, Development
Partners; Ghana Education Trust Fund 
(GETFund)
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5.3.4. Conclusion
Pharmacy workforce retention was the main challenge identified 
by the 2009 pharmacy workforce assessment. 
This challenge emanated from many other factors relating 
to pre-service pharmacy education, job descriptions not specific 
to functional job areas, limited opportunities for career 
development, and inadequate rewards systems for the workforce.
The MoH and its agencies such as the Pharmacy Council, 
in consultation with the MoE and the Universities, is 
addressing pre-service pharmacy education challenges with 
the introduction of the Pharm D programme and the 
establishment of the College of Pharmacists to expand career 
development opportunities locally. Need-based post-service 
education programmes for all categories of the pharmacy 
workforce has also been implemented by the Pharmacy 
Council in collaboration with related agencies and donors.
There are efforts to improve the rewards systems and also 
streamline workforce training and development to meet 
institutional and personal needs to improve workforce retention 
and hence the quality of lives of all people living in Ghana.
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Summary
• The analysis of the General Pharmaceutical Council’s 2010 
   register of pharmacists indicated that there were 50,664 
   pharmacists in Great Britain, with the majority working
   in the community sector.
• There has been a period of unprecedented growth in the UK’s  
   health care workforce. Demand is also increasing.
• The UK’s current economic difficulties and restrictions on   
   public spending mean that further growth of the health    
   care workforce is unsustainable. The workforce will need to 
   work more productively in order to meet demand. Making 
   the pharmacy workforce more productive will require 
   a review of skill mix.
• There is increasing evidence that there is not an undersupply  
   of pharmacists in Great Britain.
• Health Education England (HEE) will provide sector-wide    
   leadership and oversight of workforce planning, education,    
   and training in the NHS in England. In Scotland and Wales,    
   this is the responsibility of the devolved administrations.
• It is important that a robust body of evidence is built to support    
   development of the pharmacy workforce in Great Britain.
• The Royal Pharmaceutical Society (RPS), the professional 
   leadership body for pharmacists and pharmacy, aspires to be 
   the national body that members of the profession, the public,
   and the government go to for advice about all aspects of the   
   pharmacy workforce.
5.4.1. Background
The pharmacy workforce in Great Britain continues to change. 
The General Pharmaceutical Council (GPhC) have regulated 
pharmacists since September 2010 (previously, the regulator 
was the Royal Pharmaceutical Society of Great Britain). 
Mandatory registration of pharmacy technicians with the 
GPhC has been in place since July 2011. Pharmacy assistants 
are not formally regulated but pharmacists are professionally 
accountable for this part of the workforce. The GPhC’s 
functions include approving qualifications, accrediting 
education and training providers, maintaining registers, 
setting standards, and establishing fitness to practice 
requirements. The Royal Pharmaceutical Society (RPS) is 
now the professional leadership body for pharmacists and 
pharmacy in England, Scotland, and Wales. The RPS promotes 
pharmacy to ensure that pharmacists are recognised within 
the NHS and wider society as experts in medicines. The RPS
is facilitating effective approaches to workforce planning 
and development for the profession.
Effective workforce planning and development supports 
pharmacy service quality by ensuring that a sufficient number 
of pharmacy staff with the right skills are in the right place, 
at the right time, at the right price [1]. Key to this is being able 
to understand the pharmacy workforce. Each year, an analysis 
of the register of pharmacists is conducted, providing useful 
demographic data. The most recent published analysis conducted 
in August 2010 [2] indicated that there were 50,664 pharmacists 
in Great Britain and that the register had grown by 2% since 2009. 
Information was also provided about age, gender, ethnicity, and 
entrants/exits from the register. Numbers of independent 
and supplementary prescribers were also described.       
Findings from the pharmacy workforce census [3] conducted in 
2008 provide information about the socio-demographic profile 
and employment patterns of pharmacists. Analysis based on 
data from respondents to the census (from 69.6% of registered 
GB resident pharmacists) indicates that most pharmacists were 
employed in the community sector (71.0%), with 21.4% work-
ing in hospital pharmacy. Significantly, community pharmacy 
locum posts accounted for 23.1% of all posts.
5.4.2. Key issues
The NHS
Over the decade between September 2000 and September 
2010, the National Health Service (NHS) workforce grew by 30% 
[4], reaching 1.4 million people employed and maintaining 
its place as the third largest workforce in the world. The UK’s 
(Great Britain and Northern Ireland) economic difficulties and 
restrictions on public spending have made this growth 
unsustainable. The focus now is to increase the productivity 
of the workforce – in other words, provide the same quality 
of service with the same number of staff or less. However, 
demand for health is increasing: The population is living longer 
and is more reliant on medicines. In England the proportion of 
the population aged 60 and over has risen from 20.7% in 2000 
to 22.4% in 2010, and there is a strong relationship between the 
proportion of the population aged 60 and over and the number 
of prescription items dispensed.
This relationship is reflected in the rising number of 
prescriptions dispensed each year. In 2010 community 
pharmacies dispensed 926.7 million prescription items [5], 
an increase of 3.5% from 2009 and an increase of 58.2% 
from 2000. Evidence from the NHS Pharmacy Education 
and Development Committee’s 2011 National NHS 
Pharmacy Establishment and Vacancy Survey [6],
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5.3.4. Conclusion
Pharmacy workforce retention was the main challenge identified 
by the 2009 pharmacy workforce assessment. 
This challenge emanated from many other factors relating 
to pre-service pharmacy education, job descriptions not specific 
to functional job areas, limited opportunities for career 
development, and inadequate rewards systems for the workforce.
The MoH and its agencies such as the Pharmacy Council, 
in consultation with the MoE and the Universities, is 
addressing pre-service pharmacy education challenges with 
the introduction of the Pharm D programme and the 
establishment of the College of Pharmacists to expand career 
development opportunities locally. Need-based post-service 
education programmes for all categories of the pharmacy 
workforce has also been implemented by the Pharmacy 
Council in collaboration with related agencies and donors.
There are efforts to improve the rewards systems and also 
streamline workforce training and development to meet 
institutional and personal needs to improve workforce retention 
and hence the quality of lives of all people living in Ghana.
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• The analysis of the General Pharmaceutical Council’s 2010 
   register of pharmacists indicated that there were 50,664 
   pharmacists in Great Britain, with the majority working
   in the community sector.
• There has been a period of unprecedented growth in the UK’s  
   health care workforce. Demand is also increasing.
• The UK’s current economic difficulties and restrictions on   
   public spending mean that further growth of the health    
   care workforce is unsustainable. The workforce will need to 
   work more productively in order to meet demand. Making 
   the pharmacy workforce more productive will require 
   a review of skill mix.
• There is increasing evidence that there is not an undersupply  
   of pharmacists in Great Britain.
• Health Education England (HEE) will provide sector-wide    
   leadership and oversight of workforce planning, education,    
   and training in the NHS in England. In Scotland and Wales,    
   this is the responsibility of the devolved administrations.
• It is important that a robust body of evidence is built to support    
   development of the pharmacy workforce in Great Britain.
• The Royal Pharmaceutical Society (RPS), the professional 
   leadership body for pharmacists and pharmacy, aspires to be 
   the national body that members of the profession, the public,
   and the government go to for advice about all aspects of the   
   pharmacy workforce.
5.4.1. Background
The pharmacy workforce in Great Britain continues to change. 
The General Pharmaceutical Council (GPhC) have regulated 
pharmacists since September 2010 (previously, the regulator 
was the Royal Pharmaceutical Society of Great Britain). 
Mandatory registration of pharmacy technicians with the 
GPhC has been in place since July 2011. Pharmacy assistants 
are not formally regulated but pharmacists are professionally 
accountable for this part of the workforce. The GPhC’s 
functions include approving qualifications, accrediting 
education and training providers, maintaining registers, 
setting standards, and establishing fitness to practice 
requirements. The Royal Pharmaceutical Society (RPS) is 
now the professional leadership body for pharmacists and 
pharmacy in England, Scotland, and Wales. The RPS promotes 
pharmacy to ensure that pharmacists are recognised within 
the NHS and wider society as experts in medicines. The RPS
is facilitating effective approaches to workforce planning 
and development for the profession.
Effective workforce planning and development supports 
pharmacy service quality by ensuring that a sufficient number 
of pharmacy staff with the right skills are in the right place, 
at the right time, at the right price [1]. Key to this is being able 
to understand the pharmacy workforce. Each year, an analysis 
of the register of pharmacists is conducted, providing useful 
demographic data. The most recent published analysis conducted 
in August 2010 [2] indicated that there were 50,664 pharmacists 
in Great Britain and that the register had grown by 2% since 2009. 
Information was also provided about age, gender, ethnicity, and 
entrants/exits from the register. Numbers of independent 
and supplementary prescribers were also described.       
Findings from the pharmacy workforce census [3] conducted in 
2008 provide information about the socio-demographic profile 
and employment patterns of pharmacists. Analysis based on 
data from respondents to the census (from 69.6% of registered 
GB resident pharmacists) indicates that most pharmacists were 
employed in the community sector (71.0%), with 21.4% work-
ing in hospital pharmacy. Significantly, community pharmacy 
locum posts accounted for 23.1% of all posts.
5.4.2. Key issues
The NHS
Over the decade between September 2000 and September 
2010, the National Health Service (NHS) workforce grew by 30% 
[4], reaching 1.4 million people employed and maintaining 
its place as the third largest workforce in the world. The UK’s 
(Great Britain and Northern Ireland) economic difficulties and 
restrictions on public spending have made this growth 
unsustainable. The focus now is to increase the productivity 
of the workforce – in other words, provide the same quality 
of service with the same number of staff or less. However, 
demand for health is increasing: The population is living longer 
and is more reliant on medicines. In England the proportion of 
the population aged 60 and over has risen from 20.7% in 2000 
to 22.4% in 2010, and there is a strong relationship between the 
proportion of the population aged 60 and over and the number 
of prescription items dispensed.
This relationship is reflected in the rising number of 
prescriptions dispensed each year. In 2010 community 
pharmacies dispensed 926.7 million prescription items [5], 
an increase of 3.5% from 2009 and an increase of 58.2% 
from 2000. Evidence from the NHS Pharmacy Education 
and Development Committee’s 2011 National NHS 
Pharmacy Establishment and Vacancy Survey [6],
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which describes levels of NHS-employed pharmacy staff 
and does not include community pharmacy staff who are
contractors to the NHS, indicate that between May 2010 and 
May 2011 pharmacist staffing establishments in the NHS 
overall decreased by 0.1% across England and decreased by 
0.4% across Wales (Scotland is undertaking a separate survey 
to report NHS pharmacy establishment and vacancy rates).
Ensuring that the pharmacy workforce is able to meet this 
rising demand is likely to be challenging, especially in the 
context of the current major reorganisation of the NHS in 
England. Figure 5.4.1 shows the number of established, 
occupied, and vacant pharmacist posts (Full Time Equivalents, 
FTEs) in England and Wales from 2008-2011. 
Figure 5.4.1. Established, occupied, and vacant NHS pharmacist posts in 
England and Wales, 2008-2011
Workforce planning and development
The size and complexity of the NHS, the increasing demand for 
health services, the length of time it takes to train pharmacists 
and pharmacy staff, and the political environment within 
which it operates all conspire to make it difficult to deliver 
effective workforce planning and development of the 
pharmacy workforce [7].
Workforce planning and development is not just about 
ensuring the continued supply of high quality pharmacy staff 
for the future in order to meet health demand, it is also about 
developing career pathways so that pharmacy staff remain 
engaged and actively participating in the workforce. There is 
a strong link between staff engagement and productivity. 
Increasingly, the creation of new roles has been the impetus 
for workforce development. Roles such as prescribing have 
been developed with the required education delivered by 
universities supporting learning in the workplace. There 
are also opportunities for new roles (e.g. public health).
Making the pharmacy workforce more productive will require 
a review of skill mix. Up-skilling of the pharmacy technician 
workforce in many hospitals to undertake the role of an 
acredited checker of final prescriptions has freed up pharmacists’ 
time to develop more clinically-orientated duties and new roles. 
Technology such as automation of dispensaries and electronic 
prescribing may also improve the productivity of the pharmacy 
workforce, though further evidence is required.
Balancing the supply and demand 
of pharmacists
The pharmacy workforce model of 2003 [8] stated that, by 2013, 
there would be a significant shortage of pharmacists. However, 
the removal of pharmacists from the Home Office’s Shortage
Occupation List [9], growth in the number of pharmacy 
undergraduates, reduced vacancy rates in the NHS, changes 
in the health system, and the current economic environment 
provide evidence that there is not an overall undersupply of 
pharmacists. Increased demand (e.g. higher numbers of 
prescription items dispensed) is not in itself evidence of 
shortage as the workforce may be working more productively.
Indeed, the pharmacist workforce may be in danger of 
moving to oversupply, but there are considerable geographical 
variations and differences between sectors; up-to-date 
workforce intelligence is needed to fully understand the 
current situation. Other workforce risks will need to be 
identified to plan for the future.
The Centre for Workforce Intelligence (CfWI) provides advice to 
health and social care planners, clinicians and commissioners 
in England about workforce planning and development. 
In 2011, the CfWI identified other risks to the pharmacy 
workforce, [10] including:
• Non-alignment of pre-registration trainee pharmacist 
   placements with the expansion of undergraduate 
   placements (in the long-term this may be mitigated by 
   the proposals for the integrated undergraduate degree 
   and pre-registration year)
• Age profile: In 2010, 10.6% of registered pharmacists are 
   aged 60 or over (11.6% in 2009) which means that a large 
   proportion of the workforce could be lost within a few years
• Part-time working and high proportion of female pharmacists   
   (in other words, the supply of pharmacists is not being maximised)
• Locum workforce: The high proportion of locums in the 
   workforce may not be a sustainable model
• The academic workforce: Do we have enough pharmacists    
   teaching at schools of pharmacy?
• Wellbeing of pharmacists: Increased workload and other 
   factors could be having an adverse effect on the wellbeing 
   of pharmacists
• Retaining pharmacists within meaningful careers
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5.4.3. Strategies
The coalition government has laid down a proposal for planning and developing the health care workforce outlined in Liberating 
the NHS: Developing the Health care Workforce [11], including the creation of Health Education England (HEE). HEE will provide 
sector-wide leadership and oversight of workforce planning, education, and training in the NHS in England (see Figure 5.4.2). 
HEE has undertaken its role in shadow form from April 2012 and taken over the current role of Medical Education England (MEE), 
albeit an expanded one as HEE will have oversight of nursing and allied health professions in addition to pharmacy, medicine, 
dentistry, and health care scientists. The Modernising Pharmacy Careers (MPC) Programme Board (part of MEE) was established 
in 2009 to ensure the pharmacy workforce has the knowledge, skills, and capabilities to deliver pharmacy services of the future. 
MPC’s work focuses on education and training (pre-qualification), developing pharmacy careers (post-qualification), 
and cross-cutting projects (e.g. workforce models and new ways of working).
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which describes levels of NHS-employed pharmacy staff 
and does not include community pharmacy staff who are
contractors to the NHS, indicate that between May 2010 and 
May 2011 pharmacist staffing establishments in the NHS 
overall decreased by 0.1% across England and decreased by 
0.4% across Wales (Scotland is undertaking a separate survey 
to report NHS pharmacy establishment and vacancy rates).
Ensuring that the pharmacy workforce is able to meet this 
rising demand is likely to be challenging, especially in the 
context of the current major reorganisation of the NHS in 
England. Figure 5.4.1 shows the number of established, 
occupied, and vacant pharmacist posts (Full Time Equivalents, 
FTEs) in England and Wales from 2008-2011. 
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The size and complexity of the NHS, the increasing demand for 
health services, the length of time it takes to train pharmacists 
and pharmacy staff, and the political environment within 
which it operates all conspire to make it difficult to deliver 
effective workforce planning and development of the 
pharmacy workforce [7].
Workforce planning and development is not just about 
ensuring the continued supply of high quality pharmacy staff 
for the future in order to meet health demand, it is also about 
developing career pathways so that pharmacy staff remain 
engaged and actively participating in the workforce. There is 
a strong link between staff engagement and productivity. 
Increasingly, the creation of new roles has been the impetus 
for workforce development. Roles such as prescribing have 
been developed with the required education delivered by 
universities supporting learning in the workplace. There 
are also opportunities for new roles (e.g. public health).
Making the pharmacy workforce more productive will require 
a review of skill mix. Up-skilling of the pharmacy technician 
workforce in many hospitals to undertake the role of an 
acredited checker of final prescriptions has freed up pharmacists’ 
time to develop more clinically-orientated duties and new roles. 
Technology such as automation of dispensaries and electronic 
prescribing may also improve the productivity of the pharmacy 
workforce, though further evidence is required.
Balancing the supply and demand 
of pharmacists
The pharmacy workforce model of 2003 [8] stated that, by 2013, 
there would be a significant shortage of pharmacists. However, 
the removal of pharmacists from the Home Office’s Shortage
Occupation List [9], growth in the number of pharmacy 
undergraduates, reduced vacancy rates in the NHS, changes 
in the health system, and the current economic environment 
provide evidence that there is not an overall undersupply of 
pharmacists. Increased demand (e.g. higher numbers of 
prescription items dispensed) is not in itself evidence of 
shortage as the workforce may be working more productively.
Indeed, the pharmacist workforce may be in danger of 
moving to oversupply, but there are considerable geographical 
variations and differences between sectors; up-to-date 
workforce intelligence is needed to fully understand the 
current situation. Other workforce risks will need to be 
identified to plan for the future.
The Centre for Workforce Intelligence (CfWI) provides advice to 
health and social care planners, clinicians and commissioners 
in England about workforce planning and development. 
In 2011, the CfWI identified other risks to the pharmacy 
workforce, [10] including:
• Non-alignment of pre-registration trainee pharmacist 
   placements with the expansion of undergraduate 
   placements (in the long-term this may be mitigated by 
   the proposals for the integrated undergraduate degree 
   and pre-registration year)
• Age profile: In 2010, 10.6% of registered pharmacists are 
   aged 60 or over (11.6% in 2009) which means that a large 
   proportion of the workforce could be lost within a few years
• Part-time working and high proportion of female pharmacists   
   (in other words, the supply of pharmacists is not being maximised)
• Locum workforce: The high proportion of locums in the 
   workforce may not be a sustainable model
• The academic workforce: Do we have enough pharmacists    
   teaching at schools of pharmacy?
• Wellbeing of pharmacists: Increased workload and other 
   factors could be having an adverse effect on the wellbeing 
   of pharmacists
• Retaining pharmacists within meaningful careers
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5.4.3. Strategies
The coalition government has laid down a proposal for planning and developing the health care workforce outlined in Liberating 
the NHS: Developing the Health care Workforce [11], including the creation of Health Education England (HEE). HEE will provide 
sector-wide leadership and oversight of workforce planning, education, and training in the NHS in England (see Figure 5.4.2). 
HEE has undertaken its role in shadow form from April 2012 and taken over the current role of Medical Education England (MEE), 
albeit an expanded one as HEE will have oversight of nursing and allied health professions in addition to pharmacy, medicine, 
dentistry, and health care scientists. The Modernising Pharmacy Careers (MPC) Programme Board (part of MEE) was established 
in 2009 to ensure the pharmacy workforce has the knowledge, skills, and capabilities to deliver pharmacy services of the future. 
MPC’s work focuses on education and training (pre-qualification), developing pharmacy careers (post-qualification), 
and cross-cutting projects (e.g. workforce models and new ways of working).
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HEE will be responsible for health care workforce planning 
and development across England. At the local level, Local 
Education and Training Boards (LETBs) accountable to HEE will 
commission education and training as well as be responsible 
for workforce planning for specific geographical areas. There 
are three LETBs emerging in London and a further 11 reported 
across the rest of England. The LETBs will be health care 
provider lead and will share approximately £4.8 billion of the 
current NHS budget for education and training. The LETBs will 
be supported by the CfWI, which will provide an overall profile 
of the health care workforce.
Workforce planning and development in Scotland and Wales 
is the responsibility of the devolved administrations. 
The Scottish Government’s health directorate provides central 
management of the NHS that oversees the work of 14 area 
NHS boards. These boards plan and deliver health services for 
people in their area. The Welsh Assembly Government is 
responsible for the delivery of the NHS in Wales and seven
 local health boards are responsible for planning, securing, 
and delivering all health care services in their areas.
5.4.4. Outcomes
Approaches to workforce planning
Traditional workforce planning in pharmacy (and indeed the 
other health care professions) has tended to focus on trends 
in the supply of and demand for pharmacists. However, it is 
becoming harder to forecast workforce supply and demand, 
particularly given the long lead times needed to train 
pharmacists. Perhaps the question of whether pharmacy has 
been able to accurately plan its workforce is the wrong one, 
as it can never be an exact science. A better question might be: 
How useful is workforce planning in delivering outcomes for 
patients? Steps must therefore be taken to measure outcomes 
for patients and to increase flexibility to change workforce 
skills more quickly in response to changes in patterns of disease 
and treatment. Such a change can be achieved by a stronger 
competence-based approach in all training, which recognise 
general and advanced levels of skills and enable pharmacy staff 
to acquire new skills for new tasks in a shorter period of time.
A strong voice
The planning and development of the overall health care 
workforce must be integrated, rather than just looking at the 
needs of each professional group in isolation. For instance, 
training of overlapping general skills across the professions 
can be shared. Much can also be learnt from other health care 
professions in Great Britain, such as medicine. In 2007 the 
inquiry into Modernising Medical Careers made a number of 
recommendations “in the interest of the health and wealth of 
the nation” [12] so that medical education and training could 
aspire to excellence, including:
• Shared principles on postgraduate medical training,
• Consensus on the role of doctors at various career stages,
• Subjecting health service workforce planning and 
   commissioning to external scrutiny, and
• Developing a mechanism for providing coherent advice by  
   the profession (i.e. strong leadership for the entire profession).
MEE was formed following the inquiry. The RPS has a strong voice, 
and it led the pharmacy profession’s response to important 
consultations that affect the quality, recognition, and supply of the 
pharmacy workforce, including the work of the Modernising Careers 
Programme Board, proposed government changes to Higher 
Education, and settlement of migrants and the European 
Commission’s green paper Modernising the Professional 
Qualifications Directive. 
Evidence has also been submitted to the Health Select Committee 
inquiry into education, training, and workforce planning.
Supporting the evidence base
The future of pharmacy is dependent on the profession’s 
ability to generate a robust body of evidence to inform 
workforce development. For instance, evidence of an 
imbalance in the number of pharmacists could inform a 
number of measures, including altering the number of 
training commissions. 
Workforce intelligence has provided insight, but needs 
to be more than just analysis (e.g. a headcount of the number 
of pharmacy staff). Further evidence that the pharmacy 
workforce is fit for purpose is also needed. The General 
Pharmaceutical Council accredits schools of pharmacy 
degree programmes, but do newly qualified pharmacists 
meet the needs of patients?
The RPS aspires to be the national body that members of the 
profession, the public, and the government go to for advice 
about all aspects of the pharmacy workforce by:
• Engaging with the whole profession to ensure that the RPS 
   is the authoritative voice on workforce development 
   for pharmacy across England, Scotland, and Wales.
• Informing the development and application of workforce    
   policy through facilitation of research and provision of    
   robust pharmacy workforce intelligence.
• Supporting implementation of solutions, which deliver 
   a capable, flexible, and adaptable workforce that is able to 
   improve productivity, performance, and health outcomes
................................................................................. .................................................................................
5.4.5. Conclusion
The RPS has been working closely with MPC and the CfWI to 
facilitate effective workforce planning and development. 
It will be important that the RPS influence HEE/LETBs and the 
GB’s devolved administrations to make the right decisions about 
planning the pharmacy workforce. In partnership with the 
CfWI, the RPS is forming a workforce engagement group of key 
stakeholders and partners to maintain oversight of the pharmacy 
workforce by scrutinising workforce plans, facilitating research, 
promoting opportunities, and mitigating risks for the pharmacy 
workforce. The RPS also is also tackling important workforce 
issues (such as professional empowerment) via its English, 
Scottish, and Welsh Pharmacy Boards.
The pharmacy workforce has come a long way in 10 years - 
consultant pharmacists, pharmacist prescribers, and up-skilled 
pharmacy technicians have all emerged. The next 10 years will be 
challenging, but new opportunities are already on the horizon.
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5.5. Country case study: Japan
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Summary
• After the massive 9.0 magnitude earthquake and nuclear 
   reactor problem in the Fukushima prefecture in March 2011,   
   the Japanese economy remains in a recovery phase. The fiscal
   budget (April 2012) was enacted at a total of 90.33 trillion yen    
   (USD 1.11 trillion). Of this, expenditure for social security, 
   including medical expenses accounts, was 26.39 trillion yen
   (USD 320 million).
• Japan is well on the way to becoming a “super-aged” society.   
   The health care system needs to be reformed in order to 
   address the challenges of a low birth rate and an aging 
   population.
• There are presently two pharmacy education programmes: 
   1) a six-year programme that aims to educate pharmacists   
   and 2) a four-year programme that aims to educate 
   pharmaceutical scientists. In April 2012, 8,182 pharmacists   
   graduated from the 6-year programme to enter the workforce.
• In a revision of the sales system for over-the-counter (OTC)   
   drugs, an examination system regarding registered assistants 
   to sell OTC medicines was implemented.
• The development of the community health care programme 
   is scheduled for 2013. In this proposed government policy,   
   pharmacies and pharmacists are expected to play an 
   important role in enhancing the home health care programme.
• Pharmacists will be a key professional to seek balance between   
   cost and effectiveness through rational use of medicines.
5.5.1. Background
After the massive 9.0 magnitude earthquake and nuclear 
reactor problem in the Fukushima prefecture in March 2011, 
the Japanese economy remains in a recovery phase. The fiscal 
budget (April 2012) was enacted at a total of 90.33 trillion 
yen ($1.11 trillion). Of this, expenditure for social security, 
including medical expenses accounts, was 26.39 trillion yen 
($320 million) [1, 2]. In Japan, the numbers of pharmacists 
and pharmacies as of December 2008 are 267,751 and 53,304, 
respectively, as summarized in Table 5.5.1. The number 
of pharmacists is 209.7 for every 100,000 people. As compared 
with 2006, the number of pharmacists and pharmacies 
increased 15,218 and 1,352, respectively.
Table 5.5.1. Number of pharmacists and pharmacies
Source: Data from Ministry of Health, Labour and Welfare [3, 4]
The total number of registered pharmacists has increased 
by 15,218 from 2006 to 2008 (a rise of 6%). The number 
of pharmacists working in community pharmacy has increased, 
while those working in hospitals have remained constant. 
Pharmacists have many responsibilities in health care, research 
and education. In the health care system, community pharmacists 
contribute by dispensing, providing OTC drugs, and other activities. 
Hospital pharmacists work with medical team members to provide 
in-patient care. 
According to the School Health and Safety Act [5], all schools 
(excluding universities) need a designated pharmacist (school 
pharmacist) to monitor appropriate environmental conditions 
(classroom illumination, air ventilation, examination of 
tap water etc.).
Other pharmacists work in the pharmaceutical industry to 
develop new drugs and formulation and provide drug 
information to health care professionals. Other important 
roles of pharmacists are to educate pharmacists and lead 
continuous professional development programmes in 
pharmacy schools and other related organizations.
Community pharmacies can be classified into two groups. 
Some pharmacies focus on dispensing and patient counselling. 
Others deal with drug supply and also cosmetic goods, usually 
involving a chain drug store group. Pharmacy education has 
changed from a four-year to a six-year programme in 2006. 
Therefore, in the intervening two years, fewer pharmacists en-
tered the workforce. Many pharmacies, especially chain drug 
stores, are now offering job opportunities to enhance 
or expand their business.
In hospital settings, tenured pharmacists can get preferential 
remuneration for pharmaceutical services. Furthermore, there is 
no pharmacy technician cadre in Japan. This situation provides 
pharmacy students and pharmacists with opportunities for this 
career direction. However, it has been pointed out that this may 
lead to unequal workforce distribution.
.................................................................................
                   2006                  2008
                          NUMBER             %       NUMBER             %
Total Pharmacists                                   252,533            100.0           267,751           100.0
   Community Pharmacist                     125,254             49.6             135,716            50.7
   Hospital Pharmacist                             48,964               19.4              50,336             18.8
   Academia/Graduate student             8,845                 3.5                9,276                3.5
   Pharmaceutical Industry                   45,415               18.0              37,643              14.1
   Government                                               5,951                 2.4                 6,280                2.3
   Others         18,086                7.2               18,476               6.9
Total Community Pharmacies       51,952                 --                 53,304                 --
.................................................................................
5.5.2. Key workforce issues
Training programme for pharmacy students 
and pharmacists
In 2006, the Ministry of Education, Culture, Sports, Science 
& Technology in Japan introduced a new six-year programme 
to educate pharmacists. There are presently two pharmacy 
education programmes: 1) a six-year programme that aims to 
educate pharmacists and 2) a four-year programme that aims 
to educate pharmaceutical scientists. In April 2012, 8,182 
pharmacist graduates from the six-year programme entered 
the workforce (Table 5.5.2). In doing so, they passed the 
Pharmaceutical Common Achievement Test consisting of 
Computer-Based Testing (CBT) and Objective Structured 
Clinical Examination (OSCE) in their fourth year. The fifth year 
comprises pharmacy practice training over 22 weeks: 
11 weeks in hospital and 11 weeks in community settings. 
This specialized clinical training represents the largest 
difference compared with the previous programmes. However, 
evaluating improved clinical skills remains a challenge.
Table 5.5.2. Results of national examination of pharmacists carried out March 2012 [6]
An increase in the number of pharmacy schools (from 46 in 2002 to 
74 in 2012) could have the effect of decreasing the quality of school 
entrants. Also, the extended educational period of the pharmacy 
programme could adversely affect the number of pharmacy 
students due to total higher tuition fees.
From this, a concern remains about whether all pharmacists 
graduate from the six-year programmes have appropriate clinical 
competencies to become effective pharmacists in the future.
Reform of the pharmaceutical supply system
Before 2006, medicines were classified into two groups: 
prescription and non-prescription medicines.
In 2006, to provide easier access to self-medication, OTC 
medicines were further classified into three categories 
according to potential risk of medicines (first, second, and 
third-class OTC), and an OTC supply system with a registered 
salesperson was implemented (Table 5.5.3) [7]. An examination 
system to qualify the registered salespersons is carried out 
by the governor of each prefecture. The number of registered 
salespersons is 95,696 as of March 2011 [8].
Table 5.5.3. Classification of OTC drugs [7]
Information for rational use of medicines should be provided 
by specialists in accordance with the degree of potential risk. 
First-class OTC medicines should be supplied only by a 
pharmacist who provides additional written information. 
However, a survey on supply compliance for first-class OTC 
drugs in 2010 indicated that the rate of compliance in 
pharmacies was only 31.5% [9].
Home health care programme for elderly 
people in the community
Japan is well on the way to becoming a “super-aged” society 
resulting from a low birth rate and an aging population. 
The number of elderly people over 65 years old is expected to 
reach a maximum in 2025. Enhancement of the home health 
care programme is a key issue. The development of 
community health care programmes is scheduled in 2013,
 and the published policies from the government have stated 
that each prefecture is responsible for the planning of 
community health care programmes to meet local needs. 
In the programme, pharmacies and pharmacists are expected 
to play an important role as part of a multidisciplinary health 
care team involving doctors, nurses and other health care 
professionals. The role of pharmacists is to contribute to the 
rational use of medicines and medicines management, 
and pharmacists will need to expand and improve their 
capabilities in order to become actively involved in these 
community health care programmes.
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      Number
Total
     Candidates           9,785
     Successful candidates          8,641
     Pass rate (%)           88.31
Graduates of 6 year programme
     Candidates           8,583
     Successful candidates          8,182
     Pass rate (%)           95.33
Others
     Candidates           1,202
     Successful candidates            459
     Pass rate (%)           38.19
Risk category
of OTC drugs
First-class Pharmacists Necessary information for proper us
should be provid in writing
Mandatory
Not required
Pharmacists or
registered sales
persons
Effort should be made to provide
necessary information for proper use
Specialists
in charge
Response when
consulted by purchasers
Active information supply even
without question from purchasers
Second-class
Third-class
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According to the School Health and Safety Act [5], all schools 
(excluding universities) need a designated pharmacist (school 
pharmacist) to monitor appropriate environmental conditions 
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Other pharmacists work in the pharmaceutical industry to 
develop new drugs and formulation and provide drug 
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continuous professional development programmes in 
pharmacy schools and other related organizations.
Community pharmacies can be classified into two groups. 
Some pharmacies focus on dispensing and patient counselling. 
Others deal with drug supply and also cosmetic goods, usually 
involving a chain drug store group. Pharmacy education has 
changed from a four-year to a six-year programme in 2006. 
Therefore, in the intervening two years, fewer pharmacists en-
tered the workforce. Many pharmacies, especially chain drug 
stores, are now offering job opportunities to enhance 
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In hospital settings, tenured pharmacists can get preferential 
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   Hospital Pharmacist                             48,964               19.4              50,336             18.8
   Academia/Graduate student             8,845                 3.5                9,276                3.5
   Pharmaceutical Industry                   45,415               18.0              37,643              14.1
   Government                                               5,951                 2.4                 6,280                2.3
   Others         18,086                7.2               18,476               6.9
Total Community Pharmacies       51,952                 --                 53,304                 --
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5.5.2. Key workforce issues
Training programme for pharmacy students 
and pharmacists
In 2006, the Ministry of Education, Culture, Sports, Science 
& Technology in Japan introduced a new six-year programme 
to educate pharmacists. There are presently two pharmacy 
education programmes: 1) a six-year programme that aims to 
educate pharmacists and 2) a four-year programme that aims 
to educate pharmaceutical scientists. In April 2012, 8,182 
pharmacist graduates from the six-year programme entered 
the workforce (Table 5.5.2). In doing so, they passed the 
Pharmaceutical Common Achievement Test consisting of 
Computer-Based Testing (CBT) and Objective Structured 
Clinical Examination (OSCE) in their fourth year. The fifth year 
comprises pharmacy practice training over 22 weeks: 
11 weeks in hospital and 11 weeks in community settings. 
This specialized clinical training represents the largest 
difference compared with the previous programmes. However, 
evaluating improved clinical skills remains a challenge.
Table 5.5.2. Results of national examination of pharmacists carried out March 2012 [6]
An increase in the number of pharmacy schools (from 46 in 2002 to 
74 in 2012) could have the effect of decreasing the quality of school 
entrants. Also, the extended educational period of the pharmacy 
programme could adversely affect the number of pharmacy 
students due to total higher tuition fees.
From this, a concern remains about whether all pharmacists 
graduate from the six-year programmes have appropriate clinical 
competencies to become effective pharmacists in the future.
Reform of the pharmaceutical supply system
Before 2006, medicines were classified into two groups: 
prescription and non-prescription medicines.
In 2006, to provide easier access to self-medication, OTC 
medicines were further classified into three categories 
according to potential risk of medicines (first, second, and 
third-class OTC), and an OTC supply system with a registered 
salesperson was implemented (Table 5.5.3) [7]. An examination 
system to qualify the registered salespersons is carried out 
by the governor of each prefecture. The number of registered 
salespersons is 95,696 as of March 2011 [8].
Table 5.5.3. Classification of OTC drugs [7]
Information for rational use of medicines should be provided 
by specialists in accordance with the degree of potential risk. 
First-class OTC medicines should be supplied only by a 
pharmacist who provides additional written information. 
However, a survey on supply compliance for first-class OTC 
drugs in 2010 indicated that the rate of compliance in 
pharmacies was only 31.5% [9].
Home health care programme for elderly 
people in the community
Japan is well on the way to becoming a “super-aged” society 
resulting from a low birth rate and an aging population. 
The number of elderly people over 65 years old is expected to 
reach a maximum in 2025. Enhancement of the home health 
care programme is a key issue. The development of 
community health care programmes is scheduled in 2013,
 and the published policies from the government have stated 
that each prefecture is responsible for the planning of 
community health care programmes to meet local needs. 
In the programme, pharmacies and pharmacists are expected 
to play an important role as part of a multidisciplinary health 
care team involving doctors, nurses and other health care 
professionals. The role of pharmacists is to contribute to the 
rational use of medicines and medicines management, 
and pharmacists will need to expand and improve their 
capabilities in order to become actively involved in these 
community health care programmes.
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      Number
Total
     Candidates           9,785
     Successful candidates          8,641
     Pass rate (%)           88.31
Graduates of 6 year programme
     Candidates           8,583
     Successful candidates          8,182
     Pass rate (%)           95.33
Others
     Candidates           1,202
     Successful candidates            459
     Pass rate (%)           38.19
Risk category
of OTC drugs
First-class Pharmacists Necessary information for proper us
should be provid in writing
Mandatory
Not required
Pharmacists or
registered sales
persons
Effort should be made to provide
necessary information for proper use
Specialists
in charge
Response when
consulted by purchasers
Active information supply even
without question from purchasers
Second-class
Third-class
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5.5.3. Strategies used and lessons learnt
Training programme for pharmacy students 
and pharmacists
To educate pharmacists towards appropriate clinical 
competencies, a six-year programme for pharmacist 
education was started in 2006. At the time of introducing the 
six-year course, we began developing a model/core curriculum 
for pharmacy students to gain a minimal level of clinical skills.
Both hospital pharmacists and community pharmacists now 
work collaboratively with pharmacy schools.
Reform of the pharmaceutical supply system
Relaxation of regulations is a global trend, and Japan is no 
exception. The Japanese government introduced registered 
salespersons who can sell second-and third-class OTC drugs. 
It is probably true that pharmacists can provide better safety 
in self-medication through OTC drugs.
Although first-class OTC drugs are sold only by pharmacists, 
the number of community pharmacies with no OTC drugs is 
increasing because they are focused on dispensing 
prescriptions. The Japanese Pharmaceutical Association, 
however, advocates that all drugs used for self-medication be 
supplied to purchasers through pharmacists, with counselling 
for effective and safe use.
Home health care programme for elderly 
people in the community
In 2000, a long-term care insurance system was introduced 
to respond to society’s major concern about aging [10]. 
Pharmacists’ involvement includes providing medicines 
management for long-term care. This role should expand, and 
there is a need for more community-based pharmaceutical care. 
The number of pharmacies contributing to long-term care is 
increasing, including providing new roles (eg home parenteral 
nutrition or domiciliary medicines adherence counselling). 
However, many pharmacists do not have the necessary clinical 
skills to evaluate patient conditions. The community 
workforce is in need of targeted skills and practitioner 
development infrastructure.
5.5.4. Outcomes
Training programme for pharmacy students 
and pharmacists
There is no outcomes evidence for the effect of the new 
six-year programme at this stage. The outcomes will be 
evaluated by the Japan Accreditation Board for
Pharmaceutical Education [11]. New challenges are:
a. Controlling the appropriate capacity (entry) in pharmacy   
     schools and accrediting/credentialing the clinical 
     competencies of novices;
b. Improving the core curriculum for training of pharmacy   
     students in pharmacy schools; and
c. Reorganizing clinical practice experiences at pharmacies   
     and hospitals. The Japan Pharmaceutical Association (JPA) 
     has established a new education system (the Japan 
     Pharmaceutical Association Lifelong Learning Support 
     System - JPALS) in order to support CPD from March 2012 [12].   
     The JPALS is expected to play an important role in this area.
Reform of pharmaceutical supply system
The number of community pharmacies with no OTC drugs 
is increasing, and the rate of compliance in the supply of 
first-class OTC drugs is low (31.5%). Many pharmacists did not 
have enough experience in dealing with OTC drugs in the past 
because they focused on dispensing of prescriptions. 
The challenges are:
a. Enhancement of the supply system for OTC medicines and
b. Establishing a national training programme and guidelines   
     for the safe supply of OTC medicines.
Home health care programme for elderly 
people in the community
The number of pharmacies and pharmacists involved 
in the long-term care system are increasing.
Pharmacists will be expected to play an important role 
in this community health care programme.
However, other health care professionals still do not accept 
the role of pharmacists in these settings.
More effort is needed to improve workforce capabilities 
to achieve confidence by other health professionals and 
to produce better patient outcomes.
In conclusion, the total numbers of pharmacists and pharmacies 
are not currently an issue. However, because of the imbalance of 
work environments (community pharmacy, hospital pharmacy,
 or drug store), a shortage of pharmacists in some fields is 
reported. This may result in some areas having poor access 
to appropriate pharmaceutical services. This maldistribution of 
pharmacies and pharmacists needs to be addressed. 
Education and development programmes for pharmacy students 
and pharmacists are in development. The next step is to increase 
the public and professional awareness about the importance of 
pharmacists in Japan’s health care system by the profession itself.
................................................................................. .................................................................................
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• The focus on experiential education methods to develop 
   work-based competency has shown quick competency 
   development with immediate application to the workplace.
• Engaging practitioners, locally active international organizations,   
   and academia is a constructive way to promote local needs 
   and best practice in pharmacy workforce development.
5.6.1. Background
A picture of the Pacific
Twenty-two independent island countries scattered over 30 
million square kilometres of the Pacific Ocean, comprising of 
more than 7500 islands, form the Pacific Islands. The Pacific 
Islands encompass a wide variety of ethnic, cultural, and 
linguistic groupings that can be broadly divided into 
Melanesia, Micronesia and Polynesia.
The region has a population of approximately 9.6 million 
people distributed among a number of small island states 
with populations varying from 1170 in Tokelau to more 
than 6,000,000 in Papua New Guinea (PNG) [1].
Pharmacy in the Pacific
Approximately 300 pharmacy personnel are distributed 
throughout the public sector of PICs (excluding the PNG 
estimate of 75), with more than 80% of these filled by 
pharmacy assistants or similar mid-level cadres [2, 3]. 
This reliance on mid-level cadres is consistent with global 
trends and reflects the unavailability of more highly qualified 
pharmacists [4, 5]. There is less than one pharmacist per 
10,000 population on average across PICs [3], a ratio similar 
to that found in sub-Saharan African countries [6].
Essential medicine supply management (EMSM) is the main 
function carried out by government pharmacy departments 
across PICs, with clinical hospital pharmacy developing in 
selected tertiary hospitals of larger countries where sufficient 
pharmacists are available (eg Tonga and Fiji).
Community pharmacy is active in most of the region’s 
countries, with non-pharmacist cadres playing a significant 
role in many countries.
Health care in PICs is delivered in rural environments where 
approximately 80% of the population reside [7]. The workforce 
responsible for maintaining the medicines supply system in 
PICs is made up of nurses, midwives, nurse aids, and other 
health personnel at the primary health care level (Level 1);
pharmacy supply and health personnel at the provincial/
regional level (Level 2); and pharmacists where available and 
stores managers at the national level (Level 3) [3]. (Figure 5.6.1)
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Countries (PICs)
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Summary
• Twenty-two independent island countries scattered over 
   30 million square kilometres of the Pacific Ocean, comprising 
   of more than 7500 islands, form the Pacific Islands.
• Approximately 300 pharmacy personnel are distributed 
   throughout the public sector of PICs, with more than 80% of 
   these filled by pharmacy assistants or similar mid-level cadres.
• A lack of education capacity to support competency 
   development of the cadres involved in pharmacy-related 
   services is one of the main issues affecting pharmacy 
   workforce development in PICs.
• A new approach has been developed involving a partnership 
   between UNFPA Suva Sub-Regional office, the University of   
   Canberra, Ministry of Health officials, and health personnel 
   within identified PICs.
• Cultural principles of learning and a pharmacy competency 
   framework for PICs have been developed and used to create    
   novel, experiential competency-based training approaches
   for specific cadres.
LEVEL 3: NATIONAL TERTIARY
Example Cadres: Pharmacists and stores personnel
Place of work: National level in Medical Stores or Pharmacy 
departments
Medicines ﬂow from National Level to Provincial Hospital/Store
LEVEL 1: SECONDARY
Example Cadre: Nurses, primary health care workers and nurse aids
Place of work: Clinics, area health centres and aid posts
Training/knowledge products: 5 day RHCS in-service workshop
Medicines ﬂow from the Primary Care Centre to the Patient
LEVEL 2: SECONDARY
Example Cadres: Pharmacy assistants, stores personnel, nurses 
and other mid-level cadres
Place of work: Hospitals, provincial stores level, area health centres
Training/knowledge products: Certiﬁcate III in Hospital/Health 
Services Pharmacy Support (junior staff), Certiﬁcate IV 
in Hospital/Health Services Pharmacy Support (Supervising staff)
Medicines ﬂow from Provincial Hospital/Store to Primary Care Centre
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Figure 5.6.1. An overview of government pharmacy support workforce 
cadres in PICs
5.6.2. Key issues
A lack of education capacity to support competency 
development of the cadres involved in pharmacy related 
services is one of the main issues affecting pharmacy 
workforce develo ment in PICs.
Evidence of the shortfall is provided by the Australian Agency 
for International Development (AusAID), UNFPA, and the World 
Health Organization (WHO), which report continued problems 
in maintaining the supply of essential medicines through to 
the clinics and aid posts of PICs [8-13].
WHO asserts that “many maternal and child health related 
deaths in the region may be prevented with readily 
available essential medicines provided by suitably trained 
health personnel” [13].
Pacific pharmacy education
Training in EMSM has been conducted in the Pacific over the 
last several years by UNFPA, United Nations Children’s Fund 
(UNICEF) and WHO [14]. To a large extent, EMSM training in 
PICs has been fragmented, superficial, and without a long-term 
plan to sustain the competencies needed for continued 
availability of essential medicines. Each agency has promoted 
their EMSM framework and principles, but with limited 
reference to local competencies or cultural requirements 
for effective training [3].
Generalised EMSM training has been used in the past and 
assumes all target audiences are the same.
Within PICs, expected competencies are different for various 
health personnel depending on their level of activity within 
the medicines supply system [3, 15]. Any new training strategy 
should acknowledge this variation and should ensure that 
the core competencies of medication selection, procurement, 
distribution, use, and management are addressed.
The Fiji National University (FNU) and the University of Papua 
New Guinea (UPNG) are the only universities in the region 
providing diploma and degree level pharmacy education, 
with most graduates going into the private sector. No formal 
certificate training is available for mid-level cadres involved 
in EMSM, apart from semi-structured localised training in the 
Solomon Islands and Tonga.
FNU and UPNG initially ran pharmacy assistant courses before 
upgrading to their current programme based on traditional 
Australian curricula [16]. With more than 80% of pharmacy 
staff posts filled by non-pharmacists with limited formal 
training, the need for a focus in this area is clear [3].
Health personnel need to be competent in relevant aspects 
of EMSM in order to direct their country supply systems effec-
tively. This material is often missing from pre-service 
curricula, while skills in appropriate EMSM are often assumed. 
As a result, many heath personnel lack the skills required 
for this essential part of their day-to-day work [3].
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departments
Medicines ﬂow from National Level to Provincial Hospital/Store
LEVEL 1: SECONDARY
Example Cadre: Nurses, primary health care workers and nurse aids
Place of work: Clinics, area health centres and aid posts
Training/knowledge products: 5 day RHCS in-service workshop
Medicines ﬂow from the Primary Care Centre to the Patient
LEVEL 2: SECONDARY
Example Cadres: Pharmacy assistants, stores personnel, nurses 
and other mid-level cadres
Place of work: Hospitals, provincial stores level, area health centres
Training/knowledge products: Certiﬁcate III in Hospital/Health 
Services Pharmacy Support (junior staff), Certiﬁcate IV 
in Hospital/Health Services Pharmacy Support (Supervising staff)
Medicines ﬂow from Provincial Hospital/Store to Primary Care Centre
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Figure 5.6.1. An overview of government pharmacy support workforce 
cadres in PICs
5.6.2. Key issues
A lack of education capacity to support competency 
development of the cadres involved in pharmacy related 
services is one of the main issues affecting pharmacy 
workforce develo ment in PICs.
Evidence of the shortfall is provided by the Australian Agency 
for International Development (AusAID), UNFPA, and the World 
Health Organization (WHO), which report continued problems 
in maintaining the supply of essential medicines through to 
the clinics and aid posts of PICs [8-13].
WHO asserts that “many maternal and child health related 
deaths in the region may be prevented with readily 
available essential medicines provided by suitably trained 
health personnel” [13].
Pacific pharmacy education
Training in EMSM has been conducted in the Pacific over the 
last several years by UNFPA, United Nations Children’s Fund 
(UNICEF) and WHO [14]. To a large extent, EMSM training in 
PICs has been fragmented, superficial, and without a long-term 
plan to sustain the competencies needed for continued 
availability of essential medicines. Each agency has promoted 
their EMSM framework and principles, but with limited 
reference to local competencies or cultural requirements 
for effective training [3].
Generalised EMSM training has been used in the past and 
assumes all target audiences are the same.
Within PICs, expected competencies are different for various 
health personnel depending on their level of activity within 
the medicines supply system [3, 15]. Any new training strategy 
should acknowledge this variation and should ensure that 
the core competencies of medication selection, procurement, 
distribution, use, and management are addressed.
The Fiji National University (FNU) and the University of Papua 
New Guinea (UPNG) are the only universities in the region 
providing diploma and degree level pharmacy education, 
with most graduates going into the private sector. No formal 
certificate training is available for mid-level cadres involved 
in EMSM, apart from semi-structured localised training in the 
Solomon Islands and Tonga.
FNU and UPNG initially ran pharmacy assistant courses before 
upgrading to their current programme based on traditional 
Australian curricula [16]. With more than 80% of pharmacy 
staff posts filled by non-pharmacists with limited formal 
training, the need for a focus in this area is clear [3].
Health personnel need to be competent in relevant aspects 
of EMSM in order to direct their country supply systems effec-
tively. This material is often missing from pre-service 
curricula, while skills in appropriate EMSM are often assumed. 
As a result, many heath personnel lack the skills required 
for this essential part of their day-to-day work [3].
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As current essential medicines supply provision continues 
to fall short of WHO and UN targets, a new systematic, 
needs-based approach for essential medicines supply 
management (EMSM) education is zrequired as a first step 
in developing a competent workforce in PICs.
5.6.3. Strategies used and lessons learnt
A new approach has been developed involving a partnership 
between UNFPA Suva sub-regional office, the University of 
Canberra (UC), Ministry of Health officials and the health 
personnel within identified PICs (Federated States of 
Micronesia, Republic of Kiribati, PNG, Solomon Islands, 
Kingdom of Tonga, Tuvalu, and Republic of Vanuatu).
The FIP-PET “needs-based” approach to pharmacy education 
[17] and a participatory action research (PAR) methodology 
have been used to form a systematic framework to provide a 
regional solution to these educational deficiencies (See Figure 
in Part 4. Pharmacy education). Such a framework is consistent 
with local cultural norms and has the effect of meeting the 
expectations of donor organisations and local Ministries of 
Health by providing immediate, tangible benefits that can be
presented to the global research community.
In the health sector, PAR is based on reflection, data collection, 
and action that aims to improve health and reduce health 
inequities through involving heath personnel who, in turn, take 
actions to improve their own circumstances [18]. Any resultant 
action is then further researched, and an interactive reflective 
cycle perpetuates data collection, reflection, and action.
This systematic strategy has as its starting point the need 
to understand local culture and its impact on learning and 
teaching, the mapping of competency requirements, and an 
understanding of currently available information and materials. 
Subsequently, this information has been applied to develop 
and trial new pedagogical approaches to the training of health 
personnel involved in EMSM. 
This strategy seeks to support the existing systems of the country.
It is important to note that education is only part of a 
sustainable approach to HRH development.
The “HRH Action Framework” demonstrates the 
interrelationship between human resource management 
systems, leadership, partnership, finance, education, and 
policy (Figure 5.6.2) [19]. The framework identifies that 
education should not be considered in isolation, but is one of 
six interrelated components that need to be addressed 
for sustained development in HRH to be achieved [19]. 
Any new approach to EMSM education must integrate 
into the overarching HRH plan for individual PICs.
Figure 5.6.2. WHO Global Health Workforce Alliance (GHWA) Health Action 
Framework (HAF) [19] 
(The HRH Action Framework is an initiative of the GHWA and represents a 
collaborative effort between the U.S. Agency for International Development 
(USAID) and WHO. Republished with permission)
Through engaging in this regional strategy, we have learnt 
that considering culture and countryspecific requirements is 
important to the countries. The focus on practical, work-based 
competency has shown quick competency development with 
immediate application to the workplace. Overall, engaging 
practitioners, locally active international organizations, and 
academia is a constructive way to promote the needs and best 
practice of pharmacy education.
5.6.4. Outcomes
A literature search and several focus groups were conducted
involving various levels of health care personnel in PICs to determine 
cultural learning needs and expectations of training approaches.
Using this data, we have established 20 principles that should 
be considered when preparing training for PICs (publication in 
process). These principles take into account cultural considerations 
and the priorities of health care workers in the region and are used 
to guide the development of training materials.
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There is a scarcity of information available in the published 
and grey literature concerning the competencies required for 
medical supply management of various cadres of health care 
workers in PICs. In-country competency mapping exercises 
were conducted in PNG, Vanuatu, and the Solomon Islands 
with online validation activities and focus groups conducted 
to verify a pharmacy competency framework for Pacific Island 
Countries (available from main author on request). 
The validated competency framework is service-based rather 
than cadre specific, containing 113 competencies organised 
into four clusters: 
1) Organisation and Management Competencies - a systems 
focus, 2) Professional/Personal Competencies - a practice 
focus, 3) Pharmaceutical Public Health Competencies - a 
population focus, and 4) Pharmaceutical Care Competencies - a 
patient focus.
A service-based approach allows wider application to the 
diverse pharmacy practice environments of PICs. Health 
personnel responsible for the delivery of pharmacy services 
are encouraged to use this tool when considering appropriate 
training in EMSM and when monitoring staff effectiveness 
in their local environments.
Existing training materials for health personnel involved in 
EMSM at the facility level were reviewed by locally practising 
health personnel. The personnel concluded that currently-used 
materials do not cover the expected competency requirements 
for these health personnel, while the structure and content 
of the materials assessed do not consistently meet the local 
criteria for best practice in training.
In considering cultural aspects of learning and the competency 
requirements for various cadres of staff, three different 
competency development approaches have been developed 
and are being trialled in a creative commons environment:
1- A country specific five-day skills based workshop with 
    workplace follow up for primary health care workers, 
    including nurses, midwives and nurse aids (Level 1);
2- A ten month on-the-job certificate using a combination of    
    distance and short intensive sessions with workplace follow   
    up for health care workers in medicines supply at the 
    provincial level (Level 2); and
3- A short intensive workshop with workplace mentoring and   
    follow up for pharmacists and stores managers at a national  
    level (Level 3).
Level 1 competency-based education model
The Level 1 teaching methodology uses an individual, 
needs-based approach to develop a practical training manual 
and a country specific interactive workshop with a focus on 
medicines supply management competencies. To do this, 
a “pre-Level 1 training screening tool” is used in conjunction
with stakeholder engagement by phone and e-mail
to determine the current standard opperating procedures and 
policies that affect medicines supply management in that country. 
This data is then used to develop a competency based, problem 
oriented, practical training manual and an interactive five-day 
workshop with the involvement of local health care personnel.
Skills games, role play, group discussion, story telling, and 
site visits provide the basis of the experiential workshop with 
limited use of computer projection and maximum involvment 
by local health care personnel. Selected competencies and 
participant self-assessment are measured before and after the 
workshop. Three months after the workshop, heath care 
personnel are visited by a local supervisor to note the 
translation of developed compitencies into the local 
environment anddiscuss any workplace-related issues. 
Level 1 workshops have been conducted in nine countries with 
a total of 224 particpants. Participant feedback indicates that 
the practical nature of the workshop with specific reference 
to workplace activities has enabled compenency improvment. 
This has been confirmed though our assessment of the 
students. The use of group work enabling communication 
in local languages and group discussions where participants 
can hear and share ideas have been documented as highlights 
consistent with their cultural approach.
Level 2 competency-based education model
In the absence of training programmes in the region for Level 
2 health care workers, we are currently trialling a ten-month 
on-the-job certificate (certified under the Australian 
Qualifications Framework), using a combination of distance 
and short in-country intensive sessions in Vanuatu and Fiji 
with a total of 33 participants. The course is coordinated by 
the University of Canberra. The development process engaged 
Ministry of Health staff and local academic institutions, where 
they exist, to help develop the overall course structure and 
required training material. Mechanisms are being explored 
using mobile phone to provide out of country support. Local 
supervision is provided through the use of senior staff within 
the pharmacy and medical stores environment, supported by 
the University of Canberra.
This course aims to develop competent staff who are able to 
deliver services in the areas of EMSM, enabling those who have 
completed the course to better support pharmacy and medical 
supply management systems within their respective country 
environments. This course is designed for junior staff or 
entry-level workers.
Level 3 competency-based education model
In September 2010, a regional, two-week competency development 
workshop was hosted by UNFPA for pharmacists and medical
stores personnel who hold national responsibilities for medicines 
supply management in 16 PICs. The focus of the workshop was 
on the development and local application of medicines supply 
competencies. To facilitate this approach, participants 
established work plans and a framework for a peer group 
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As current essential medicines supply provision continues 
to fall short of WHO and UN targets, a new systematic, 
needs-based approach for essential medicines supply 
management (EMSM) education is zrequired as a first step 
in developing a competent workforce in PICs.
5.6.3. Strategies used and lessons learnt
A new approach has been developed involving a partnership 
between UNFPA Suva sub-regional office, the University of 
Canberra (UC), Ministry of Health officials and the health 
personnel within identified PICs (Federated States of 
Micronesia, Republic of Kiribati, PNG, Solomon Islands, 
Kingdom of Tonga, Tuvalu, and Republic of Vanuatu).
The FIP-PET “needs-based” approach to pharmacy education 
[17] and a participatory action research (PAR) methodology 
have been used to form a systematic framework to provide a 
regional solution to these educational deficiencies (See Figure 
in Part 4. Pharmacy education). Such a framework is consistent 
with local cultural norms and has the effect of meeting the 
expectations of donor organisations and local Ministries of 
Health by providing immediate, tangible benefits that can be
presented to the global research community.
In the health sector, PAR is based on reflection, data collection, 
and action that aims to improve health and reduce health 
inequities through involving heath personnel who, in turn, take 
actions to improve their own circumstances [18]. Any resultant 
action is then further researched, and an interactive reflective 
cycle perpetuates data collection, reflection, and action.
This systematic strategy has as its starting point the need 
to understand local culture and its impact on learning and 
teaching, the mapping of competency requirements, and an 
understanding of currently available information and materials. 
Subsequently, this information has been applied to develop 
and trial new pedagogical approaches to the training of health 
personnel involved in EMSM. 
This strategy seeks to support the existing systems of the country.
It is important to note that education is only part of a 
sustainable approach to HRH development.
The “HRH Action Framework” demonstrates the 
interrelationship between human resource management 
systems, leadership, partnership, finance, education, and 
policy (Figure 5.6.2) [19]. The framework identifies that 
education should not be considered in isolation, but is one of 
six interrelated components that need to be addressed 
for sustained development in HRH to be achieved [19]. 
Any new approach to EMSM education must integrate 
into the overarching HRH plan for individual PICs.
Figure 5.6.2. WHO Global Health Workforce Alliance (GHWA) Health Action 
Framework (HAF) [19] 
(The HRH Action Framework is an initiative of the GHWA and represents a 
collaborative effort between the U.S. Agency for International Development 
(USAID) and WHO. Republished with permission)
Through engaging in this regional strategy, we have learnt 
that considering culture and countryspecific requirements is 
important to the countries. The focus on practical, work-based 
competency has shown quick competency development with 
immediate application to the workplace. Overall, engaging 
practitioners, locally active international organizations, and 
academia is a constructive way to promote the needs and best 
practice of pharmacy education.
5.6.4. Outcomes
A literature search and several focus groups were conducted
involving various levels of health care personnel in PICs to determine 
cultural learning needs and expectations of training approaches.
Using this data, we have established 20 principles that should 
be considered when preparing training for PICs (publication in 
process). These principles take into account cultural considerations 
and the priorities of health care workers in the region and are used 
to guide the development of training materials.
.................................................................................
POLICY
FINANCE
HUMAN 
RESOURCES
MANAGEMENT
SYSTEMS
LEADERSHIP
PARTNERSHIP EDUCATION
IMPROVED HEALTH
WORKFORCE
HEALTH SERVICES
EQUITY
EFFECTIVENESS
EFFICIENCY
QUALITY
BETTER HEALTH 
OUTCOMES S
OTHER HEALTH
SYSTEMS
COMPONENTS
COUNTRY SPECIFIC
CONTEXTS INCLUDING
LABOR MARKETS
        
       
      
      
     
     
     
    
    
    
    
 M
O
N
IT
O
RI
N
G
 &
 E
VA
LU
AT
IO
N
 
 
    
    
    
    
    
   
   
   
   
   
   
   
    
    
    
    
    
    
    
    
    
     
    
     
      
      
       
        
         
            S
ITUATIONAL ANALYSIS 
 
 
 
 
                PLAN
N
IN
G
IMPLEMENTATION     
.................................................................................
There is a scarcity of information available in the published 
and grey literature concerning the competencies required for 
medical supply management of various cadres of health care 
workers in PICs. In-country competency mapping exercises 
were conducted in PNG, Vanuatu, and the Solomon Islands 
with online validation activities and focus groups conducted 
to verify a pharmacy competency framework for Pacific Island 
Countries (available from main author on request). 
The validated competency framework is service-based rather 
than cadre specific, containing 113 competencies organised 
into four clusters: 
1) Organisation and Management Competencies - a systems 
focus, 2) Professional/Personal Competencies - a practice 
focus, 3) Pharmaceutical Public Health Competencies - a 
population focus, and 4) Pharmaceutical Care Competencies - a 
patient focus.
A service-based approach allows wider application to the 
diverse pharmacy practice environments of PICs. Health 
personnel responsible for the delivery of pharmacy services 
are encouraged to use this tool when considering appropriate 
training in EMSM and when monitoring staff effectiveness 
in their local environments.
Existing training materials for health personnel involved in 
EMSM at the facility level were reviewed by locally practising 
health personnel. The personnel concluded that currently-used 
materials do not cover the expected competency requirements 
for these health personnel, while the structure and content 
of the materials assessed do not consistently meet the local 
criteria for best practice in training.
In considering cultural aspects of learning and the competency 
requirements for various cadres of staff, three different 
competency development approaches have been developed 
and are being trialled in a creative commons environment:
1- A country specific five-day skills based workshop with 
    workplace follow up for primary health care workers, 
    including nurses, midwives and nurse aids (Level 1);
2- A ten month on-the-job certificate using a combination of    
    distance and short intensive sessions with workplace follow   
    up for health care workers in medicines supply at the 
    provincial level (Level 2); and
3- A short intensive workshop with workplace mentoring and   
    follow up for pharmacists and stores managers at a national  
    level (Level 3).
Level 1 competency-based education model
The Level 1 teaching methodology uses an individual, 
needs-based approach to develop a practical training manual 
and a country specific interactive workshop with a focus on 
medicines supply management competencies. To do this, 
a “pre-Level 1 training screening tool” is used in conjunction
with stakeholder engagement by phone and e-mail
to determine the current standard opperating procedures and 
policies that affect medicines supply management in that country. 
This data is then used to develop a competency based, problem 
oriented, practical training manual and an interactive five-day 
workshop with the involvement of local health care personnel.
Skills games, role play, group discussion, story telling, and 
site visits provide the basis of the experiential workshop with 
limited use of computer projection and maximum involvment 
by local health care personnel. Selected competencies and 
participant self-assessment are measured before and after the 
workshop. Three months after the workshop, heath care 
personnel are visited by a local supervisor to note the 
translation of developed compitencies into the local 
environment anddiscuss any workplace-related issues. 
Level 1 workshops have been conducted in nine countries with 
a total of 224 particpants. Participant feedback indicates that 
the practical nature of the workshop with specific reference 
to workplace activities has enabled compenency improvment. 
This has been confirmed though our assessment of the 
students. The use of group work enabling communication 
in local languages and group discussions where participants 
can hear and share ideas have been documented as highlights 
consistent with their cultural approach.
Level 2 competency-based education model
In the absence of training programmes in the region for Level 
2 health care workers, we are currently trialling a ten-month 
on-the-job certificate (certified under the Australian 
Qualifications Framework), using a combination of distance 
and short in-country intensive sessions in Vanuatu and Fiji 
with a total of 33 participants. The course is coordinated by 
the University of Canberra. The development process engaged 
Ministry of Health staff and local academic institutions, where 
they exist, to help develop the overall course structure and 
required training material. Mechanisms are being explored 
using mobile phone to provide out of country support. Local 
supervision is provided through the use of senior staff within 
the pharmacy and medical stores environment, supported by 
the University of Canberra.
This course aims to develop competent staff who are able to 
deliver services in the areas of EMSM, enabling those who have 
completed the course to better support pharmacy and medical 
supply management systems within their respective country 
environments. This course is designed for junior staff or 
entry-level workers.
Level 3 competency-based education model
In September 2010, a regional, two-week competency development 
workshop was hosted by UNFPA for pharmacists and medical
stores personnel who hold national responsibilities for medicines 
supply management in 16 PICs. The focus of the workshop was 
on the development and local application of medicines supply 
competencies. To facilitate this approach, participants 
established work plans and a framework for a peer group 
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and external mentoring programme. It is envisaged that this 
mentoring programme will be utilized and assessed to 
determine if a mentoring approach aids in the implementation 
of the country specific work plans to develop local medicines 
supply competencies.
5.6.5. The future
By the end of 2012, validated pedagogical approaches for the 
development of medicines supply competencies in two of 
the three cadre levels will be completed and made available 
to the wider international community in a creative commons 
environment.
We are still to determine whether the competency-based 
education approaches we have developed can be made 
sustainable in the local environment. In the future, these 
pedagogical approaches will be made available to a broader 
range of academic institutions in the region, including 
universities, tertiary colleges, and ministries of health. 
To aid in the uptake of these new approaches, it is envisaged 
that in-country academic workshops will be conducted 
detailing the pedagogical approaches and aiding their 
implementation in various health care curricula. Uptake 
of the new approaches and their implementation will then
be monitored over the following twelve months.
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5.7. Country Case Study: Singapore
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Summary
• Ageing population, increasing burden of chronic diseases,  
  and rising health care costs are significant challenges that 
  must be addressed by the pharmacy profession in Singapore
• Collaboration of pharmacy profession with other health 
  care members to achieve safe, optimum, seamless care for 
  patients and the public is key
• Investing in capacity and capability building of pharmacists   
  is crucial. This includes manpower development, education,   
  training, leadership, specialisation for pharmacists, and role
  redesign of pharmacy support workforce
• Information, communication, and automation technology   
  is being leveraged to provide safe, quality and cost effective   
  pharmacy services
• Policies and regulations are being developed or used to drive   
  and achieve safe and quality care
• A unified philosophy that galvanises the pharmacy profession   
  and focus on patients through professional practice, ethics, 
  and values is being developed and propagated
5.7.1. Background
Singapore is an island city-state with a population of 5.18 
million people [1]. It has a well-established health care system, 
public and private, with an excellent reputation for quality 
medicine. In the World Health Report on health systems, 
Singapore was ranked number one in Asia and sixth globally [2]. 
Health care provision comprises a mix of seven public hospitals 
and six specialty centres, which together accounts for 72% 
of inpatient beds, with 16 private hospitals accounting for the 
remaining 28%. Primary health care is easily accessible through 
an extensive and convenient network of some 2000 private 
general practitioners and 18 public outpatient polyclinics. 
Private practitioners provide 80% of primary health care services 
whilst government polyclinics provide the remaining 20% [3].
Health care financing is based on a combination of 
government subsidies (Medisave, Medishield, Medifund), 
through taxation and individual responsibility.
The health care system in Singapore faces major challenges 
- a growing and ageing population, increasing burden of 
chronic diseases, and rising health care costs. As such, the shift 
from episodic care to long-term care, community-based disease 
prevention, and treatment of chronic diseases are necessary.
Pharmacists in Singapore work in diverse settings, including 
community pharmacies, hospitals, pharmaceutical industry, 
academia, and research. As of December 2011, there are 2013 
pharmacists registered with the Singapore Pharmacy Council. 
Approximately 50% of the registered pharmacists work in 
patient care with a majority working in public institutions. 
The pharmacist-to-population ratio is approximately 1:2800 [4].
Rising to the challenge, pharmacists are embracing new 
professional roles, aside from their traditional dispensing role, 
to ensure the provision of optimal and cost-effective 
pharmaceutical care.
Areas where pharmacists are making a significant difference 
to the care of patients include chronic disease management 
through pharmacist-run clinics, antibiotic stewardship, 
speciality practice (oncology, infectious disease, critical care, 
and psychiatry), medication review, medication reconciliation, 
and medication therapy management services.
5.7.2. Key challenges facing the pharmacy 
workforce
Ageing population and increase in burden 
of chronic diseases
Singapore has one of the lowest fertility rates in the world 
(the total fertility rate for 2007 is 1.27) and one of the fastest 
ageing populations. By 2030, one in five Singaporean residents 
will be aged 65 and above. This situation is similar to other East 
Asian countries such as Japan and South Korea. With longer 
life expectancies and an ageing population, chronic diseases 
will become a growing burden.
The prevalence rates for hypertension, diabetes mellitus, 
and dyslipidemia (high blood cholesterol) are 23.5%, 11.3% 
and 17.4% respectively [3].
Health care professional workforce production
To meet health care demands, it is estimated that the country 
needs to grow the health care professional workforce (doctors, 
nurses, dentists and pharmacists) by 50%, or about 20,000 more, 
by the year 2020. Greater numbers of pharmacists are needed in 
direct patient care and in community settings to look after the 
elderly and those with chronic illnesses. Pharmacists will also be 
required in health programmes focussing on disease prevention, 
promotion of healthy lifestyles, and health screening.
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and external mentoring programme. It is envisaged that this 
mentoring programme will be utilized and assessed to 
determine if a mentoring approach aids in the implementation 
of the country specific work plans to develop local medicines 
supply competencies.
5.6.5. The future
By the end of 2012, validated pedagogical approaches for the 
development of medicines supply competencies in two of 
the three cadre levels will be completed and made available 
to the wider international community in a creative commons 
environment.
We are still to determine whether the competency-based 
education approaches we have developed can be made 
sustainable in the local environment. In the future, these 
pedagogical approaches will be made available to a broader 
range of academic institutions in the region, including 
universities, tertiary colleges, and ministries of health. 
To aid in the uptake of these new approaches, it is envisaged 
that in-country academic workshops will be conducted 
detailing the pedagogical approaches and aiding their 
implementation in various health care curricula. Uptake 
of the new approaches and their implementation will then
be monitored over the following twelve months.
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Summary
• Ageing population, increasing burden of chronic diseases,  
  and rising health care costs are significant challenges that 
  must be addressed by the pharmacy profession in Singapore
• Collaboration of pharmacy profession with other health 
  care members to achieve safe, optimum, seamless care for 
  patients and the public is key
• Investing in capacity and capability building of pharmacists   
  is crucial. This includes manpower development, education,   
  training, leadership, specialisation for pharmacists, and role
  redesign of pharmacy support workforce
• Information, communication, and automation technology   
  is being leveraged to provide safe, quality and cost effective   
  pharmacy services
• Policies and regulations are being developed or used to drive   
  and achieve safe and quality care
• A unified philosophy that galvanises the pharmacy profession   
  and focus on patients through professional practice, ethics, 
  and values is being developed and propagated
5.7.1. Background
Singapore is an island city-state with a population of 5.18 
million people [1]. It has a well-established health care system, 
public and private, with an excellent reputation for quality 
medicine. In the World Health Report on health systems, 
Singapore was ranked number one in Asia and sixth globally [2]. 
Health care provision comprises a mix of seven public hospitals 
and six specialty centres, which together accounts for 72% 
of inpatient beds, with 16 private hospitals accounting for the 
remaining 28%. Primary health care is easily accessible through 
an extensive and convenient network of some 2000 private 
general practitioners and 18 public outpatient polyclinics. 
Private practitioners provide 80% of primary health care services 
whilst government polyclinics provide the remaining 20% [3].
Health care financing is based on a combination of 
government subsidies (Medisave, Medishield, Medifund), 
through taxation and individual responsibility.
The health care system in Singapore faces major challenges 
- a growing and ageing population, increasing burden of 
chronic diseases, and rising health care costs. As such, the shift 
from episodic care to long-term care, community-based disease 
prevention, and treatment of chronic diseases are necessary.
Pharmacists in Singapore work in diverse settings, including 
community pharmacies, hospitals, pharmaceutical industry, 
academia, and research. As of December 2011, there are 2013 
pharmacists registered with the Singapore Pharmacy Council. 
Approximately 50% of the registered pharmacists work in 
patient care with a majority working in public institutions. 
The pharmacist-to-population ratio is approximately 1:2800 [4].
Rising to the challenge, pharmacists are embracing new 
professional roles, aside from their traditional dispensing role, 
to ensure the provision of optimal and cost-effective 
pharmaceutical care.
Areas where pharmacists are making a significant difference 
to the care of patients include chronic disease management 
through pharmacist-run clinics, antibiotic stewardship, 
speciality practice (oncology, infectious disease, critical care, 
and psychiatry), medication review, medication reconciliation, 
and medication therapy management services.
5.7.2. Key challenges facing the pharmacy 
workforce
Ageing population and increase in burden 
of chronic diseases
Singapore has one of the lowest fertility rates in the world 
(the total fertility rate for 2007 is 1.27) and one of the fastest 
ageing populations. By 2030, one in five Singaporean residents 
will be aged 65 and above. This situation is similar to other East 
Asian countries such as Japan and South Korea. With longer 
life expectancies and an ageing population, chronic diseases 
will become a growing burden.
The prevalence rates for hypertension, diabetes mellitus, 
and dyslipidemia (high blood cholesterol) are 23.5%, 11.3% 
and 17.4% respectively [3].
Health care professional workforce production
To meet health care demands, it is estimated that the country 
needs to grow the health care professional workforce (doctors, 
nurses, dentists and pharmacists) by 50%, or about 20,000 more, 
by the year 2020. Greater numbers of pharmacists are needed in 
direct patient care and in community settings to look after the 
elderly and those with chronic illnesses. Pharmacists will also be 
required in health programmes focussing on disease prevention, 
promotion of healthy lifestyles, and health screening.
.................................................................................
58 59
.................................................................................
The Department of Pharmacy at the National University 
of Singapore, the only institution that produces pharmacy 
graduates, is steadily increasing its training capacity from 
the current 160 to eventually reach an annual intake of 240 
pharmacy students. Besides increasing our local pipeline, 
foreign-trained pharmacists are supplementing our pool of 
pharmacists to meet pharmacist manpower demands. A total 
of 138 pharmacy degrees are recognised by the Singapore 
Pharmacy Council [5].
Capability building
As health care evolves, the pharmacy profession will have 
opportunities for new and expanded roles and responsibilities. 
The undergraduate pharmacy curriculum and the pre-registration 
training programme need to better integrate knowledge and 
skills training and facilitate smoother transition from university 
to practice.
Tomorrow’s pharmacy workforce needs to develop with 
emerging practice trends (Table 5.7.1).
Building capacity and capability of health care professionals 
are crucial means to ensure the accessibility and quality of 
health care delivery. Integrating care and ensuring seamless 
continuity is critical to produce desired health outcomes for 
patients as the health care focus shifts from hospital to the 
community. Pharmacists play significant roles to improve care 
and treatment for patients across the health care continuum, 
particularly in cost-effective drug therapy management and
adding value to the health care team through reducing 
drug-related problems and preventable adverse drug events.
Table 5.7.1. Emerging practice trends in Singapore
5.7.3. Key strategic areas and proposed actions
The pharmacy profession in Singapore has been steadily 
progressing and keeping pace with the growth of Singapore’s 
medical and health care sector. Pharmacy leadership in the 
country has identified the following key strategic areas to 
direct the pharmacy workforce towards the nation’s Health 
care 2020 Master Plan (Table 5.7.2):
1- Manpower Management
2- Education and continuing professional development
3- Information, communication, and automation technology
4- Policies and regulation
5- Leadership
.................................................................................
Technology-driven, cost-effective management of drug distribution. Centralized and automated 
medication preparation and distribution in major hospitals. Health information technology 
interconnectivity and support.
Interdisciplinary and team-based health care delivery, education, and training. Majority of pharmacists’ 
time is spent providing direct patient care in many practice settings, in high risk and therapeutically 
complex patients requiring specialist knowledge and skill.
Allocation of health care resources driven by metrics and outcomes. Health care 2020 Master Plan 
focuses on three strategic objectives: enhancing the accessibility, quality, and affordability of care. 
Benchmarking systems incorporate measurements of treatment outcomes, medication safety, and 
total cost of care.
Expanding job roles of pharmacists and pharmaceutical scientists to keep up with changes such 
as new regulatory frameworks and product groups.
1
2
3
4
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Table 5.7.2. The key strategies and proposed actions
Strategic Areas                                                                                                        Proposed Key Actions
- Lead and collaborate with organisations in succession planning to achieve a uniﬁed philosophy of pharmacy practice
- Lead and collaborate with professional organisations and academia to create a national programme for leadership development 
  and training in pharmacy
 
1. Manpower Management
Coordinated approach to ensure 
the pharmacy workforce meets 
future health care system 
and Singaporeans’ needs
2. Education and continu.ing
professional development (CPD)
Collaborative approach to ensure 
high quality education and CPD 
programmes to support patient
centred, outcomes-focused care.
3. Information, communication 
and automation technology (ICAT)
Create a profession�wide strategy
for development and use of
technology to facilitate delivery 
of safe and effective use of 
medication to patients.
4. Policies and Regulation
Change supported by regulatory
authorities, committed to review
and amend policies, regulation 
or legislation to address and 
encourage necessary initiatives, 
such as interdisciplinary team�
based care.
5. Leadership
Coordinated strategy to capitalize 
on collective strengths of 
professional organisations 
and academia to focus on the 
profession’s effort towards 
a uniﬁed philosophy of 
pharmacy practice.
- Achieve consensus on enhanced skills and knowledge for pharmacists within key pharmacy practice sectors.
- Promote greater understanding of factors determining pharmacist and pharmacy support workforce workplace satisfaction. 
- Address manpower numbers, recruitment, and retention i sues.
- Encourage pharmacists to pursue positions of leadership in government, educational institutions, and stakeholder organizations.
- Lead and collaborate in research initiatives to evaluate the effect of pharmacy practice on patient health, population health, and health    
  care services and the effect of changes in the utilization of pharmacy human resources.
- Promote the availability of appropriate numbers of pharmacy support workforce with better qualiﬁcations, expanded responsibilities, 
  and accountability as pharmacists’ roles evolve.
- Collaborate with the University to ensure that core pharmacy curricula address the knowledge, skills, and values required for future   
  pharmacy practice
- Lead and collaborate with key stakeholders to implement accessible programmes to upgrade competencies to support the 
  implementation of new services, specialty practices, and new practice models
- Create partnerships to develop learning programmes, including promotion and increase in inter�professional and intr professional 
  education and training
- Conduct and utilize research to develop, evaluate, and improve education and CPD programmes
- Address policies and practice issues relevant to electronic transfer of prescriptions and automation technology
- Promote adequate funding for implementation and maintenance of ICAT in pharmacy 
- Ensure that the development and implementation of ICAT in various settings facilitates continuity of care and improves the delivery 
  of safe and effective use of medication to patients
- Lead and collaborate in research to evaluate how the use of ICAT by pharmacy affects health care services and outcomes
- Protect the public through ongoing reconciliation of professional practice, professional competencies, and competency performance 
  assessment, in parallel with broadening scopes of practice
- Enabling regulatory framework, authorizing pharmacists to deliver expanded services in new practice models, including but not limited  
  to: initiating, modifying, continuing, and monitoring drug therapy; ordering and accessing laboratory results; and administering drugs 
  and vaccines by injection, in both collaborative and independent practice models
- Develop a regulatory framework that grants more authority, responsibility and accountability to pharmacists and pharmacy support workforce.
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Coordinated approach to ensure 
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technology to facilitate delivery 
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and amend policies, regulation 
or legislation to address and 
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- Lead and collaborate in research to evaluate how the use of ICAT by pharmacy affects health care services and outcomes
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  to: initiating, modifying, continuing, and monitoring drug therapy; ordering and accessing laboratory results; and administering drugs 
  and vaccines by injection, in both collaborative and independent practice models
- Develop a regulatory framework that grants more authority, responsibility and accountability to pharmacists and pharmacy support workforce.
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5.7.4. Current key strategic outcomes
Improved career structure for progression and advancement
A review of the pharmacy career structure in the public health care sector was conducted with a new career pathway framework 
being introduced in 2009 (Figure 5.7.1). Under the new career framework, pharmacists in the public health care sector can develop 
their career in professional, clinical, or research tracks. Besides enhancing professional development, the new career framework 
also attracts and retains pharmacists and expands the pool of future pharmacy leaders needed to guide the profession.
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Salary revision and benchmarking
Through regular salary review exercises, the salaries of 
pharmacists in the public health care sector are adjusted. 
The most recent salary review was completed in April 2012.
Training scholarships
The Ministry of Health has set aside funding to encourage 
more pharmacists to pursue specialist training. 
The funding provides 35 scholarships in specialist residency 
training and supports another 43 in doctorate and master’s 
degree programmes.
Establishment of pharmacy specialization 
framework
The establishment of Pharmacy Specialist Accreditation 
Board (PSAB) in February 2012 is an exciting development for 
pharmacists. PSAB defines the specialties in the practice of 
pharmacy and certifies those who meet the requisites of both 
qualifications and experience for registration as specialists in 
the public sector. The Singapore Pharmacy Council will 
maintain the Register of Specialists.
Role redesign of pharmacy technicians
Pharmacy technicians form an important component, 
accounting for up to 73% of our workforce in some 
institutions. Development of the pharmacy technician 
workforce, competencies, and new roles will therefore serve 
as an important strategy to mitigate the effects of pharmacist 
shortages and support expanded roles for pharmacists 
in clinical areas.
Review of pre-registration pharmacist 
training framework
The Singapore Pharmacy Council has recently completed its review 
of the existing pre-registration pharmacist’s training programme. 
The review has led to structural and delivery changes to training 
and review of the undergraduate pharmacy curriculum. 
The training will be centrally coordinated, with compulsory and 
elective modules aimed at achieving desired minimum practice 
competencies. It is important for joint development of education 
and training to ensure continuity of transition from undergraduate 
studies to practice.
Training framework for pharmacy support 
workforce
The first structured pharmacy technician training course was 
run by the Pharmaceutical Society of Singapore (PSS) more 
than 17 years ago to meet the evolving pharmacy service 
needs in hospitals. In 2009, PSS achieved Approved Training 
Organisation (ATO) status from the Singapore Workforce
Development Agency (WDA). WDA accredit pharmacy 
technicians and assistants training courses and the 
government subsidizes the course fees as part of the 
country’s adult learning and skills development strategy.
Collaboration with Agency of Integrated Care
PSS, in collaboration with the Agency of Integrated Care 
(AIC), embarked on a pilot pharmaceutical care programme 
in Voluntary Welfare Organizations (VWO) nursing homes in 
August 2011. The programme includes: a) Medication review 
and reconciliation for nursing home residents, b) Drawing up 
policies and procedures with nursing homes to ensure safe 
medication use practices, and c) Training of and support for 
nursing staff to ensure better understanding of medications 
used by residents and safe medication practices. Preliminary 
data show positive outcomes including safer and improved 
medication use process, resolution of drug-related problems, 
and good nursing staff feedback for the training provided by 
pharmacists. PSS and AIC will present the pilot programme 
results and will discuss with the Ministry to explore the 
mandatory requirement for nursing homes to engage 
pharmacist services.
Leverage on information technology and 
automation to advance care and services
Singapore has developed a pharmacy blueprint with a vision 
to deliver quality care and adding value through pharmacy 
information technology (IT). The mission is to develop a world 
class pharmacy IT system that enables value-added services to 
achieve quality, integrated patient care across the health care 
continuum. This is driven by pharmacists working with 
patients and other health care providers to look into our 
health care delivery processes. In hospitals, this is being done 
in inpatient and outpatient areas. Three hospitals have 
completed their inpatient closed loop medication 
management systems and by 2014 will implement outpatient 
automation systems. These will bring pharmacy practice 
to another level of safety and efficiency, enabling pharmacists 
to concentrate on improving patient care, reviewing 
drug-related problems, and reducing preventable adverse 
drug events. Other automation such as robots for intravenous 
compounding and cytotoxic preparation will be explored 
as these mature.
Facilitating and enabling legislation 
and regulation
Pharmacist specialisation is provided for under the Pharmacist 
Registration Act 2007. By September 2012, the pharmacist 
specialist register will include the following disciplines: 
oncology and pharmacotherapy geriatrics, cardiology, psychiatry, 
.................................................................................
Figure 5.7.1. Pharmacy career framework
 in the public health care sector
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results and will discuss with the Ministry to explore the 
mandatory requirement for nursing homes to engage 
pharmacist services.
Leverage on information technology and 
automation to advance care and services
Singapore has developed a pharmacy blueprint with a vision 
to deliver quality care and adding value through pharmacy 
information technology (IT). The mission is to develop a world 
class pharmacy IT system that enables value-added services to 
achieve quality, integrated patient care across the health care 
continuum. This is driven by pharmacists working with 
patients and other health care providers to look into our 
health care delivery processes. In hospitals, this is being done 
in inpatient and outpatient areas. Three hospitals have 
completed their inpatient closed loop medication 
management systems and by 2014 will implement outpatient 
automation systems. These will bring pharmacy practice 
to another level of safety and efficiency, enabling pharmacists 
to concentrate on improving patient care, reviewing 
drug-related problems, and reducing preventable adverse 
drug events. Other automation such as robots for intravenous 
compounding and cytotoxic preparation will be explored 
as these mature.
Facilitating and enabling legislation 
and regulation
Pharmacist specialisation is provided for under the Pharmacist 
Registration Act 2007. By September 2012, the pharmacist 
specialist register will include the following disciplines: 
oncology and pharmacotherapy geriatrics, cardiology, psychiatry, 
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oncology and pharmacotherapy geriatrics, cardiology, 
psychiatry, and infectious disease. This will allow pharmacists 
to practise at a specialist level dealing with complex disease 
states and pharmacotherapy problems. It is also congruent with 
advancing pharmacists’ careers and fulfilling aspirations 
in clinical areas.
The Electronic Transaction Act in Singapore allows electronic 
prescriptions to be recognised and this has further strengthened 
our push towards making computerised physician order entry 
a reality nationally. Even prescriptions for controlled drugs can be 
performed electronically if there are sufficient security measures.
The national electronic health record launched recently has 
meant that pharmacists can now access patients’ medical and 
medication records. Medication reconciliation by pharmacists 
is now more thorough and efficient. Together with the Health 
Sciences Authority computerised medical information system 
(CMIS), the database for adverse drug reaction reporting will 
enable safer medication therapies for Singaporeans.
The Ministry of Health National Medication Safety Taskforce 
set up in 2010 articulated a national medication safety 
strategy focussing on standardisation of medication practices, 
promoting medication safety culture amongst health care 
providers, building awareness of medication safety in patients, 
and enhancing medication delivery systems.
5.7.5. Conclusion
Past leaders in pharmacy practice and education envisaged 
that pharmacy would be a health profession that ensures the 
integrity of drug therapy. Embracing this legacy, the profession 
needs to continue to set its sights on the quality use of 
medicines. This vision is built on the fact that the less-than- 
optimal use of medicines is a major public health problem 
and that pharmacy is the right profession to address this 
concern. The profession’s movement in the 1990s toward 
patient-centred practice continues to develop with 
emerging practice trends and patient care needs.
We are also cognizant of our diverse backgrounds in 
community, hospital, marketing, sales and distribution, 
manufacturing, regulatory, and academia. A unified philosophy 
that clearly identifies the patient as the primary beneficiary 
of the profession and its services is an important lever to move 
the profession as a body to meet the rising demands on the 
health care system and changes in the delivery of health care. 
In our strategies, we seek to focus on the commonality that 
binds us all through professional practice, ethics, and values 
and continue to work together for the common good of the 
public and the profession.
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Summary
• South Africa has 12,813 pharmacists; the majority work in   
   community (43%) and hospital (35%) settings, but they are 
   inequitably distributed geographically and between public   
   and private health care sectors. The proportion of 
   pharmacists working in the public health care sector has 
   increased over the past few years, probably due to the 
   introduction of community service for pharmacists, 
   increased salaries, opportunities for career advancement,   
   and improved conditions of service.
• The country has grown its pharmacy support workforce in 
   the public and private sectors to 9, 071 pharmacist assistants 
   aided by government funding for employers to support   
   training. Training for two new cadres, pharmacy technicians   
   and pharmacy technical assistants, with increased scopes 
   of practice is planned to commence in 2015.
• Eight Schools of Pharmacy produce on average 476 graduates   
   annually, with the curriculum and teaching and learning 
   methodologies developing to meet health services requirements.
   The current challenge to double the number of graduates 
   to meet the projected health service requirements is 
   overwhelming, given the constraints of academia, but is an   
   area of active engagement of the South African Pharmacy 
   Council (SAPC) and Schools of Pharmacy.
• New roles proposed for pharmacists promise to utilise    
   pharmacists’ professional skills to the benefit of the health   
   services, although precisely how they will be integrated into 
   South Africa’s reforming health system is yet to be determined.
• The Pharmacy Human Resources in South Africa 2011, 
   published by the SAPC, provides comprehensive information 
   on the current pharmacy workforce in the country, together  
   with strategies for future development of the profession. 
   It will assist the Minister of Health in developing integrated 
   plans for the country’s health system. Unless otherwise 
   referenced, the data in this case study is derived from 
   this publication.
5.8.1. Background
South African pharmacy workforce
South Africa’s pharmacy workforce is made up of pharmacists 
and two levels of pharmacy support personnel, basic 
pharmacist assistants and post-basic pharmacist assistants, 
registered with the South African Pharmacy Council (SAPC). 
In 2010, South Africa had just over 12,813 pharmacists and 9,071 
pharmacist assistants, which includes those in training, with 
considerable differences in distribution across the nine 
provinces, particularly between urban and rural areas.
The greatest numbers of pharmacists work in community 
(43%) and hospital (35%) settings, with smaller numbers in 
industry (6%), wholesale (3%), professional administration (3%) 
and academia (1%). The majority of pharmacists in South Africa 
are younger than 55 years, and in two provinces more than 
60% are below 35 years. Over the past four decades, in line with 
international trends, the pharmacy workforce in South Africa 
has feminised from an 83:17 ratio of male to female in 1970s to
40:60 ratio in 2010.
The educational requirements to register as a pharmacist are a 
four-year Bachelor of Pharmacy degree followed by a one-year 
internship. South Africa has eight schools of pharmacy at 
universities around the country producing on average 476 
graduates per year. On completing their internships, all 
pharmacists are required to work in a public sector 
(government) pharmacy for one year prior to working in the 
sector of their choice. Pharmacist assistants complete a course 
of training with an accredited provider and undergo in-service 
training under the supervision of an approved pharmacist tutor.
Context of the South African health system
South Africa is situated at the southern tip of Africa and has 
a population of 50 million, of whom 57% reside in urban areas. 
Whilst it is ranked as an upper middle-income country, 
a distinguishing feature is its very high inequality (Gini 
coefficient), which has not improved since the establishment 
of the first democratic government in 1994.
South Africa has poor health outcomes for the proportion it 
spends on health, and will be one of the countries likely to 
miss its health Millennium Development Goal targets [1]. 
The reasons for poor health outcomes put forward recently in 
the Negotiated Service Delivery Agreement (NDSA) are South 
Africa’s quadruple burden of disease characterised by the 
coexistence of diseases associated with underdevelopment, 
non-communicable diseases, a high injury burden, and HIV and 
TB epidemics; poverty and unemployment; and an inequitable 
and underperforming health service [2].
Approximately eight million (17%) South Africans are covered 
by private medical schemes, but a larger proportion use parts 
of private delivery systems such as general practitioners (24.3%) 
and pharmacies. The remainder rely on public health services.
South Africa began reforming its fragmented hospital-centric 
health departments in 1994 to a unified health system with 
a primary health care (PHC) approach based on the district 
health system and published a national drug policy in 1996 
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Figure 5.8.1. Pharmacies and pharmacists per 100,000 for all provinces
Source: Stats SA, 2009; SAPC Register, April 2010
SAPC records from 2010 show that 63% of pharmacists worked 
in the private sector, 29% in the public sector, and 8% were 
unknown. Considering that over 80% of the population rely 
on public health services and only 29% of pharmacists work in 
the sector, the inequity in access to the pharmacy workforce 
is glaring. Previous records indicate even lower proportions 
of pharmacists working in the public sector, especially in rural 
and underserved areas.
Slow production of pharmacy graduates
South Africa produces on average 476 pharmacy graduates 
per year. About 86 of these are foreign students, mostly from 
southern African countries, who will not be permitted to 
practise in South Africa. Recent estimates indicate that the 
number of graduates needs to double to meet projected 
demands. This means that the eight existing Schools of 
Pharmacy need to increase their outputs or new schools need 
to open. Both options require additional academic staff, 
physical infrastructure, and increased throughput. This is 
challenging in the current environment in which attracting 
and retaining academic staff is difficult due to low salary 
levels (junior lecturer salaries are sometimes lower than 
starting salaries in the private and public health sectors) and 
schools having to compete for resources in higher education.
Few pharmacy support workers
South Africa has fewer registered pharmacy support 
workers than pharmacists, 9,071 to 12,813, implying that many 
tasks performed by pharmacists could be done by assistants. 
However, a recent report indicated that, in some settings, 
pharmacy support personnel were underutilised, which seems 
to indicate poor role allocation and skill mix in the provision 
of pharmaceutical services.
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on improving health outcomes [5]. Two interrelated initiatives 
currently underway are the PHC re-engineering strategy, with a
population-oriented service model of PHC, and the National 
Health Insurance (NHI), which will introduce universal health 
insurance over a 14-year period [6,7]. These reforms promise to 
have farreaching effects on the public and private health 
sectors, but as yet the implications are unknown.
South Africa’s high disease burden, particularly HIV and TB, 
high inequality, and a reforming health system provide 
challenges and opportunities for the pharmacy workforce.
5.8.2. Key issues
Pharmacy workforce planning
The pharmacy workforce is a critical part of any health system, and 
planning the South African pharmacy workforce is important if high 
quality pharmaceutical services are to be delivered to the whole 
population. This includes the production of pharmacists and 
pharmacy support workers, and the optimal use of existing 
pharmacy personnel. One of the first steps in planning for the future 
is having a clear picture of the current production and practice of 
the pharmacy workforce, but until recently, the data available was 
limited. The SAPC recognised the need for accurate data and analysis 
of human resource needs. 
In February 2012, the Council published its report, Pharmacy Human 
Resources in South Africa 2011 [8]. The document will assist the 
Minister of Health in refining and implementing pharmacy 
workforce requirements in the HRH Strategy for the Health Sector 
2012/13-2016/17 published towards the end of 2011 [9].
Pharmacy workforce shortages
All areas of pharmacy practice in the country report shortages: 
community, hospital, industry, and academia, with vacancy 
rates for pharmacists of up to 76% reported in the public 
sector in one province. However, the situation has changed 
recently in that private hospitals and community pharmacies 
also report difficulties in attracting and retaining pharmacists. 
Workforce shortages are a factor of the production of 
pharmacy graduates, as well as recruitment and retention.
Inequitable distribution of the pharmacy 
workforce
A feature, by no means unique to South Africa, is the 
inequitable distribution of the pharmacy workforce both 
geographically and by sector. The contrast between the nine 
provinces is marked, with the two most urbanised provinces, 
Gauteng (GP) and Western Cape (WC), having the highest 
numbers of pharmacists and pharmacies (Figure 5.8.1).
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5.8.3. Strategies
Pharmacy Human Resources in South Africa 
2011 Report
The Pharmacy Human Resources in South Africa 2011 
published by the SAPC is the culmination of extensive work 
by a joint task team comprising stakeholders from pharmacy 
practice and education [8]. The publication provides 
comprehensive information on the current pharmacy 
workforce situation in the country, including production and 
practice. The document aims to assist the Ministry of Health in 
developing an integrated plan for the country’s health system 
by providing accurate statistics and an informed analysis of 
the production and utilisation of pharmacy human resources.
Further, it provides a comparison with international trends 
and highlights challenges and future strategies for the 
pharmacy profession in South Africa. The report was launched 
on 24 February 2012. The information is accessible online from 
the SAPC website (http://www.sapc.za.org/G_Publications.asp).
Recruiting and retaining pharmacists in the 
public health sector
Over the past few years the government has introduced a 
range of initiatives to recruit and retain health professionals, 
including pharmacists, into the public health sector, and in 
particular to rural and underserved areas. One initiative to 
increase the number of pharmacists in the public sector
commenced in 2001 when mandatory one-year community 
service in the public sector was introduced for all pharmacists 
following registration with the SAPC. This service is carried out
immediately after the internship year and is organised 
through the national department of health in collaboration 
with the provincial health departments, which are responsible 
for placing pharmacists in public sector facilities. Over the past 
10 years, this has brought an average of 479 additional
pharmacists into the public sector each year, not all of whom 
remain in the public sector after completion of the mandatory 
year of service. A study is currently underway to determine the
number of pharmacists who remain in the public sector as well 
as the reasons why others leave it.
Despite the relative inexperience of young pharmacists, there 
are many reports of the positive contribution they make, 
particularly in rural settings. In urban settings, it appears that 
community service pharmacists are used primarily to 
supplement poorly staffed pharmacies.
Other schemes to attract and retain pharmacists in the public 
sector have focused on improving conditions of service, such 
as the introduction of rural and scarce skills allowances 
(pharmacy was named as a scarce skill by the Ministry of 
Labour in 2007). The most recent initiative implemented in 
2009-10 was the Occupation-specific Dispensation (OSD), which 
consolidated the previous two allowances and included a re-
grading component. The data from the past few years show a 
gradual increase in the proportion of pharmacists working 
in the public sector from 12% in 2004 to 29% in 2010 (Figure 5.8.2). 
Many attribute this shift to improved salaries, formal 
establishment of posts and opportunities for career advancement, 
and conditions of service in the public sector, although significant 
policy and legislative changes in regulations relating to the 
ownership and licensing of pharmacies, which previously was 
restricted to pharmacists, and the introduction of the dispensing 
fee in 2006, have affected other sectors of the pharmacy profession 
during this period.
Figure 5.8.2. Pharmacist distribution per sector 2004-2010
Source: SAPC Register, June 2010
A recent initiative commenced by the National Department of 
Health, applicable to the health workforce in both the private 
and public sectors, is the Excellence in Health care Awards, 
which recognise outstanding achievements in the health care 
sector. In collaboration with the SAPC, the National Pharmacist 
and Pharmacist’s Assistant of the Year Awards are presented 
annually at a ceremony hosted by the Minister of Health. These 
awards serve as an affirmation of excellence in pharmacy prac-
tice and appreciation of service from the government.
Scaling up pharmacy support workers
Pharmacist assistants
A few years ago, the development of pharmacy support 
workers was identified as a gap in the South African pharmacy 
workforce, and a number of strategies have been put in place to 
grow this part of the pharmacy workforce. In 2000 the SAPC 
successfully re-launched the pharmacist assistant programme 
with two levels: pharmacist assistant (basic) and pharmacist 
assistant (post-basic). The pharmacist assistant qualification is 
categorised into manufacturing, wholesale, community, and 
institutional (hospital) pharmacy [10]. Most local and provincial 
health departments, as well as private hospitals and community 
pharmacies, accessed government skills funding to support these 
training opportunities. Subsequent to this, some health 
providers have accessed further funding to train pharmacist 
assistants, for example in 2011 the Western Cape Provincial 
Department of Health received funding from the Expanded 
Public Works Programme to train 120 unemployed young people 
aged 18-25 years as pharmacist assistants. 
Overall, these initiatives have resulted in a steady increase in the 
numbers of pharmacist assistants in the country (Figure 5.8.3).
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challenging in the current environment in which attracting 
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schools having to compete for resources in higher education.
Few pharmacy support workers
South Africa has fewer registered pharmacy support 
workers than pharmacists, 9,071 to 12,813, implying that many 
tasks performed by pharmacists could be done by assistants. 
However, a recent report indicated that, in some settings, 
pharmacy support personnel were underutilised, which seems 
to indicate poor role allocation and skill mix in the provision 
of pharmaceutical services.
.................................................................................
on improving health outcomes [5]. Two interrelated initiatives 
currently underway are the PHC re-engineering strategy, with a
population-oriented service model of PHC, and the National 
Health Insurance (NHI), which will introduce universal health 
insurance over a 14-year period [6,7]. These reforms promise to 
have farreaching effects on the public and private health 
sectors, but as yet the implications are unknown.
South Africa’s high disease burden, particularly HIV and TB, 
high inequality, and a reforming health system provide 
challenges and opportunities for the pharmacy workforce.
5.8.2. Key issues
Pharmacy workforce planning
The pharmacy workforce is a critical part of any health system, and 
planning the South African pharmacy workforce is important if high 
quality pharmaceutical services are to be delivered to the whole 
population. This includes the production of pharmacists and 
pharmacy support workers, and the optimal use of existing 
pharmacy personnel. One of the first steps in planning for the future 
is having a clear picture of the current production and practice of 
the pharmacy workforce, but until recently, the data available was 
limited. The SAPC recognised the need for accurate data and analysis 
of human resource needs. 
In February 2012, the Council published its report, Pharmacy Human 
Resources in South Africa 2011 [8]. The document will assist the 
Minister of Health in refining and implementing pharmacy 
workforce requirements in the HRH Strategy for the Health Sector 
2012/13-2016/17 published towards the end of 2011 [9].
Pharmacy workforce shortages
All areas of pharmacy practice in the country report shortages: 
community, hospital, industry, and academia, with vacancy 
rates for pharmacists of up to 76% reported in the public 
sector in one province. However, the situation has changed 
recently in that private hospitals and community pharmacies 
also report difficulties in attracting and retaining pharmacists. 
Workforce shortages are a factor of the production of 
pharmacy graduates, as well as recruitment and retention.
Inequitable distribution of the pharmacy 
workforce
A feature, by no means unique to South Africa, is the 
inequitable distribution of the pharmacy workforce both 
geographically and by sector. The contrast between the nine 
provinces is marked, with the two most urbanised provinces, 
Gauteng (GP) and Western Cape (WC), having the highest 
numbers of pharmacists and pharmacies (Figure 5.8.1).
.................................................................................
N
um
be
r p
er
 1
00
.0
00
50.00
45.00
40.00
35.00
30.00
25.00
20.00
15.00
10.00
5.00
0.00
44.93
18.16
15.94
18.58
10.23
14.53 13.77
20.08
41.05
25.08
Pharmacies /100k
Pharmacists/100k
EC             FS            GP          KZN            L             MP           NC           NW           WC       TOTAL
4.87         7.24        10.36         5.96         3.62         5.77          8.10         6.46         13.29       8.73
15.94      18.16       44.93        18.58      10.23       14.53       13.77       20.08       41.05       25.08
.................................................................................
5.8.3. Strategies
Pharmacy Human Resources in South Africa 
2011 Report
The Pharmacy Human Resources in South Africa 2011 
published by the SAPC is the culmination of extensive work 
by a joint task team comprising stakeholders from pharmacy 
practice and education [8]. The publication provides 
comprehensive information on the current pharmacy 
workforce situation in the country, including production and 
practice. The document aims to assist the Ministry of Health in 
developing an integrated plan for the country’s health system 
by providing accurate statistics and an informed analysis of 
the production and utilisation of pharmacy human resources.
Further, it provides a comparison with international trends 
and highlights challenges and future strategies for the 
pharmacy profession in South Africa. The report was launched 
on 24 February 2012. The information is accessible online from 
the SAPC website (http://www.sapc.za.org/G_Publications.asp).
Recruiting and retaining pharmacists in the 
public health sector
Over the past few years the government has introduced a 
range of initiatives to recruit and retain health professionals, 
including pharmacists, into the public health sector, and in 
particular to rural and underserved areas. One initiative to 
increase the number of pharmacists in the public sector
commenced in 2001 when mandatory one-year community 
service in the public sector was introduced for all pharmacists 
following registration with the SAPC. This service is carried out
immediately after the internship year and is organised 
through the national department of health in collaboration 
with the provincial health departments, which are responsible 
for placing pharmacists in public sector facilities. Over the past 
10 years, this has brought an average of 479 additional
pharmacists into the public sector each year, not all of whom 
remain in the public sector after completion of the mandatory 
year of service. A study is currently underway to determine the
number of pharmacists who remain in the public sector as well 
as the reasons why others leave it.
Despite the relative inexperience of young pharmacists, there 
are many reports of the positive contribution they make, 
particularly in rural settings. In urban settings, it appears that 
community service pharmacists are used primarily to 
supplement poorly staffed pharmacies.
Other schemes to attract and retain pharmacists in the public 
sector have focused on improving conditions of service, such 
as the introduction of rural and scarce skills allowances 
(pharmacy was named as a scarce skill by the Ministry of 
Labour in 2007). The most recent initiative implemented in 
2009-10 was the Occupation-specific Dispensation (OSD), which 
consolidated the previous two allowances and included a re-
grading component. The data from the past few years show a 
gradual increase in the proportion of pharmacists working 
in the public sector from 12% in 2004 to 29% in 2010 (Figure 5.8.2). 
Many attribute this shift to improved salaries, formal 
establishment of posts and opportunities for career advancement, 
and conditions of service in the public sector, although significant 
policy and legislative changes in regulations relating to the 
ownership and licensing of pharmacies, which previously was 
restricted to pharmacists, and the introduction of the dispensing 
fee in 2006, have affected other sectors of the pharmacy profession 
during this period.
Figure 5.8.2. Pharmacist distribution per sector 2004-2010
Source: SAPC Register, June 2010
A recent initiative commenced by the National Department of 
Health, applicable to the health workforce in both the private 
and public sectors, is the Excellence in Health care Awards, 
which recognise outstanding achievements in the health care 
sector. In collaboration with the SAPC, the National Pharmacist 
and Pharmacist’s Assistant of the Year Awards are presented 
annually at a ceremony hosted by the Minister of Health. These 
awards serve as an affirmation of excellence in pharmacy prac-
tice and appreciation of service from the government.
Scaling up pharmacy support workers
Pharmacist assistants
A few years ago, the development of pharmacy support 
workers was identified as a gap in the South African pharmacy 
workforce, and a number of strategies have been put in place to 
grow this part of the pharmacy workforce. In 2000 the SAPC 
successfully re-launched the pharmacist assistant programme 
with two levels: pharmacist assistant (basic) and pharmacist 
assistant (post-basic). The pharmacist assistant qualification is 
categorised into manufacturing, wholesale, community, and 
institutional (hospital) pharmacy [10]. Most local and provincial 
health departments, as well as private hospitals and community 
pharmacies, accessed government skills funding to support these 
training opportunities. Subsequent to this, some health 
providers have accessed further funding to train pharmacist 
assistants, for example in 2011 the Western Cape Provincial 
Department of Health received funding from the Expanded 
Public Works Programme to train 120 unemployed young people 
aged 18-25 years as pharmacist assistants. 
Overall, these initiatives have resulted in a steady increase in the 
numbers of pharmacist assistants in the country (Figure 5.8.3).
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Figure 5.8.3. Registered pharmacist assistants (Pas), 2006-2010
Source: SAPC Register, 2010 [8]
New pharmacy technician and pharmacy technical assistant cadres
The pharmaceutical needs of the country increase considerably 
in the past decade, particularly with the rollout of ARVs, and the 
need for a more highly qualified pharmacy support cadre that is 
able to work at primary health care clinics under the indirect su-
pervision of a pharmacist. In response to this, the SAPC decided 
to phase out the current pharmacy support personnel (pharma-
cist assistants) and introduce two new mid-level workers, 
pharmacy technicians and pharmacy technical assistants.
These new cadres will be trained full time in higher education 
and training institutions for one and two years, respectively, 
and then perform a six-month internship [11]. Precise details 
of which institutions will provide the training is being 
negotiated with the Department of Education and Training, 
the SAPC, and individual universities.
Workforce development
The changing health needs of the country and a health system 
in flux provide challenges and opportunities for the pharmacy 
workforce. It is essential to ensure not only production of 
sufficient numbers but also that the pharmacy workforce have 
appropriate competencies to contribute optimally as members 
of the health care team.
Undergraduate education and training
A new pharmacy qualification was recently approved by the 
South African Qualification Authority to take into account 
changes in health delivery and pharmacists’ roles. The new 
curriculum will be introduced in schools of pharmacy in 2013 and 
will train generalist pharmacists to work in diverse 
settings. Innovative ways of training pharmacy undergradates 
are responding to requirements for pharmacists that are 
confident in working inter-professionally and at all levels of the 
health service, from primary and community-based care to highly 
specialised tertiary hospitals, as well as in industry and academia. 
New strategies introduced include problem-based and 
experiential learning methods and opportunities to work in 
underprivileged communities and at community clinics, as well 
as hospital settings [12]. Electronic teaching and learning 
strategies are also in development [13]. The success of these 
initiatives in producing pharmacy graduates with appropriate 
attributes and skills for the needs of the country’s health 
system will need to be evaluated.
New roles for pharmacists
Implementing the district health system in South Africa has 
resulted in an increased emphasis on primary level services, 
including the establishment of new posts for district and 
facility-based pharmacists and pharmacy support workers. 
Further work on skill mix and staffing norms for primary level 
services is required to ensure optimal use of the pharmacy 
workforce to deliver primary level pharmaceutical services.
Community pharmacies in South Africa, in line with those in 
developed countries, have expanded services from dispensing 
and OTC prescribing to a range of preventive services, such as 
blood pressure monitoring, immunisations and family planning 
counseling. The recent introduction of a fees structure for 
pharmacists providing these services paves the way for 
pharmacists to be remunerated for these new roles [14].
Other strategies currently underway to develop the pharmacy 
workforce and address gaps in health care provision include 
the proposed introduction of authorised pharmacist 
prescribers and specialities in industrial pharmacy, clinical 
pharmacy, and pharmaceutical services in public health 
[15, 16]. How all these new roles will integrate into the PHC 
re-engineering strategy and NHI reforms underway is 
unknown at the moment but they provide opportunities for 
the pharmacy profession to contribute to the creation of a 
reformed health system in South Africa [6, 7].
5.8.4. Outcomes
• Pharmacy Human Resources in South Africa 2011 published 
   by the SAPC provides a situational assessment of the current   
   South African pharmacy workforce and outlines challenges   
   and future strategies for pharmacy workforce development    
   in the country.
• The number of pharmacists working in the public sector 
   has improved significantly over past few years-improving 
   equity-and appears to be due to improvements in 
   remuneration, progress in creating career paths, 
   and improved working conditions.
• A fee structure was recently approved for pharmacists 
   working in community pharmacies to provide a range of 
   preventive health services, paving the way for pharmacists 
   to contribute to primary health care.
• The number of pharmacist assistants has increased steadily 
   to just over 9,000 since a new pharmacist assistant programme 
   was launched in 2000. Training for two new mid-level pharmacy   
   support workers, pharmacy technicians and pharmacy technical 
   assistants, with greater scopes of practice, is expected
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   to commence in 2015 to meet pharmacy workforce needs, 
   particularly for the ARV rollout and a re-engineered PHC system.
• Increasing production of pharmacy graduates remains a 
   challenge in the current higher education environment and 
   is an area that the SAPC and pharmacists in academia are       
   giving urgent attention.
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5.9. Country Case Study: Tanzania
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Summary
Pharmacy education is an important area that contributes to 
the growth of the pharmaceutical human resources and hence 
the overall pharmaceutical sector in a country. This case study
summarizes recent developments related to pharmacy 
education in Tanzania. It provides a country situational 
analysis and current information regarding pharmaceutical 
training institutions, their numbers, capacities and 
contribution in making up the profession.
• Pharmaceutical workforce challenges in Tanzania include:
1- Critical shortage of all categories of pharmaceutical workforce;
2- Inadequate growth in pharmaceutical human resources;
3- Skills mix imbalance, especially in the area of patient care; and
4- Distribution imbalances.
• The case study also discusses various strategies aimed at icreasing   
   the number of pharmaceutical personnel in the country.
5.9.1. Background
The human resources for health crisis affects 57 countries 
worldwide, including Tanzania [1-5]. In Tanzania, it is estimated 
that public and private sector dispensaries (ie, lowest level of 
facilities for health care provision), where primary care to most 
of the population is provided, were staffed by only 31% and 
16%, respectively, of the required health workforce [6].
Access to quality medicines and competent health care providers 
are fundamental aspects of the health care system. Pharmaceutical 
human resources are responsible for the management, supply, and 
use of medicines and are vital components of the architecture to 
improve access to medicines. Therefore, their availability is of 
critical importance in meeting national and global health goals, 
thus requiring special attention.
There is a pressing need for appropriate pharmaceutical 
human resources planning to develop local strategies to 
address workforce challenges. This case study provides the 
Tanzanian experience using workforce development approaches 
that cuts across all levels of the pharmaceutical workforce, 
from dispensers to pharmacists and specialized pharmaceutical 
workforce. It is based on the pharmaceutical human resources 
report of 2009 [7], which was conducted in Tanzania, and applied 
a WHO-designed methodology. 
The main objective of the assessment was to determine the 
total workforce providing pharmaceutical services in the 
public, non-governmental organisation (NGO), and private sectors.
5.9.2. Key issues
Human resources shortages
The pharmaceutical human resources report of 2009 [7] 
identified a total of 640 pharmacists (1 per 50,000 population), 
479 pharmacy technicians (1 per 80,000), and 376 pharmacy 
assistants (1 per 100,000). The study also revealed a total of 
5241 pharmaceutical outlets served by 1495 pharmaceutical 
personnel. If pharmaceutical human resources was evenly 
distributed across all pharmaceutical outlets, only about 29% 
of outlets would be staffed. This means that pharmaceutical
services are provided by unqualified (non-pharmaceutical) 
personnel in over 70% of the pharmaceutical outlets. 
It is, therefore, not surprising that 187 facilities surveyed ex-
pressed shortages of over 500 pharmaceutical personnel.
Inadequate growth in pharmaceutical 
human resources
The 2009 assessment showed limited growth in the numbers 
of pharmacists and pharmaceutical technicians between 2007 
and 2009, with a low level of new pharmaceutical personnel 
entering the workforce each year (Table 5.9.1).
Table 5.9.1. Total pharmaceutical human resources 2007 to 2009
Before 2009, there was only one pharmacy school offering a 
Bachelor of Pharmacy (BPharm) degree, which began in 1974 
with an enrolment capacity between 25 and 50 and an output 
rate of 12 to 50 students per year. By 2009, there were two 
pharmacy schools offering a BPharm Degree, with a 
combined intake of about 100 students; two pharmacy techni-
cian training schools (diploma), with an intake capacity of 
about 90 students; and one pharmaceutical assistant 
programme enrolling 20 students. All schools faced expansion 
challenges as they had significant inadequacies in physical 
infrastructure, academic human resources, and budgets. 
.................................................................................
Cadre          2007             2008              2009
Pharmacists           568                593                640
Pharmaceutical technicians         369                402                479
Pharmaceutical assistants         315                327                376
.................................................................................
Consequently, despite increasing demand for training, only 
21% and 8% of applicants to the pharmacy degree and 
pharmacy technician  diploma programmes were admitted 
in 2008 [7].
Skills mix imbalance
The assessment also identified a skills mix imbalance with 
more pharmacists than pharmaceutical technicians and 
assistants in the country. Pharmacists mainly work in urban 
areas and at higher levels of the health system and, with such 
an “upside-down triangle,” it means that vacancies at lower
levels of the health system will remain. Other cadres that do 
not have pharmaceutical competencies will continue to fill 
these gaps unless concerted efforts are made to increase the 
number of technicians and assistants.
Distribution imbalance
The distribution of pharmaceutical personnel is inequitable 
and has led to a severe shortage in rural areas and inequitable 
service provision. Pharmaceutical cadres were found to be 
concentrated in urban areas, with the ratio of personnel per 
10,000 population in a region ranging between 0.01-1.37 for 
pharmacists and 0.02-0.56 for pharmacy technicians [7]. 
This imbalance poses a major challenge to the nationwide 
provision of pharmaceutical services, since the proportion of 
the population living in rural areas is greater than that in urban 
areas. To ensure that only quality products are made available 
to the population, functional and well-resourced 
pharmaceutical supply and regulatory systems are required, 
with adequate numbers of qualified pharmaceutical personnel.
5.9.3. Strategies
The findings of the 2009 Assessment of Pharmaceutical Human 
Resources led to the development o the Pharmaceutical 
Human Resources Strategic Framework with key stakeholders, 
which could be integrated into broader human resources for 
health strategies. The Ministry of Health and Social Welfare 
(MOHSW) has begun several initiatives to address the above 
challenges, which are summarized in this section.
Pharmaceutical human resources strategic 
framework
A draft Pharmaceutical Human Resources Strategic Framework 
2011–2020 was developed by key stakeholders in April 2010 
aimed at addressing the significant shortage of pharmaceutical 
human resources. Policy goals were identified to address human 
resources planning and development (Table 5.9.2).
Table 5.9.2. Human resources issues and policy goals
.................................................................................
HR Development                                           Policy goals
HR Management                                           Policy goals
HR Planning                                              Policy goals
1        Human   
          resources   
          planning
2        Job    
          descriptions
1.3 To strengthen partnerships between the Pharmaceutical 
Society of Tanzania (PST), Pharmacy Council (PC), 
Pharmaceutical Services Unit (PSU) and Human Resources 
for Health Department to coordinate pharmaceutical human 
resources planning
1.4 To formulate and implement a pharmaceutical human 
resources plan with stakeholders’ input
1.5 To review and revise the pharmaceutical human resources 
establishment in the public sector that reﬂects needs at 
different levels
1.6 To strengthen the PC register to ensure accurate and 
up-to-date human resources information of all 
pharmaceutical cadres
2.1 To develop clear job descriptions for each 
pharmaceutical cadre in the public sector
3        Recruitment  
          and retention
4        Training   
           institution   
           and academic  
           capacity
4.1 To establish new training programmes, particularly for 
pharmaceutical technicians and assistants
4.2 To build the teaching and physical capacity of existing 
training institutions (public and private)
4.3 To review academic staff recruitment criteria to allow 
recognition of professional performance, expertise, 
and experience
4.4 To develop training programmes for teachers in 
teaching methods
4.5 To revise incentive packages for academic members
4.6 To expand post-graduate (master’s, PhD) education 
programmes to build expertise for academia (teaching 
and research)
4.7 Increase output of graduates to reach a target of 950 
pharmacists, 1450 pharmaceutical technicians, and 1500-2600 
pharmaceutical assistants by 2015
4.8 Review competency requirements and curriculum of each 
cadre to optimize length of training without compromising 
quality
5        Continuing    
          professional 
          development    
          (CPD)
5.1 To develop and certify CPD programmes for all 
pharmaceutical cadres through a partnership among the PC, 
PST, and training institutions
3.1 To improve human resources management at 
district levels
3.2 To develop and establish retention schemes 
for underserved areas
3.3 To improve the physical working environment 
in underserved areas
3.4 To implement remote supervisory support systems 
for pharmaceutical services in the public sector
3.5 To revise and improve retirement beneﬁts
3.6 To review the salary structure of all pharmaceutical cadres
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Pharmacy education is an important area that contributes to 
the growth of the pharmaceutical human resources and hence 
the overall pharmaceutical sector in a country. This case study
summarizes recent developments related to pharmacy 
education in Tanzania. It provides a country situational 
analysis and current information regarding pharmaceutical 
training institutions, their numbers, capacities and 
contribution in making up the profession.
• Pharmaceutical workforce challenges in Tanzania include:
1- Critical shortage of all categories of pharmaceutical workforce;
2- Inadequate growth in pharmaceutical human resources;
3- Skills mix imbalance, especially in the area of patient care; and
4- Distribution imbalances.
• The case study also discusses various strategies aimed at icreasing   
   the number of pharmaceutical personnel in the country.
5.9.1. Background
The human resources for health crisis affects 57 countries 
worldwide, including Tanzania [1-5]. In Tanzania, it is estimated 
that public and private sector dispensaries (ie, lowest level of 
facilities for health care provision), where primary care to most 
of the population is provided, were staffed by only 31% and 
16%, respectively, of the required health workforce [6].
Access to quality medicines and competent health care providers 
are fundamental aspects of the health care system. Pharmaceutical 
human resources are responsible for the management, supply, and 
use of medicines and are vital components of the architecture to 
improve access to medicines. Therefore, their availability is of 
critical importance in meeting national and global health goals, 
thus requiring special attention.
There is a pressing need for appropriate pharmaceutical 
human resources planning to develop local strategies to 
address workforce challenges. This case study provides the 
Tanzanian experience using workforce development approaches 
that cuts across all levels of the pharmaceutical workforce, 
from dispensers to pharmacists and specialized pharmaceutical 
workforce. It is based on the pharmaceutical human resources 
report of 2009 [7], which was conducted in Tanzania, and applied 
a WHO-designed methodology. 
The main objective of the assessment was to determine the 
total workforce providing pharmaceutical services in the 
public, non-governmental organisation (NGO), and private sectors.
5.9.2. Key issues
Human resources shortages
The pharmaceutical human resources report of 2009 [7] 
identified a total of 640 pharmacists (1 per 50,000 population), 
479 pharmacy technicians (1 per 80,000), and 376 pharmacy 
assistants (1 per 100,000). The study also revealed a total of 
5241 pharmaceutical outlets served by 1495 pharmaceutical 
personnel. If pharmaceutical human resources was evenly 
distributed across all pharmaceutical outlets, only about 29% 
of outlets would be staffed. This means that pharmaceutical
services are provided by unqualified (non-pharmaceutical) 
personnel in over 70% of the pharmaceutical outlets. 
It is, therefore, not surprising that 187 facilities surveyed ex-
pressed shortages of over 500 pharmaceutical personnel.
Inadequate growth in pharmaceutical 
human resources
The 2009 assessment showed limited growth in the numbers 
of pharmacists and pharmaceutical technicians between 2007 
and 2009, with a low level of new pharmaceutical personnel 
entering the workforce each year (Table 5.9.1).
Table 5.9.1. Total pharmaceutical human resources 2007 to 2009
Before 2009, there was only one pharmacy school offering a 
Bachelor of Pharmacy (BPharm) degree, which began in 1974 
with an enrolment capacity between 25 and 50 and an output 
rate of 12 to 50 students per year. By 2009, there were two 
pharmacy schools offering a BPharm Degree, with a 
combined intake of about 100 students; two pharmacy techni-
cian training schools (diploma), with an intake capacity of 
about 90 students; and one pharmaceutical assistant 
programme enrolling 20 students. All schools faced expansion 
challenges as they had significant inadequacies in physical 
infrastructure, academic human resources, and budgets. 
.................................................................................
Cadre          2007             2008              2009
Pharmacists           568                593                640
Pharmaceutical technicians         369                402                479
Pharmaceutical assistants         315                327                376
.................................................................................
Consequently, despite increasing demand for training, only 
21% and 8% of applicants to the pharmacy degree and 
pharmacy technician  diploma programmes were admitted 
in 2008 [7].
Skills mix imbalance
The assessment also identified a skills mix imbalance with 
more pharmacists than pharmaceutical technicians and 
assistants in the country. Pharmacists mainly work in urban 
areas and at higher levels of the health system and, with such 
an “upside-down triangle,” it means that vacancies at lower
levels of the health system will remain. Other cadres that do 
not have pharmaceutical competencies will continue to fill 
these gaps unless concerted efforts are made to increase the 
number of technicians and assistants.
Distribution imbalance
The distribution of pharmaceutical personnel is inequitable 
and has led to a severe shortage in rural areas and inequitable 
service provision. Pharmaceutical cadres were found to be 
concentrated in urban areas, with the ratio of personnel per 
10,000 population in a region ranging between 0.01-1.37 for 
pharmacists and 0.02-0.56 for pharmacy technicians [7]. 
This imbalance poses a major challenge to the nationwide 
provision of pharmaceutical services, since the proportion of 
the population living in rural areas is greater than that in urban 
areas. To ensure that only quality products are made available 
to the population, functional and well-resourced 
pharmaceutical supply and regulatory systems are required, 
with adequate numbers of qualified pharmaceutical personnel.
5.9.3. Strategies
The findings of the 2009 Assessment of Pharmaceutical Human 
Resources led to the development o the Pharmaceutical 
Human Resources Strategic Framework with key stakeholders, 
which could be integrated into broader human resources for 
health strategies. The Ministry of Health and Social Welfare 
(MOHSW) has begun several initiatives to address the above 
challenges, which are summarized in this section.
Pharmaceutical human resources strategic 
framework
A draft Pharmaceutical Human Resources Strategic Framework 
2011–2020 was developed by key stakeholders in April 2010 
aimed at addressing the significant shortage of pharmaceutical 
human resources. Policy goals were identified to address human 
resources planning and development (Table 5.9.2).
Table 5.9.2. Human resources issues and policy goals
.................................................................................
HR Development                                           Policy goals
HR Management                                           Policy goals
HR Planning                                              Policy goals
1        Human   
          resources   
          planning
2        Job    
          descriptions
1.3 To strengthen partnerships between the Pharmaceutical 
Society of Tanzania (PST), Pharmacy Council (PC), 
Pharmaceutical Services Unit (PSU) and Human Resources 
for Health Department to coordinate pharmaceutical human 
resources planning
1.4 To formulate and implement a pharmaceutical human 
resources plan with stakeholders’ input
1.5 To review and revise the pharmaceutical human resources 
establishment in the public sector that reﬂects needs at 
different levels
1.6 To strengthen the PC register to ensure accurate and 
up-to-date human resources information of all 
pharmaceutical cadres
2.1 To develop clear job descriptions for each 
pharmaceutical cadre in the public sector
3        Recruitment  
          and retention
4        Training   
           institution   
           and academic  
           capacity
4.1 To establish new training programmes, particularly for 
pharmaceutical technicians and assistants
4.2 To build the teaching and physical capacity of existing 
training institutions (public and private)
4.3 To review academic staff recruitment criteria to allow 
recognition of professional performance, expertise, 
and experience
4.4 To develop training programmes for teachers in 
teaching methods
4.5 To revise incentive packages for academic members
4.6 To expand post-graduate (master’s, PhD) education 
programmes to build expertise for academia (teaching 
and research)
4.7 Increase output of graduates to reach a target of 950 
pharmacists, 1450 pharmaceutical technicians, and 1500-2600 
pharmaceutical assistants by 2015
4.8 Review competency requirements and curriculum of each 
cadre to optimize length of training without compromising 
quality
5        Continuing    
          professional 
          development    
          (CPD)
5.1 To develop and certify CPD programmes for all 
pharmaceutical cadres through a partnership among the PC, 
PST, and training institutions
3.1 To improve human resources management at 
district levels
3.2 To develop and establish retention schemes 
for underserved areas
3.3 To improve the physical working environment 
in underserved areas
3.4 To implement remote supervisory support systems 
for pharmaceutical services in the public sector
3.5 To revise and improve retirement beneﬁts
3.6 To review the salary structure of all pharmaceutical cadres
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Mobilizing resources to develop human 
resources for health
At a higher level, the country was successful in its application 
for support to the Global Fund to Fight AIDS, Tuberculosis and 
Malaria Round 9 for Health Systems Strengthening ($149 million 
USD over five years). For a phase one implementation that ends 
in 2013, funds of $82.9 million USD have been allocated to the 
country. Out of this, 36% is set to increase production of health 
workers and 21% to enhance health workforce recruitment 
and retention. Some pharmacists have been recruited 
through these funds.
Emergency hiring and hiring retired health 
workers
Various strategies are in place to improve the recruitment 
and retention of health workers in Tanzania, including an 
emergency hiring initiative supported by the Benjamin 
William Mkapa HIV/AIDS Foundation. However, so far only five 
pharmacists and four technicians (out of 364 tutors and health 
workers) have been recruited through this initiative since 2010, 
to work mostly in rural areas (personal communication).
Two-year renewable contracts are also being offered to retired 
health workers, including pharmacists, if they are willing to 
continue providing services in the public sectors. At the same 
time, local governments are also being encouraged to employ 
pharmaceutical staff where there are shortages in their Councils.
Scaling up education and training
Scaling up and quality improvement of pharmacy education 
and training are essential for addressing workforce shortages 
and for meeting basic health needs in the country. The number 
of training institutions providing pre-service education for 
pharmacists and pharmaceutical technicians has doubled over 
the last five years. The number of schools of pharmacy offering 
a BPharm degree programme has increased from two to four 
since 2010, one of which also offers post-graduate programmes. 
However, these are still inadequate to cater for the needs of 
the country, and the private sector is being encouraged to open 
more schools; operating schools are encouraged to address 
the challenges hindering the increase in enrolees.
The number of schools offering diploma programmes for 
pharmaceutical technicians has also increased, from two to 
five (Table 5.9.3). To ensure more pharmacy assistants and 
technicians are produced, the Pharmacy Council is currently in 
the process of introducing a cascading curriculum to provide 
a path for career growth, particularly for pharmacy assistants. 
This will be a modular curriculum, in which students planning 
to earn a diploma will have the option to exit the programme
early after completing several modules and receive a certifi-
cate instead. This certificate gives them recognition by the PC 
as dispensers, and they can continue their education later with 
higher modules until they complete the full diploma. This 
approach will allow Accredited Drug Dispensing Outlets (ADDO) 
dispensers with limited training to enrol and receive adequate 
training and recognition by the PC. With the cascading 
curriculum, they have a chance for career growth and increased 
opportunities to work not only in the private sector but also in 
the public sector. As per the Tanzania Food and Drug Agency, 
currently there are 10,445 ADDO dispensers in the country with 
3,873 ADDO outlets distributed throughout the country and 
mainly in rural areas (personal communication).
Table 5.9.3. Pharmacy schools, location, year of establishment, and 
qualification offered
1The diploma programmes started much earlier
2The enrolment capacity is 100 students per cadre but did not get enough 
students last year due to higher entrance requirements.
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Public
Faith-Based
Organisation
Faith-Based
Organisation
Faith-Based
Organisation
Faith-Based
Organisation
Private 
Private
BPharm (50) 
MPharm, PhD, 
and Diploma1
BPharm Degree (65)
 
BPharm (35) 
and Diploma1 (55)
Diploma (20) 
and Certiﬁcate (20)
Diploma (35) 
BPharm2, 
Diploma (3), 
and Certiﬁcate (7)
Certiﬁcate (50)
1974
2008
 
2011
2010
2010
2011
2010
Dar es salaam
Dodoma
 
Mwanza
Moshi
Iringa
Dar es salaam
Dar es salaam
Pharmacy 
school 
Type of 
Institution Town/City 
Year it 
started
Academic qualiﬁcation 
offered (no. of students 
per enrolment)
1
2
3
4
5
6
7
Muhimbili 
University 
of Health 
and Allied 
Services 
(MUHAS)
St John’s 
University 
of Tanzania 
(SJUT)
Bugando 
Catholic
University 
of Health 
and Allied 
Services 
(CUHAS)
Kilimanjaro 
School of
Pharmaceutical 
Sciences
Ruaha 
University 
College
(RUCO)
Kampala 
International
University 
(KIU)
Royal 
Pharmaceutical
Collage
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Needs-based education and training
Currently, there is a growing demand for clinically-oriented 
pharmacists who can work in a multidisciplinary health care 
team. At Muhimbili University of Health and Allied Services 
(MUHAS), this demand has been addressed through review of 
the BPharm curriculum, focusing more on patient care. 
However, capacity building of teaching staff to meet such 
transformations has remained a challenge. MUHAS, as a higher 
learning institution, is required to review its curricula 
regularly, usually every five years, previously undertaken 
in 2002. In addition, the government, through the Tanzania 
Commission for Universities (TCU), the regulatory authority for 
higher education, directed that all curricula in higher learning 
institutions be transformed from content-based to 
competencybased curricula to address the various needs of 
the country. Therefore, MUHAS embarked on a curriculum 
review in November 2008 through a partnership project, the 
Academic Learning Project, between MUHAS and the 
University of California San Francisco. The project, which was 
funded by the Bill and Melinda Gates Foundation, had several 
objectives. All MUHAS curricula, including the BPharm 
curriculum, were reviewed, and implementation of the new 
curricula began in October 2011.
The review process involved identification of competencies 
considered necessary for pharmacy graduates and analysis of 
the previous curriculum in order to identify any gaps and 
redundancies and make appropriate improvements. 
The process involved not only faculty and students, but also 
external stakeholders, such as professional regulatory 
authorities and associations, former pharmacy graduates, their 
employers, and their co-workers. Views from these stakeholders 
were obtained through surveys (tracer study) or their 
participation in curriculum review retreats, and eventually 
taken into account in the curriculum’s revision. 
The BPharm curriculum was revised, made competency-based, 
and modularized to make it easy for one to transfer credits 
when moving from one institution to another. In addition, the 
content was also revised,focusing more on patient care; more 
student time was allocated to clinical exposure. The revised 
curriculum was subjected to approval at the university level 
and by TCU. It is anticipated that other pharmacy schools in the 
country will also revise their curricula towards a competency-
based model and with greater focus on patient care.
Academic institutions are important centres for conducting 
needs assessments of pharmaceutical personnel in the country 
and in designing various continuing education programmes so 
as to build capacity of the pharmaceutical workforce and enable 
personnel to cope up with innovations in pharmacy. Currently, 
MUHAS is implementing a short course in good manufacturing 
practice and other aspects of industrial pharmacy to support 
regulatory functions and build capacity of local manufacturers.
5.9.4. Recommendations for pharmaceutical 
human resources development
The study on the pharmaceutical human resources was an eye 
opener to policy makers, donors, and other stakeholders, and it 
has galvanized some action. However more effort is needed if 
stakeholders want to see positive outcomes. Listed below are 
some of the recommendations made by stakeholders during 
the development of the strategic plan for pharmaceutical 
human resources in 2010, which are still relevant:
• Improved pharmacy workforce planning, training, and 
  education are needed in order to prepare an adequate and   
  competent pharmaceutical workforce in the country. 
  Al though the number of pharmacy schools in the country 
  has increased, efforts are still needed to attract investors 
  in the establishment of new pharmacy schools.
• In collaboration with the PC and other stakeholders, 
  pharmacy schools should be at the frontline in designing and   
  instituting well-structured continuing education programmes 
  so as to provide the support needed for pharmaceutical 
  personnel to cope with medicines development.
• Training institutions should find the means to address the 
  challenges of inadequate infrastructure, tutors, and funds to 
  enable them to increase the number of enrolees and output. 
  The implementation of these recommendations will definitely 
  bring change in the right direction in pharmaceutical 
  workforce development.
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Mobilizing resources to develop human 
resources for health
At a higher level, the country was successful in its application 
for support to the Global Fund to Fight AIDS, Tuberculosis and 
Malaria Round 9 for Health Systems Strengthening ($149 million 
USD over five years). For a phase one implementation that ends 
in 2013, funds of $82.9 million USD have been allocated to the 
country. Out of this, 36% is set to increase production of health 
workers and 21% to enhance health workforce recruitment 
and retention. Some pharmacists have been recruited 
through these funds.
Emergency hiring and hiring retired health 
workers
Various strategies are in place to improve the recruitment 
and retention of health workers in Tanzania, including an 
emergency hiring initiative supported by the Benjamin 
William Mkapa HIV/AIDS Foundation. However, so far only five 
pharmacists and four technicians (out of 364 tutors and health 
workers) have been recruited through this initiative since 2010, 
to work mostly in rural areas (personal communication).
Two-year renewable contracts are also being offered to retired 
health workers, including pharmacists, if they are willing to 
continue providing services in the public sectors. At the same 
time, local governments are also being encouraged to employ 
pharmaceutical staff where there are shortages in their Councils.
Scaling up education and training
Scaling up and quality improvement of pharmacy education 
and training are essential for addressing workforce shortages 
and for meeting basic health needs in the country. The number 
of training institutions providing pre-service education for 
pharmacists and pharmaceutical technicians has doubled over 
the last five years. The number of schools of pharmacy offering 
a BPharm degree programme has increased from two to four 
since 2010, one of which also offers post-graduate programmes. 
However, these are still inadequate to cater for the needs of 
the country, and the private sector is being encouraged to open 
more schools; operating schools are encouraged to address 
the challenges hindering the increase in enrolees.
The number of schools offering diploma programmes for 
pharmaceutical technicians has also increased, from two to 
five (Table 5.9.3). To ensure more pharmacy assistants and 
technicians are produced, the Pharmacy Council is currently in 
the process of introducing a cascading curriculum to provide 
a path for career growth, particularly for pharmacy assistants. 
This will be a modular curriculum, in which students planning 
to earn a diploma will have the option to exit the programme
early after completing several modules and receive a certifi-
cate instead. This certificate gives them recognition by the PC 
as dispensers, and they can continue their education later with 
higher modules until they complete the full diploma. This 
approach will allow Accredited Drug Dispensing Outlets (ADDO) 
dispensers with limited training to enrol and receive adequate 
training and recognition by the PC. With the cascading 
curriculum, they have a chance for career growth and increased 
opportunities to work not only in the private sector but also in 
the public sector. As per the Tanzania Food and Drug Agency, 
currently there are 10,445 ADDO dispensers in the country with 
3,873 ADDO outlets distributed throughout the country and 
mainly in rural areas (personal communication).
Table 5.9.3. Pharmacy schools, location, year of establishment, and 
qualification offered
1The diploma programmes started much earlier
2The enrolment capacity is 100 students per cadre but did not get enough 
students last year due to higher entrance requirements.
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Needs-based education and training
Currently, there is a growing demand for clinically-oriented 
pharmacists who can work in a multidisciplinary health care 
team. At Muhimbili University of Health and Allied Services 
(MUHAS), this demand has been addressed through review of 
the BPharm curriculum, focusing more on patient care. 
However, capacity building of teaching staff to meet such 
transformations has remained a challenge. MUHAS, as a higher 
learning institution, is required to review its curricula 
regularly, usually every five years, previously undertaken 
in 2002. In addition, the government, through the Tanzania 
Commission for Universities (TCU), the regulatory authority for 
higher education, directed that all curricula in higher learning 
institutions be transformed from content-based to 
competencybased curricula to address the various needs of 
the country. Therefore, MUHAS embarked on a curriculum 
review in November 2008 through a partnership project, the 
Academic Learning Project, between MUHAS and the 
University of California San Francisco. The project, which was 
funded by the Bill and Melinda Gates Foundation, had several 
objectives. All MUHAS curricula, including the BPharm 
curriculum, were reviewed, and implementation of the new 
curricula began in October 2011.
The review process involved identification of competencies 
considered necessary for pharmacy graduates and analysis of 
the previous curriculum in order to identify any gaps and 
redundancies and make appropriate improvements. 
The process involved not only faculty and students, but also 
external stakeholders, such as professional regulatory 
authorities and associations, former pharmacy graduates, their 
employers, and their co-workers. Views from these stakeholders 
were obtained through surveys (tracer study) or their 
participation in curriculum review retreats, and eventually 
taken into account in the curriculum’s revision. 
The BPharm curriculum was revised, made competency-based, 
and modularized to make it easy for one to transfer credits 
when moving from one institution to another. In addition, the 
content was also revised,focusing more on patient care; more 
student time was allocated to clinical exposure. The revised 
curriculum was subjected to approval at the university level 
and by TCU. It is anticipated that other pharmacy schools in the 
country will also revise their curricula towards a competency-
based model and with greater focus on patient care.
Academic institutions are important centres for conducting 
needs assessments of pharmaceutical personnel in the country 
and in designing various continuing education programmes so 
as to build capacity of the pharmaceutical workforce and enable 
personnel to cope up with innovations in pharmacy. Currently, 
MUHAS is implementing a short course in good manufacturing 
practice and other aspects of industrial pharmacy to support 
regulatory functions and build capacity of local manufacturers.
5.9.4. Recommendations for pharmaceutical 
human resources development
The study on the pharmaceutical human resources was an eye 
opener to policy makers, donors, and other stakeholders, and it 
has galvanized some action. However more effort is needed if 
stakeholders want to see positive outcomes. Listed below are 
some of the recommendations made by stakeholders during 
the development of the strategic plan for pharmaceutical 
human resources in 2010, which are still relevant:
• Improved pharmacy workforce planning, training, and 
  education are needed in order to prepare an adequate and   
  competent pharmaceutical workforce in the country. 
  Al though the number of pharmacy schools in the country 
  has increased, efforts are still needed to attract investors 
  in the establishment of new pharmacy schools.
• In collaboration with the PC and other stakeholders, 
  pharmacy schools should be at the frontline in designing and   
  instituting well-structured continuing education programmes 
  so as to provide the support needed for pharmaceutical 
  personnel to cope with medicines development.
• Training institutions should find the means to address the 
  challenges of inadequate infrastructure, tutors, and funds to 
  enable them to increase the number of enrolees and output. 
  The implementation of these recommendations will definitely 
  bring change in the right direction in pharmaceutical 
  workforce development.
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Summary
• Case studies in countries facing severe health care workforce   
   shortages - Ghana, Ethiopia, Malawi, Nigeria, Sudan and Tanzania    
   identified clear areas and needs for increased workforce 
   production and potential solutions to increase capacity.
• When relevant stakeholders are informed and brought 
   together to address workforce issues there are greater 
   possibilities for coordinated workforce planning and 
   implementation.
• Adequate investment in education is required, as education    
  provides the foundation for building a competent health 
  care workforce.
• The WHO guidelines on transforming and scaling up health 
   professional education and training include 17 recommendations  
   for strengthening the health care workforce focusing on the areas 
   of: governance and implementation; education and training 
   institutions; regulation and accreditation; financing; and 
   monitoring and evaluation.
• The WHO guidelines are highly relevant to the transformation 
  and scaling up pharmacy education.
6.1. Background
Strengthening the health care workforce
In response to the grave shortage of health workers, especially in 
57 countries, the World Health Organization (WHO) has adopted 
several recent resolutions for health systems strengthening [1].
These resolutions have been translated into action in the area 
of health professional education through the development 
of policy and technical guidelines designed to improve and 
transform the quantity, quality and relevance of health worker 
education and training. The production of the right types of 
health workers is fundamental to face the health challenges 
of the 21st century.
Pharmaceutical workforce capacity 
development
The attainment of national medicines policy objectives requires 
adequate finances and available, trained pharmaceutical 
personnel  with the necessary skill mix. However, in many 
sub-Saharan African countries there is a severe shortage of 
pharmaceutical human resources. This shortage continues in 
spite of growing workforce demands resulting from substantial 
donor investment in medicines for the three priority disease 
areas, HIV/AIDS, tuberculosis and malaria [2]. 
The shortage can be attributed to the neglect of pharmaceutical 
workforce capacity development by policymakers, donors, 
and international organizations [3].
Recognizing the importance of pharmaceutical human 
resources development, and in line with the World Health 
Organization (WHO) Medicines Strategy 2008–2013 to enhance 
human resources capacity to improve access to essential 
medicines of adequate quality [4], WHO’s Essential Medicines
Department supported a pilot programme in four countries 
in 2009. The programme sought to quantify the workforce 
providing pharmaceutical services in both the public and pri-
vate sectors in Ghana, Nigeria, Sudan, and the United Republic 
of Tanzania. Financial support was received from the European 
Union. Also, a set of tools was piloted to assess the availability, 
development, distribution, attrition and shortages 
of pharmaceutical human resources [5].
The results of the four country studies revealed that:
• Pharmaceutical human resources development was 
   identified as a challenge and not based on the specific 
   needs of the countries’ pharmaceutical services.
• The pharmaceutical course enrolment levels were low in all    
   four countries. For example, only one out of 10 applicants were 
   enrolled in Nigeria. The enrolment levels are 20% for BPharm 
   and 33% for MPharm in Tanzania, while in Ghana the enrolment   
   for BPharm is 13% (130 enrollees per 1000 applicants).
• Pharmaceutical workforce development in all four countries   
   is also hindered by issues with their pharmacy training facilities.  
   Inadequate infrastructure, lack of funding, insufficient teaching 
   staff, weak accreditation system, and substandard quality of the    
   education are amongst the main issues.
Based on the study results, each country developed a 
pharmaceutical human resources strategic framework to address 
these issues. All the stakeholders recognized that there are 
opportunities in each educational system that should be used 
to help overcome barriers and achieve policy goals for human 
resources development. For example, improving training facilities 
can be achieved by making optimal use of private sector 
contributions and funding from other sectors, including from 
governmental and nongovernmental organizations. In Nigeria, 
funding opportunities for research and infrastructure were 
identified from the federal government, and the National 
Universities Commission and the Raw Materials Development 
Council [6]. Funded, collaborative partnerships between local 
universities and universities overseas, such as that between the 
United Republic of Tanzania and United States of America, 
can be expanded and used as an opportunity to build teaching 
and infrastructure capacity to train pharmacists, pharmacy 
technicians, and assistants [7].
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Another weakness of the pharmacy education systems in the 
four countries is the under development of regular curriculum 
review in training institutions. The use of a competency-based
approach to education and curriculum development has been 
identified by the countries as a policy goal. The involvement 
of all stakeholders in recognizing the importance of needs-
based education is the necessary starting point for instigating 
improvements in the pharmacy curriculum. Educational
outcomes should be clear. This can be achieved by having a 
detailed indicative curriculum for accreditation of pharmacy 
courses that provides curriculum developers and evaluators 
with a checklist of the items that should appear in a 
curriculum [8]. To overcome the financial difficulties involved 
in adapting international models to national requirements [5], 
the tools already developed and used in some of the countries 
such as Sudan can be borrowed [9]. All the countries provide
academic training programmes to train teaching staff. 
The issue of academic staff shortages can be resolved 
by improving remuneration and defining a clear career 
structure for teacher practitioners [5].
An investment in the development of e-learning facilities 
and systems may bring a long-term solution to the problem 
of academic capacity. Internationally developed e-learning 
packages can provide access to international academic 
research databases. In some of the countries, like Nigeria, 
the National University Commission provides online access 
to e-books and journals [5]. Moreover, donor agencies are 
willing to invest in this area [5]. The willingness of donor 
agencies to fund the development of information and 
communication technology-compliant facilities should 
also be explored.
Pharmacists’ roles are evolving worldwide and pharmacy 
education systems should be flexible enough to respond to 
educational needs [7]. The pharmacy profession is moving from 
a purely dispensing role to a medication management role [10]. 
The education system must therefore have the flexibility 
necessary to respond to the evolving nature of the profession. 
In order to meet current and future needs, existing continuing 
professional development and post-graduate programmes 
should be developed to optimize pharmacists’ competencies 
[11]. The further specialization of the pharmacy profession 
requires the strengthening of pharmaceutical support staff, 
such as pharmacy technicians and assistants [12]. In Tanzania, 
the opportunities for correcting skill mix imbalances and for 
scaling up the annual output of pharmaceutical assistants 
include: large labour market demand for pharmaceutical cadres; 
the availability of university laboratories that are underused 
and that could offer evening programmes; the availability of 
facilities outside training institutions (halls, centres, etc.); 
and collaboration with nongovernmental organizations and the 
Ministry of Health and Social Welfare, to advertise to 
prospective students [6].
The results of the assessment of the pharmaceutical 
workforce in the four countries form the basis on which 
to transform and scale up pharmacy education in order 
to strengthen the workforce.
6.2. Increasing capacity for workforce 
production
It is important to keep in mind that the purpose of addressing 
workforce production is to improve population health. This 
requires fundamental reforms in multiple spheres, namely: 
modification and use of teaching methods that have proven 
most effective in adult education to be applied within 
education and training institutions; modification of curricula 
to focus on national/community needs; improving the 
competency of and increasing the number of faculty or using 
health service providers as adjunct faculty; and of course 
increasing the numbers of adequately-trained health 
professionals, while ensuring that they are equitably 
distributed among all geographical areas and health services, 
from primary to tertiary levels, to provide high quality care.
Our global challenge together is to educate and manage the 
largest expansion of health workers in history. This should be 
done on the basis of the best available evidence in capacity 
building to ensure models of best practice are replicated and 
adapted within country and regional contexts.
Expanding the number of health professionals must be part of 
a national health plan. This requires political commitment and 
leadership at the highest levels, as well as strong governance 
at the institutional level that views communities as partners 
in improving health outcomes. The guidelines on transforming 
and scaling up health professional education and training tackle 
these complex and interconnected issues in five different areas:
1- Governance and implementation;
2- Education and training institutions;
3- Regulation and accreditation;
4- Financing; and
5- Monitoring and evaluation.
There are some countries, which have made significant steps 
to scale up health professional education and/or address the 
quality of health worker training.
Malawi
In Malawi, an evaluation of the UK Department for 
International Development (DFID) funded programme has 
shown that the programme was successful in achieving its 
primary objective of “increasing the number of professional 
health workers in Ministry of Health and the Christian Health 
Association of Malawi (CHAM) institutions.” The evaluation 
reported that across the 11 priority cadres, the total number of 
professional health workers increased by 53%, from 5,453 
in 2004 to 8,369 in 2009. However, “only 4 of the 11 cadres 
met or exceeded their targets, as set out in the original EHRP 
design document.” The conclusion of the evaluation report 
further stated that “the investments made by the Government 
have resulted in tangible increases in access to health services
and lives saved for the people of Malawi.” [13]
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Summary
• Case studies in countries facing severe health care workforce   
   shortages - Ghana, Ethiopia, Malawi, Nigeria, Sudan and Tanzania    
   identified clear areas and needs for increased workforce 
   production and potential solutions to increase capacity.
• When relevant stakeholders are informed and brought 
   together to address workforce issues there are greater 
   possibilities for coordinated workforce planning and 
   implementation.
• Adequate investment in education is required, as education    
  provides the foundation for building a competent health 
  care workforce.
• The WHO guidelines on transforming and scaling up health 
   professional education and training include 17 recommendations  
   for strengthening the health care workforce focusing on the areas 
   of: governance and implementation; education and training 
   institutions; regulation and accreditation; financing; and 
   monitoring and evaluation.
• The WHO guidelines are highly relevant to the transformation 
  and scaling up pharmacy education.
6.1. Background
Strengthening the health care workforce
In response to the grave shortage of health workers, especially in 
57 countries, the World Health Organization (WHO) has adopted 
several recent resolutions for health systems strengthening [1].
These resolutions have been translated into action in the area 
of health professional education through the development 
of policy and technical guidelines designed to improve and 
transform the quantity, quality and relevance of health worker 
education and training. The production of the right types of 
health workers is fundamental to face the health challenges 
of the 21st century.
Pharmaceutical workforce capacity 
development
The attainment of national medicines policy objectives requires 
adequate finances and available, trained pharmaceutical 
personnel  with the necessary skill mix. However, in many 
sub-Saharan African countries there is a severe shortage of 
pharmaceutical human resources. This shortage continues in 
spite of growing workforce demands resulting from substantial 
donor investment in medicines for the three priority disease 
areas, HIV/AIDS, tuberculosis and malaria [2]. 
The shortage can be attributed to the neglect of pharmaceutical 
workforce capacity development by policymakers, donors, 
and international organizations [3].
Recognizing the importance of pharmaceutical human 
resources development, and in line with the World Health 
Organization (WHO) Medicines Strategy 2008–2013 to enhance 
human resources capacity to improve access to essential 
medicines of adequate quality [4], WHO’s Essential Medicines
Department supported a pilot programme in four countries 
in 2009. The programme sought to quantify the workforce 
providing pharmaceutical services in both the public and pri-
vate sectors in Ghana, Nigeria, Sudan, and the United Republic 
of Tanzania. Financial support was received from the European 
Union. Also, a set of tools was piloted to assess the availability, 
development, distribution, attrition and shortages 
of pharmaceutical human resources [5].
The results of the four country studies revealed that:
• Pharmaceutical human resources development was 
   identified as a challenge and not based on the specific 
   needs of the countries’ pharmaceutical services.
• The pharmaceutical course enrolment levels were low in all    
   four countries. For example, only one out of 10 applicants were 
   enrolled in Nigeria. The enrolment levels are 20% for BPharm 
   and 33% for MPharm in Tanzania, while in Ghana the enrolment   
   for BPharm is 13% (130 enrollees per 1000 applicants).
• Pharmaceutical workforce development in all four countries   
   is also hindered by issues with their pharmacy training facilities.  
   Inadequate infrastructure, lack of funding, insufficient teaching 
   staff, weak accreditation system, and substandard quality of the    
   education are amongst the main issues.
Based on the study results, each country developed a 
pharmaceutical human resources strategic framework to address 
these issues. All the stakeholders recognized that there are 
opportunities in each educational system that should be used 
to help overcome barriers and achieve policy goals for human 
resources development. For example, improving training facilities 
can be achieved by making optimal use of private sector 
contributions and funding from other sectors, including from 
governmental and nongovernmental organizations. In Nigeria, 
funding opportunities for research and infrastructure were 
identified from the federal government, and the National 
Universities Commission and the Raw Materials Development 
Council [6]. Funded, collaborative partnerships between local 
universities and universities overseas, such as that between the 
United Republic of Tanzania and United States of America, 
can be expanded and used as an opportunity to build teaching 
and infrastructure capacity to train pharmacists, pharmacy 
technicians, and assistants [7].
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Another weakness of the pharmacy education systems in the 
four countries is the under development of regular curriculum 
review in training institutions. The use of a competency-based
approach to education and curriculum development has been 
identified by the countries as a policy goal. The involvement 
of all stakeholders in recognizing the importance of needs-
based education is the necessary starting point for instigating 
improvements in the pharmacy curriculum. Educational
outcomes should be clear. This can be achieved by having a 
detailed indicative curriculum for accreditation of pharmacy 
courses that provides curriculum developers and evaluators 
with a checklist of the items that should appear in a 
curriculum [8]. To overcome the financial difficulties involved 
in adapting international models to national requirements [5], 
the tools already developed and used in some of the countries 
such as Sudan can be borrowed [9]. All the countries provide
academic training programmes to train teaching staff. 
The issue of academic staff shortages can be resolved 
by improving remuneration and defining a clear career 
structure for teacher practitioners [5].
An investment in the development of e-learning facilities 
and systems may bring a long-term solution to the problem 
of academic capacity. Internationally developed e-learning 
packages can provide access to international academic 
research databases. In some of the countries, like Nigeria, 
the National University Commission provides online access 
to e-books and journals [5]. Moreover, donor agencies are 
willing to invest in this area [5]. The willingness of donor 
agencies to fund the development of information and 
communication technology-compliant facilities should 
also be explored.
Pharmacists’ roles are evolving worldwide and pharmacy 
education systems should be flexible enough to respond to 
educational needs [7]. The pharmacy profession is moving from 
a purely dispensing role to a medication management role [10]. 
The education system must therefore have the flexibility 
necessary to respond to the evolving nature of the profession. 
In order to meet current and future needs, existing continuing 
professional development and post-graduate programmes 
should be developed to optimize pharmacists’ competencies 
[11]. The further specialization of the pharmacy profession 
requires the strengthening of pharmaceutical support staff, 
such as pharmacy technicians and assistants [12]. In Tanzania, 
the opportunities for correcting skill mix imbalances and for 
scaling up the annual output of pharmaceutical assistants 
include: large labour market demand for pharmaceutical cadres; 
the availability of university laboratories that are underused 
and that could offer evening programmes; the availability of 
facilities outside training institutions (halls, centres, etc.); 
and collaboration with nongovernmental organizations and the 
Ministry of Health and Social Welfare, to advertise to 
prospective students [6].
The results of the assessment of the pharmaceutical 
workforce in the four countries form the basis on which 
to transform and scale up pharmacy education in order 
to strengthen the workforce.
6.2. Increasing capacity for workforce 
production
It is important to keep in mind that the purpose of addressing 
workforce production is to improve population health. This 
requires fundamental reforms in multiple spheres, namely: 
modification and use of teaching methods that have proven 
most effective in adult education to be applied within 
education and training institutions; modification of curricula 
to focus on national/community needs; improving the 
competency of and increasing the number of faculty or using 
health service providers as adjunct faculty; and of course 
increasing the numbers of adequately-trained health 
professionals, while ensuring that they are equitably 
distributed among all geographical areas and health services, 
from primary to tertiary levels, to provide high quality care.
Our global challenge together is to educate and manage the 
largest expansion of health workers in history. This should be 
done on the basis of the best available evidence in capacity 
building to ensure models of best practice are replicated and 
adapted within country and regional contexts.
Expanding the number of health professionals must be part of 
a national health plan. This requires political commitment and 
leadership at the highest levels, as well as strong governance 
at the institutional level that views communities as partners 
in improving health outcomes. The guidelines on transforming 
and scaling up health professional education and training tackle 
these complex and interconnected issues in five different areas:
1- Governance and implementation;
2- Education and training institutions;
3- Regulation and accreditation;
4- Financing; and
5- Monitoring and evaluation.
There are some countries, which have made significant steps 
to scale up health professional education and/or address the 
quality of health worker training.
Malawi
In Malawi, an evaluation of the UK Department for 
International Development (DFID) funded programme has 
shown that the programme was successful in achieving its 
primary objective of “increasing the number of professional 
health workers in Ministry of Health and the Christian Health 
Association of Malawi (CHAM) institutions.” The evaluation 
reported that across the 11 priority cadres, the total number of 
professional health workers increased by 53%, from 5,453 
in 2004 to 8,369 in 2009. However, “only 4 of the 11 cadres 
met or exceeded their targets, as set out in the original EHRP 
design document.” The conclusion of the evaluation report 
further stated that “the investments made by the Government 
have resulted in tangible increases in access to health services
and lives saved for the people of Malawi.” [13]
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In terms of the pharmacy workforce, the country previously 
relied on foreign training until establishing the first pharmacy 
course and graduating the first cohort of local pharmacists in 
2009. There is also currently one technician training institution, 
which aims to train over 50 technicians a year.
Ethiopia
In Ethiopia there was a decision made by the government to 
adopt a “flooding” policy of producing a significant number 
of health workers, including not only health professionals but 
also health extension workers.
There is a big shortage of health workers at every level 
throughout the country, but this is particularly the case in 
rural areas. Information from the Human Resources for Health 
(HRH) observatory shows that 84% of the population resides in 
rural areas while the remaining 12 million (16 %) live in urban 
areas, making Ethiopia one of the least urbanized countries 
in the world [14]. Rural areas, therefore, are where the toll of a 
host of communicable and non-communicable diseases
is most acutely felt. The government, therefore, decided to 
focus its efforts on areas where they can save the most lives. 
In fulfillment of this effort, the government has trained and 
placed teams of specialized health officers, midwives, and 
anesthesia professionals aimed at reducing maternal 
mortality at each of the nation’s 800 primary hospitals. 
A other programme will add several thousand new doctors 
to address the country’s shortage of physicians.
The country’s HRH Plan [14] has taken into account the skill 
mix of health workers based on needs and determinants. 
“This model is considered appropriate as it takes into 
consideration the health service location, the staffing level, 
population growth and economic growth as the bases for 
estimating health workforce requirements (and projecting
them for the future). The projections for the health workforce 
requirements of Ethiopia by the year 2020 are based on the 
assumption of universal primary health service coverage, and 
hence a three-fold increase in the production of HRH by 2020. 
It is expected that this plan will increase the health workforce 
density level from 0.8 to 1.8 per 1000 population.” However, this 
is not to say that Ethiopia will not face a lack of adequate 
workforce since the level reported in the HRH Observatory data 
is 0.84 health workers per 1000 population which is below the 
standard set by WHO of 2.3 health workers per 1000 population 
(based on the numbers of doctors, nurses, and midwives).
In terms of pharmacy workforce production, the number 
of providers, especially in the private sector, has expanded 
greatly in the past 10 years with currently over 18 pharmacy 
schools graduating almost 1900 students in 2011 and 26 
technician training programs graduating 6000 technicians in 
2011. The government strategic plan outlines a projected need 
of 2200 pharmacists and 10,000 pharmacy technicians by 2020.
6.3. Recommendations for scaling up 
workforce production
A total of 17 recommendations are being made in the WHO 
guidelines on transforming and scaling up health professional 
education and training that can be subsumed under the 
5 domains listed above. Among the 17 recommendations, all 
governments are recommended to adopt five. Under the areas 
of governance and implementation, they cover:
1- Political commitment and leadership for health professional 
     education and training into the human resources for health    
     plan of the country/state/province in keeping with 
     administrative/legislative responsibilities.
2- Alignment of the education plan with HRH and health 
     systems national plans.
3- Formal collaboration and shared accountability between 
     the Ministry of Health and the Ministry of Education as well 
     as other relevant ministries and/or the civil service 
     commission in the country.
4- Alignment of information on HRH training and education   
     with HRH information systems.
5- Ensuring platforms/mechanisms to support the 
     implementation of the reform and scale-up plan, for  
     instance the creation or strengthening of national or 
     sub-national institutions, capacities or mechanisms 
     (e.g. legislation, policies, procedures).
Other recommendations that are included under the 
remaining four domains include:
- Either instituting and/or strengthening the regulation 
  of health professional education to ensure quality and  
  relevance and ensuring accreditation of institutions 
  and programmes.
- Strengthening and updating faculty as well as recruiting   
  health professionals as adjunct faculty where feasible 
  and acceptable.
- Ensuring continuing professional development for both   
  health professionals and faculty, in the case of the latter,   
  through policy that makes it mandatory.
- Curriculum development for relevance to community needs.
- Streamlining educational pathways, or ladder programmes, 
  for the advancement of practicing health professionals, 
  in both undergraduate and postgraduate programmes.
- Improving interprofessional education for collaboration 
  and better patient care.
- Introducing technologies (simulation, technology, 
  eLearning) that enhance and support patient care, diversify   
  health care capability, link facilities, and increase the 
  accessibility of trained health workers to information 
  and material to keep practice relevant.
- Human resources for health information systems that allow   
  for better planning of skill mix and deployment, but are also   
  indicators of the adequacy of health professionals.
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- Retention of health workers in rural and remote areas where 
  there are usually hard-to-reach and underserved populations.
- Adequate investment in health professional education both 
  at the international and domestic level (addressing funding 
  and addressing economic constraints) and instituting 
  mechanisms that make education and training more accessible 
  to those wishing to pursue a career as a health professional.
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relied on foreign training until establishing the first pharmacy 
course and graduating the first cohort of local pharmacists in 
2009. There is also currently one technician training institution, 
which aims to train over 50 technicians a year.
Ethiopia
In Ethiopia there was a decision made by the government to 
adopt a “flooding” policy of producing a significant number 
of health workers, including not only health professionals but 
also health extension workers.
There is a big shortage of health workers at every level 
throughout the country, but this is particularly the case in 
rural areas. Information from the Human Resources for Health 
(HRH) observatory shows that 84% of the population resides in 
rural areas while the remaining 12 million (16 %) live in urban 
areas, making Ethiopia one of the least urbanized countries 
in the world [14]. Rural areas, therefore, are where the toll of a 
host of communicable and non-communicable diseases
is most acutely felt. The government, therefore, decided to 
focus its efforts on areas where they can save the most lives. 
In fulfillment of this effort, the government has trained and 
placed teams of specialized health officers, midwives, and 
anesthesia professionals aimed at reducing maternal 
mortality at each of the nation’s 800 primary hospitals. 
A other programme will add several thousand new doctors 
to address the country’s shortage of physicians.
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“This model is considered appropriate as it takes into 
consideration the health service location, the staffing level, 
population growth and economic growth as the bases for 
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2011. The government strategic plan outlines a projected need 
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     as other relevant ministries and/or the civil service 
     commission in the country.
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     with HRH information systems.
5- Ensuring platforms/mechanisms to support the 
     implementation of the reform and scale-up plan, for  
     instance the creation or strengthening of national or 
     sub-national institutions, capacities or mechanisms 
     (e.g. legislation, policies, procedures).
Other recommendations that are included under the 
remaining four domains include:
- Either instituting and/or strengthening the regulation 
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  relevance and ensuring accreditation of institutions 
  and programmes.
- Strengthening and updating faculty as well as recruiting   
  health professionals as adjunct faculty where feasible 
  and acceptable.
- Ensuring continuing professional development for both   
  health professionals and faculty, in the case of the latter,   
  through policy that makes it mandatory.
- Curriculum development for relevance to community needs.
- Streamlining educational pathways, or ladder programmes, 
  for the advancement of practicing health professionals, 
  in both undergraduate and postgraduate programmes.
- Improving interprofessional education for collaboration 
  and better patient care.
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  eLearning) that enhance and support patient care, diversify   
  health care capability, link facilities, and increase the 
  accessibility of trained health workers to information 
  and material to keep practice relevant.
- Human resources for health information systems that allow   
  for better planning of skill mix and deployment, but are also   
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- Retention of health workers in rural and remote areas where 
  there are usually hard-to-reach and underserved populations.
- Adequate investment in health professional education both 
  at the international and domestic level (addressing funding 
  and addressing economic constraints) and instituting 
  mechanisms that make education and training more accessible 
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As governments, health care systems, and communities strive 
to provide quality, effective and safe health care to their 
populations, resource constraints will continue to raise the 
question of how to best use available resources; equally 
important is how to better use future health resources. In a 
global context of repeated “calls to action” from international 
bodies, it is clear that a strong focus will remain on the 
provision of adequate and capable human resources for 
health. For the global pharmacy workforce, this is a time when 
opportunities are opening up for the profession to innovate, 
add value to health care systems, and improve health through 
ensuring the responsible use of medicines.
The 2012 FIP Global Pharmacy Workforce Report presents 
the current pharmacy workforce situation in 90 countries and 
territories around the world, representing nearly four million 
pharmaceutical human resources for health. Analyses in this 
report reveal a pharmacy workforce distribution and 
composition with wide variance across (and within) countries 
and territories. Meanwhile, Africa remains the region with the 
most intense pharmacy workforce crisis, having the least 
capacity to provide appropriately supervised pharmaceutical 
services for their populations. Pharmaceutical human 
resources capacity building is a priority in several African 
countries and strategies from three of these countries (Ghana, 
South Africa and Tanzania) are presented in depth in this report. 
Collaboration at every level ensures that well-coordinated 
pharmaceutical human resource planning takes place and that 
strategic plans are successfully resourced and implemented.
The nine case studies in this report provide examples of the chal-
lenges, strategies, and outcomes achieved in the area of 
pharmacy workforce planning, management, and 
development in varying settings from low to high-income and 
small to large populations. Overall, these case studies identify 
similar challenges, including: significant workforce shortages and 
distribuition imbalances, lack of integrated workforce planning, 
the need for transforming pre-service education and continuing 
professional education, ensuring appropriate skills mix and clear 
role definition as well as the challenge of assessing professional 
and clinical roles/performance. However, the approaches taken 
to tackle these challenges differ and important lessons can be 
learned from each separate case study. In reviewing each 
separate country’s needs and strategies, the importance of 
having a needs-based approach to the provision of quality 
pharmaceutical services and pharmacy education is reinforced.
Needs-based professional pharmacy education is the 
foundation for the development of a competent and capable 
pharmaceutical workforce. This report highlights the status 
of pharmacy education with data from 90 countries, 
including over 3800 educational institutions that educate 
and train pharmacists and the pharmacy support workforce. 
These institutions must be socially accountable to and play a 
key role in delivering a pharmacy workforce that is 
capable and adaptable to local needs.
The key themes identified throughout the case reports are 
concerned with leadership, partnership and collaboration. 
There is a strong sense of the importance of empowering 
pharmacists to be leaders in health care and their communities, 
and to be innovators in order to best face the challenges ahead in 
improving health. Multi-stakeholder collaboration is identified as 
an additional important factor for progressing and improving the 
pharmaceutical human resources in every country FIP strongly 
endorses workforce solutions that are based on collaborative 
best practice and the formation of strong national (and regional) 
partnerships; FIP Education Initiatives is committed to the 
principles of sharing best practice.
FIP has collaborated closely with WHO in pharmacy education 
and the pharmacy workforce, and as such, it is important for FIP 
to be actively involved in the development and dissemination of 
the newly adopted WHO Guidelines on Transforming and Scaling 
up Health Professions Education (see Part 6). These guidelines 
present evidence-based information and guidance that is rel-
evant to consider, adapt, and apply in every country context. 
It is equally important to realise that we are at the initial stages 
of mapping the international workforce and associated 
influences. From this perspective, we are only just beginning 
to recognise the enormity of the task facing workforce 
developers and professional leadership bodies; this will be 
a sustained global effort.
FIP is committed to fostering a greater understanding of the 
global pharmacy workforce and invites all actors not just to read 
this report but to actively participate and share experiences and 
strategies in addressing pharmacy workforce challenges through 
the global FIPEd platform and communities of practice.
Reports such as this, and the previous 2009 Global Pharmacy 
Workforce Report, have set out to recognise the major challenges 
facing both the profession and global healthcare systems. 
The quality, scope and capability of the workforce are dependent 
on the nature of initial and life long professional development 
curricula, and the quality of available practitioner support and 
recognition structures. It is crucial that professional leadership 
bodies, and their stakeholder partners, consider and act to ensure 
that the talents developed at the educational level impact the 
access to, and quality of, medication use. The 2020 Vision and 
mission adopted by FIP, recognises this important linkage
between lifelong professional education and innovation, 
and driving health care improvement.
.................................................................................
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As governments, health care systems, and communities strive 
to provide quality, effective and safe health care to their 
populations, resource constraints will continue to raise the 
question of how to best use available resources; equally 
important is how to better use future health resources. In a 
global context of repeated “calls to action” from international 
bodies, it is clear that a strong focus will remain on the 
provision of adequate and capable human resources for 
health. For the global pharmacy workforce, this is a time when 
opportunities are opening up for the profession to innovate, 
add value to health care systems, and improve health through 
ensuring the responsible use of medicines.
The 2012 FIP Global Pharmacy Workforce Report presents 
the current pharmacy workforce situation in 90 countries and 
territories around the world, representing nearly four million 
pharmaceutical human resources for health. Analyses in this 
report reveal a pharmacy workforce distribution and 
composition with wide variance across (and within) countries 
and territories. Meanwhile, Africa remains the region with the 
most intense pharmacy workforce crisis, having the least 
capacity to provide appropriately supervised pharmaceutical 
services for their populations. Pharmaceutical human 
resources capacity building is a priority in several African 
countries and strategies from three of these countries (Ghana, 
South Africa and Tanzania) are presented in depth in this report. 
Collaboration at every level ensures that well-coordinated 
pharmaceutical human resource planning takes place and that 
strategic plans are successfully resourced and implemented.
The nine case studies in this report provide examples of the chal-
lenges, strategies, and outcomes achieved in the area of 
pharmacy workforce planning, management, and 
development in varying settings from low to high-income and 
small to large populations. Overall, these case studies identify 
similar challenges, including: significant workforce shortages and 
distribuition imbalances, lack of integrated workforce planning, 
the need for transforming pre-service education and continuing 
professional education, ensuring appropriate skills mix and clear 
role definition as well as the challenge of assessing professional 
and clinical roles/performance. However, the approaches taken 
to tackle these challenges differ and important lessons can be 
learned from each separate case study. In reviewing each 
separate country’s needs and strategies, the importance of 
having a needs-based approach to the provision of quality 
pharmaceutical services and pharmacy education is reinforced.
Needs-based professional pharmacy education is the 
foundation for the development of a competent and capable 
pharmaceutical workforce. This report highlights the status 
of pharmacy education with data from 90 countries, 
including over 3800 educational institutions that educate 
and train pharmacists and the pharmacy support workforce. 
These institutions must be socially accountable to and play a 
key role in delivering a pharmacy workforce that is 
capable and adaptable to local needs.
The key themes identified throughout the case reports are 
concerned with leadership, partnership and collaboration. 
There is a strong sense of the importance of empowering 
pharmacists to be leaders in health care and their communities, 
and to be innovators in order to best face the challenges ahead in 
improving health. Multi-stakeholder collaboration is identified as 
an additional important factor for progressing and improving the 
pharmaceutical human resources in every country FIP strongly 
endorses workforce solutions that are based on collaborative 
best practice and the formation of strong national (and regional) 
partnerships; FIP Education Initiatives is committed to the 
principles of sharing best practice.
FIP has collaborated closely with WHO in pharmacy education 
and the pharmacy workforce, and as such, it is important for FIP 
to be actively involved in the development and dissemination of 
the newly adopted WHO Guidelines on Transforming and Scaling 
up Health Professions Education (see Part 6). These guidelines 
present evidence-based information and guidance that is rel-
evant to consider, adapt, and apply in every country context. 
It is equally important to realise that we are at the initial stages 
of mapping the international workforce and associated 
influences. From this perspective, we are only just beginning 
to recognise the enormity of the task facing workforce 
developers and professional leadership bodies; this will be 
a sustained global effort.
FIP is committed to fostering a greater understanding of the 
global pharmacy workforce and invites all actors not just to read 
this report but to actively participate and share experiences and 
strategies in addressing pharmacy workforce challenges through 
the global FIPEd platform and communities of practice.
Reports such as this, and the previous 2009 Global Pharmacy 
Workforce Report, have set out to recognise the major challenges 
facing both the profession and global healthcare systems. 
The quality, scope and capability of the workforce are dependent 
on the nature of initial and life long professional development 
curricula, and the quality of available practitioner support and 
recognition structures. It is crucial that professional leadership 
bodies, and their stakeholder partners, consider and act to ensure 
that the talents developed at the educational level impact the 
access to, and quality of, medication use. The 2020 Vision and 
mission adopted by FIP, recognises this important linkage
between lifelong professional education and innovation, 
and driving health care improvement.
.................................................................................
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Tanzania – Mildred Kinyawa, Pharmacy Council, Ministry of Health and Social 
Welfare.
Thailand – Kamonsak Reungjarearnrung, Bumrungrad Hospital; Wongwiwat
Tassaneeyakul, Faculty of Pharmaceutical Sciences, Khon Kaen University.
Togo – Sakariyaou Alaniyin, Ordre National des Pharmaciens du Togo.
Tonga (Kingdom of) – Megan Arnold, AYAD/Tongan Ministry of Health; Melenaite
Mahe, Ministry of Health.
Turkey – Harun Kizilay, Turkish Pharmacists’ Association.
Tuvalu – Natano Elisala, Ministry of Health.
Uganda – Richard Adome, Makerere University.
Ukraine – Olga Grintsova, National University of Pharmacy.
Uruguay – Carlos Lacava, Asociación de Química y Farmacia del Uruguay (AQFU:
Uruguayan Association of Chemistry and Pharmacy).
USA – Tina Brock, School of Pharmacy, University of California, San Francisco; 
Lucinda Maine, American Association of Colleges of Pharmacy; Christine Malati, US 
Agency for International Development; Douglas Scheckelhoff, American Society of 
Health� System Pharmacists; Tana Wuliji, URC.
Vanuatu – Amanda Sanburg, Ministry of Health.
Vietnam – Nguyen Xuan Hung, Vietnam Pharmaceutical Association.
Zambia – Lungwani Tyson Muungo, University of Zambia, School of Medicine.
Zimbabwe – Charles Maponga, University of Zimbabwe, College of Health Sciences, 
School of Pharmacy; Iaac Magaya, Pharmacists Council of Zimbabwe. 
FIP – Luc Besançon, Xuan Hao Chan, Ton Hoek, Gonçalo Sousa Pinto, FIP Ofﬁce; 
Henri Manasse, Jennifer Marriott, Ross McKinnon, FIP Education Initiatives 
Steering Committee.
FIP Collaborating Centre – Dalia Almaghaslah, Naoko Arakawa, Ian Bates, Andreia 
Bruno, Denys Gibbons, Soﬁa Nordenmalm, School of Pharmacy, University College 
London. 
WHO – Gilles Forte, Helen Tata, Erica Wheeler, Mario Dal Poz.
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